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 Abstract 
For millions of people, damaged cartilage is a major source of pain and 
disability. As those people often discover upon seeking medical treatment, once 
damaged, cartilage is very difficult to repair. Finding better clinical therapies for 
damaged cartilage has generated a huge amount of research interest, and has led 
to the studies detailed in this thesis. This work was broadly motivated by the 
aim of advancing our understanding of cartilage tissue engineering – that is, the 
creation of new cartilage from a combination of biomaterials, cells and growth 
factors.  
Biomaterials are a key part of cartilage tissue engineering therapies. Historically 
the main purpose of using biomaterials in these therapies was to provide 
structural support for cells while the damaged tissue regenerated. More recently, 
it has been recognised that the composition and properties of the biomaterial 
influence the cell responses and quality of the newly formed tissue. This has led 
to the development of biomaterials for the specific application of cartilage tissue 
engineering. 
In this thesis, the focus was on hydrogel biomaterials derived from natural 
polymers. The polymers, including gelatin, hyaluronic acid (HA) and 
chondroitin sulfate (CS), were chemically modified to become gelatin 
methacrylamide (Gel-MA), hyaluronic acid methacrylate (HA-MA) and 
chondroitin sulfate methacrylate (CS-MA) respectively, allowing them to be 
crosslinked by UV light in the presence of living cells. Using these materials, 
we investigated in vitro the viability of the encapsulated cells, the cell 
phenotype, and the quantity, composition and mechanical properties of the 
extracellular matrix they produced.  
Compared to encapsulation in other widely used hydrogels such as alginate, 
chondrocytes produced substantially more cartilage matrix when encapsulated 
in Gel-MA, and the matrix was much stiffer than that in other materials. 
However, chondrocyte redifferentiation in Gel-MA was poor. Characterisation 
of cell-free Gel-MA hydrogels showed that the compressive modulus properties 
can be controlled over a wide range – approximately 5 to 180 kPa – and that by 
increasing the viscosity of Gel-MA by supplementing it with hyaluronic acid, 
Gel-MA structures with defined a architecture and porosity could be printed.  
To address the poor redifferentiation in Gel-MA, biomimetic constructs 
containing HA-MA and/or CS-MA were evaluated. By including a small 
quantity of HA-MA in Gel-MA hydrogels (9.5% Gel-MA and 0.5% HA-MA), 
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 chondrocytes redifferentiated to their normal phenotype to a greater extent, with 
more rounded cell morphologies and chondrogenic gene expression patterns. 
Collagen type II and aggrecan were distributed throughout the gels more evenly 
in the presence of HA-MA. Crucially for cartilage, the developed mechanical 
properties of constructs with HA-MA were greatly improved compared to Gel-
MA controls.  
The effect of HA-MA on the developed mechanical properties of tissue-
engineered cartilage constructs was further investigated using a range of HA-
MA concentrations. The developed mechanical properties were highly 
dependent on HA-MA concentration, with higher HA-MA concentrations 
leading to stiffer constructs. In addition to stiffness, the failure strength was 
increased in gels with HA-MA. Collagen type X deposition, which is an 
unwanted but commonly produced protein in cartilage repair tissue, was 
observed in all gels. This reinforces the existing evidence that shows that 
prolonged growth factor exposure combined with the reactive oxygen species 
that are generated during crosslinking may induce chondrocyte hypertrophy.  
Gel-MA hydrogels were modified with processed cartilage, tissue or tendon 
tissue extracts (all equine origin). The tissues were digested with pepsin and 
modified with photocrosslinkable groups to allow the extracts to form stable 
hydrogels or be incorporated into Gel-MA hydrogels. Mesenchymal stromal 
cells (MSCs) responded more favourably to the tissue extracts than 
chondrocytes. Chondrocytes showed increased catabolic processes in the 
presence of tissue extracts, which is consistent with other research using 
collagen fragments.  
In summary, hydrogels formed from mixtures of Gel-MA and HA-MA showed 
significant promise as materials for tissue engineering models, and would be 
interesting materials to investigate in in vivo settings.  
Keywords: Tissue engineering, cartilage, hydrogels, hyaluronic acid, gelatin 
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Chapter 1 
1.1  Biomaterials and tissue engineering  
Several thousand years ago, skilled craftsmen used gold to stabilise loose teeth, 
crown damaged ones and even replace lost teeth altogether [1]. This was, most 
likely, the beginning of biomaterial technology. Following these pioneering 
exploits in dentistry, the course of biomaterial development was slow for many 
centuries. Though doctors continued to experiment with metallic materials as 
prostheses for many other body parts [2], a lack of understanding of the need for 
sanitation, along with a lack of means for sanitation, hampered success rates [3].  
The invention of polymeric materials in the 20th century, along with other 
advances in healthcare, paved the way for the modern era of biomaterials. 
Initially these were off-the-shelf materials taken from other industries, but the 
1960s saw a shift towards the large scale use of materials designed specifically 
for medical purposes [3]. Decades of systematic and widespread research in 
biomaterials followed, and it is now a market worth approximately $US44 
billion per year, and growing at 15% annually [4].  
Up until approximately the 1980s, biomaterials were first envisioned to replace 
or augment damaged tissues, while the original tissue was sacrificed and 
discarded. Although these transfers were often initially successful, most 
materials tended to degrade in the body, and the material often did not last the 
life of the patient. Concurrently, whole tissue and organ transplantations were 
increasingly used for the treatment of critical patients, although success was 
(and continues to be) constrained by the need for prolonged immunosuppressant 
medication and a demand for transplanted organs that far outstrips supply. The 
contribution of both biomaterials and organ transplants to modern medicine 
healthcare should not be understated, but the limitations of both fields led to 
ongoing research and innovations in pursuit of improved technologies. The last 
decades of the 20th century saw the emergence of a new paradigm in medicine: 
tissue engineering [5]. The concept was novel yet fundamentally simple: rather 
than replace a damaged tissue with an inert, non-viable material, or healthy 
tissue from a donor, why not use a combination of biomaterials, cells and 
biological signalling factors to facilitate the regeneration of the new, healthy 
tissue? 
The terms tissue engineering and regenerative medicine are frequently used 
interchangeably to encompass the research and clinical efforts to repair or 
regenerate damaged or diseased tissues. In this thesis, the term tissue 
engineering will generally be adopted. Tissue engineering is an interdisciplinary 
field that lies at the intersection of materials science and engineering, biology, 
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chemistry and medicine. The scope for tissue engineering is driven by the 
shortcomings of clinical medicine, while chemistry and materials science 
provide the tools to manufacture the materials, and biology provides both the 
specific requirements for material design and the potential to engineer biological 
systems. It is a field with the capacity to address many of the challenges in 
medicine and attempts have been made to engineer many different tissues, 
including bone, cartilage, skin, liver, kidney, heart, retina, pancreas, and many 
others. In large part, however, the field has yet to really prove itself, and 
currently there are relatively few cases of long term, successful clinical 
application. 
Two decades ago, Langer and Vacanti published a landmark paper outlining the 
concepts and potential of tissue engineering [5]. From this and other studies, 
three generic components have been identified as the foundations of tissue 
engineering therapies: biomaterials, cells and signalling factors [5]. As one of 
the core components, biomaterials have received a great deal of attention in 
tissue engineering research, and much of the progress of tissue engineering is 
attributable to the development of biomaterials. 
The term biocompatibility describes the interaction or suitability of a 
biomaterial in a specific biological system. Many definitions exist, but given the 
broad nature of the field, the generic definition proposed by Williams is perhaps 
most apt: “The ability of a material to perform with an appropriate host response 
in a specific application” [6]. Critically, this definition does not simply imply 
non-toxicity or non-immunogenicity, but also allows for specific responses and 
cell-material interactions, should such responses be appropriate or desirable in 
the given application. 
1.2  Cartilage 
Articular cartilage is a soft, frequently damaged tissue and unlike many tissues, 
almost completely lacks the capacity to heal itself once it is damaged. These 
properties have made it an important target for tissue engineering. There are 
currently no completely effective clinical solutions to cartilage repair, and for 
this reason the pursuit of an appropriate biomaterial for regeneration of cartilage 
is a primary aim of many research groups worldwide, as well as the subject of 
this thesis.  
Articular cartilage is a hyaline tissue that covers the ends of long bones in 
mammalian, diarthodial joints. It cushions impacts, distributes loads and 
provides a near frictionless surface for articulation. The extracellular matrix 
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(ECM) has three major components: a collagen network, proteoglycans and 
fluid [7]. The bulk composition of cartilage is approximately 70-80% water and 
20-30% matrix by weight. Structurally, cartilage is a relatively simple tissue that 
lacks nerves, blood vessels, and lymphatic vessels. The tissue contains only one 
cell type, the chondrocyte, at a remarkably low density; in human cartilage, 
chondrocytes account for only 1-5% of the total volume [8, 9]. Chondrocytes 
are a terminally differentiated, specialised cell type whose primary function is to 
produce and maintain the ECM [10, 11].  
1.3  Cartilage composition 
Collagen is the major component of the solid phase of articular cartilage, 
accounting for approximately 60% of the matrix dry weight [7]. Collagen type II 
is by far the most abundant, accounting for 90-95% of the total collagen content 
[12]. Collagen types VI, IX, X, XI, XII and XIV are embedded in the network in 
smaller quantities, although the functions of each type are not yet fully 
understood [13]. Of these, types II, IX and XI are unique to cartilage [14].  
Hyaluronic acid (HA) is a polysaccharide of particular biological importance. It 
belongs to a class of compounds known as glycosaminoglycans (GAG), but 
notable distinctions between HA and other GAGs exist. In vertebrates, 
glycosaminoglycans typically contain large numbers of sulfate and carboxyl 
groups, and therefore contain a high level of negative charge at physiological 
pH [15]. Uniquely, HA is an unsulfated GAG, composed of repeating 
disaccharide units of N-acetyl-D-glucosamine and D-glucuronic acid [16]. In 
contrast to other GAGs, which are synthesised in the rough endoplasmic 
reticulum and processed in the golgi apparatus for incorporation into 
proteoglycans, HA is produced in the plasma membrane, and contains no amino 
acid sequences in its final structure [17, 18]. HA forms extensive linear chains, 
with a molecular mass in the range 103 – 104 kDa, corresponding to 2000 – 
25,000 repeat units and a length of 2 – 25 μm [18].  
HA is ubiquitous in the extracellular matrices of higher animals, and appears in 
particularly high concentrations in soft connective tissues [16]. Despite its 
simple structure, it has many functions in cartilage and other tissues. HA is 
implicated in embryonic development, wound healing, immune responses, 
inflammation and cancer development [18, 19]. In cartilage, chondrocytes can 
directly detect and bind to HA via various receptor domains expressed on the 
cell surface, such as CD44 and the receptor for hyaluronic acid mediated 
motility (RHAMM) [20]. In addition, HA forms strong associations with 
collagen type VI [21, 22], and is a key component of the large proteoglycan 
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aggregates that contribute to the compressive strength of cartilage. It is also 
involved in the regulation of several growth factors [23], and there are likely 
many functions yet to be discovered.  
Proteoglycans are the second most abundant organic component of articular 
cartilage, accounting for 30% of the matrix dry weight [7]. Proteoglycans are 
molecules in which a large number of GAG chains are covalently linked to a 
core protein [15]. The compressive strength of cartilage is provided primarily by 
the large aggregating proteoglycan called aggrecan [14]. The core protein has a 
mass of approximately 230 kDa, and is organised into three globular domains, 
G1-G3 [14]. Located between the G2-G3 domains are sites for attachment of the 
GAGs chondroitin sulfate (CS) and keratan sulfate (KS). Up to 130 CS and KS 
chains may be covalently bonded to the core protein, resulting in a molecule 
with a molecular mass of up to 2.2 MDa [24]. Up to 100 of these proteoglycans 
are further bound to hyaluronic acid, creating a superaggregate with a molecular 
mass in the region of 200 million Daltons, of which greater than 90% is 
carbohydrate [7, 15]. Link protein (molecular weight 41 – 48 kDa) stabilises the 
non-covalent interaction between the individual aggrecan molecules and HA 
[25] (Figure 1.1B). 
The high level of fixed negative charge in aggrecan contributes to the 
biomechanical properties of cartilage in a number of ways. Adjacent charged 
groups are sufficiently close (approximately 1 – 1.5 nm apart) to allow 
electrostatic interactions and the resulting repulsive forces contribute 
significantly to swelling of the matrix [24]. In addition, the level of fixed charge 
mediates a high level of hydration, and results in a high concentration of cations 
(primarily sodium) in the fluid phase. The elevated cation concentration relative 
to the surrounding synovial fluid yields a Donnan osmotic pressure, causing a 
swelling pressure in the order of several atmospheres [26]. Finally, aggrecan, 
particularly through CS, bestows cartilage with a low hydraulic permeability, 
which limits the loss of fluid under compression and aids in compression 
resistance [27, 28].  
1.4  Zonal organisation 
The composition and structure of cartilage is organised according to depth, and 
this depth variation has been studied for over half a century [29]. The tissue is 
typically considered in four distinct zones, classified as the superficial, middle, 
deep and calcified zones with increasing depth from the articular surface [29, 
30]. The biochemical and biomechanical properties of cartilage, along with 
chondrocyte phenotype, vary significantly between zones (Figure 1.1). While 
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the structures in the superficial, intermediate and deep zones are distinct, there is 
a gradual transition between adjacent zones, with no clear boundaries [31]. 
The superficial zone accounts for 10 – 20% of the total thickness nearest the 
articular surface. The collagen network is aligned parallel to the articular surface 
(Figure 1A), and collagen content is highest in the superficial zone (85% dry 
weight). The proteoglycan content is lowest (15% dry weight), which results in 
this zone having the highest tensile strength and lowest compressive modulus 
[32]. The low compressive modulus permits substantial deformation of the 
tissue during loading [33]. Single chondrocytes are dispersed throughout the 
matrix, and secrete proteoglycan 4 (PRG4) which acts as a lubricant to reduce 
friction at the joint surface [8].  
Superficial zone 
The network orientation of the superficial zone provides a high tensile strength, 
which serves to maintain the fluid pressure of the deeper zones, and is often 
described as analogous to the wall of a pressure vessel [31]. The tensile strength 
of the network in this outer region opposes the swelling tendency of the deeper 
regions, thus preventing overexpansion of the tissue, and maintaining a positive 
fluid pressure in the lower zones.  
 
Middle/intermediate zone 
In the middle/intermediate zone (30-50% of total thickness) the collagen matrix 
is randomly oriented, and appears as a tangled mesh. The proteoglycan content 
is approximately 25% dry weight, resulting in a higher compressive modulus 
than the superficial zone [32]. Upon loading, the compressive strain aligns the 
fibres parallel to the surface. Chondrocytes in this zone are oval in shape, and 
are commonly found as singles or in pairs [34]. 
Deep zone 
The collagen network of the deep zone (30-50% of total thickness) is oriented 
perpendicularly to the calcified cartilage and underlying subchondral bone, and 
the proteoglycan level is greatest in this zone, resulting in a compressive 
modulus an order of magnitude greater than the superficial zone [33]. When 
loaded, the high charge density prevents significant compression of the tissue by 
retention of water, and when unloaded, the aligned collagen matrix provides the 
tensile strength required to prevent excessive expansion [35]. Chondrocytes in 
the deep zone are arranged in columns of cells which are aligned parallel to the 
collagen network [36]. 
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Calcified zone 
The calcified layer is very thin, (~100 μm), and its function is to provide a 
strong interface for attachment of cartilage to the subchondral bone beneath 
[30]. Collagen fibrils from the deep zone penetrate and are firmly embedded in 
the calcified zone [7]. The chondrocytes produce collagen type X, which serves 
to calcify the matrix.  
1.5  Matrix organisation around chondrocytes 
On a smaller scale, the ECM of cartilage is organised around chondrocytes into 
defined structures. With increasing distance from chondrocytes, the matrix is 
classified as pericellular, territorial or interterritorial [37] (Figure 1.1C). The 
interterritorial matrix is continuous, and provides the bulk of the mechanical 
properties. The exact function of the pericellular matrix is unclear, but it has 
been implicated in the protection of chondrocytes from mechanical stresses, 
while allowing transduction of mechanical stimuli and molecular signalling [12, 
38]. In addition, the presence of the four defining components of basement 
membranes – laminin, collagen IV, nidogen and perlecan – provides some 
indication that the pericellular matrix may be the functional equivalent of a 
basement membrane [39].  
 
 
Figure 1.1: Matrix structures in articular cartilage. (A) Schematic representation 
of the zonal structure of articular cartilage (adapted from [40]); (B) the major 
components of articular cartilage (adapted from [12]), and (C) an electron micrograph 
showing the ultrastructure of matrix surrounding a deep zone chondrocyte (from 
[41]). In (C), the tissue surrounding the chondrocyte (labelled C) is organised into the 
pericellular matrix (Pg), pericellular capsule (Pc), territorial matrix (Tm) and 
interterritorial matrix (Im).  
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1.6  Cartilage: a challenge for tissue engineering  
Unfortunately, cartilage is susceptible to damage through trauma, such as sports 
injuries or motor vehicle accidents, and disease, the most prevalent of which is 
osteoarthritis (OA) [42]. Damaged cartilage has very little capacity for self 
repair, an attribute that has been exhaustively noted in the cartilage literature, 
most notably by William Hunter, a Scottish physician who made broad 
contributions to the understanding of human anatomy and physiology (Figure 
1.2) [43].  
 
Figure 1.2: Excerpt from William Hunter’s 1743 article On the structure and 
diseases of articulating cartilage [44].  
Cartilage damage is classified as either partial thickness if it is entirely 
contained within the cartilage volume, or full-thickness if it extends into the 
subchondral bone. Partial thickness injuries display effectively no healing 
response, making medical interventions particularly important. Whereas in full-
thickness defects, blood from the bone marrow can enter the damaged cartilage, 
and some, albeit imperfect, healing response is observed [45]. The repair tissue 
that forms in full-thickness defects is akin to the scar tissue that commonly 
replaces damaged skin; it is highly fibrous, and like scars of the skin, displays 
little resemblance to the composition, structure and function of the original 
tissue. The fibrous cartilage that fills full-thickness defects does not have the 
mechanical strength or low-friction properties of hyaline cartilage, and at best 
offers only temporary relief from symptoms. Regenerating cartilage with the 
same composition, structure and functional of the original tissue has proven far 
more difficult than first envisioned [46-48]. 
Despite the limitations, the repair mechanism of full-thickness defects forms the 
basis for some of the most widely used treatments for cartilage injuries. The 
current gold standard and first line treatment for small, isolated chondral defects 
is microfracture [49]. This procedure involves debridement of the defect to 
remove loose or damaged cartilage along with the calcified layer, followed by 
perforating the subchondral bone with an awl to allow blood flow and induce 
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the healing response observed in full thickness defects. Microfracture is a 
simple, fast and low-cost procedure, and is routinely used for treatment for 
small defects (<2.5 cm2) [49]. As expected, short terms outcomes are generally 
good, however the longer-term prognosis is poor. For larger defects, 
osteochondral plugs can be harvested from the less weight bearing regions of 
the same joint or from donor tissue and used to fill the defect. While the results 
are generally good, the lack of donor tissue, and the additional damage caused 
by harvesting the plugs are significant limitations [49].  
Cartilage tissue engineering therapies aim to address the limitations of 
microfracture and osteochondral transfers. The earliest iteration, autologous 
chondrocyte implantation (ACI), was introduced by Brittberg et al. in 1994 
(Figure 1.3) [50]. The original conception of ACI required patients to undergo 
two surgeries, and has consequently now been classified as a two-stage 
procedure. During the first operation the defect is tidied by removing loose and 
damaged cartilage, and a small section of healthy cartilage is harvested from a 
non-weight bearing region. The chondrocytes are enzymatically released from 
the healthy cartilage and expanded in vitro for several weeks, with an 
approximately ~10 fold increase in the total number of cells. During the second 
surgery the expanded chondrocytes are injected as a slurry into the defect and 
covered with a periosteal flap or collagen membrane, with the hypothesis that 
the injected cells will remain viable, and over time synthesise new, healthy 
cartilage to replace the tissue that has been lost or damaged.  
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Figure 1.3: Schematic representation of autologous chondrocyte implantation. 
Healthy, non-weight bearing cartilage is harvested, the chondrocytes are isolated 
and expanded in vitro, then injected into the original defect (from [50]).  
The primary shortcoming of ACI is that the repair tissue is more similar to 
fibrocartilage than the original hyaline cartilage. Chondrocytes lose their 
distinctive phenotype during in vitro expansion, with a shift from producing 
collagen type II, which is the major component of hyaline cartilage, to collagen 
type I, which is the major component of fibrocartilage. It is likely that the 
synthesis of fibrocartilage is a result of the inability to adequate reverse the 
dedifferentiation process and to restore the original chondrocyte phenotype. 
It is now two decades since the original ACI procedure was first used in 
humans, and cartilage tissue engineering has evolved into a number of diverse 
therapies that owe their origins in some way to this original concept [51]. The 
use of biomaterials has been a common evolution of the original ACI procedure, 
and a vast variety of materials have been evaluated for this purpose. 
Biomaterials can be used to deliver cells to the defect, thus providing a 
framework for holding cells in place and acting as a temporary support structure 
for filling the defect until the new cartilage has been synthesised. In addition, 
more recently, a goal of research efforts has been to develop materials that 
promote both restoration of the original chondrocyte phenotype and production 
of new, hyaline tissue. This can be achieved by incorporating bioactive 
signalling molecules creating materials that mimic hyaline cartilage.  
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General introduction & aims 
Throughout this thesis, in vitro hydrogel models have been used to assess 
hydrogels materials for their suitability for cartilage tissue engineering, and in 
particular, the cell differentiation state, along with quantity and quality of matrix 
production  
1.7  Hypotheses 
The central hypothesis of this thesis was that gelatin-based hydrogels can be 
developed for cartilage tissue engineering using in vitro models. We 
hypothesised that by functionalising gelatin with photocrosslinkable domains, 
hydrogels with a broad range of mechanical properties could be fabricated, and 
that the thermosensitivity of gelatin could be exploited to print hydrogel 
structures. We also hypothesised that through the incorporation of GAGs and 
tissue-derived supplements, the hydrogels would create a biomimetic 
environment for enhanced chondrogenic (re)differentiation and ECM formation. 
To allow gelatin hydrogels to be photocrosslinked, we produced gelatin-
methacrylamide using a process originally described by Van den Bulcke et al. 
[52].  
1.8  Aims 
There were four main aims to address these hypotheses: 
i. To evaluate Gel-MA hydrogels in parallel with other widely used 
hydrogels for cartilage tissue engineering; 
ii. To characterise the mechanical properties of Gel-MA hydrogels, 
and evaluate the printability of Gel-MA based hydrogels; 
iii. To incorporate GAGs into Gel-MA hydrogels to enhance 
chondrogenic differentiation, and optimise the composition of the 
hydrogels; and 
iv. To test whether chondrogenesis and matrix formation can be 
enhanced by incorporating extracts from three collagen-based 
tissues: cartilage, meniscus, and tendon. 
1.9  Thesis overview 
Significant research efforts have been directed towards developing hydrogels for 
cartilage regeneration. This literature is reviewed in Chapter 2, with a particular 
focus on photocrosslinkable hydrogels and functionalisation strategies that 
enhance chondrogenesis and matrix formation. 
Chapters 3 to 7 contain the experimental contributions that address the aims and 
hypotheses. This begins with a direct comparison of four photocrosslinkable 
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hydrogels in Chapter 3. This comparison highlighted the potential utility of 
Gel-MA hydrogels, which form the focus of the subsequent chapters. In 
Chapter 4, Gel-MA hydrogels are evaluated more closely, including 
characterisation of the swelling and mechanical properties of hydrogels 
crosslinked under different conditions and formed from different concentrations 
of Gel-MA. Possibilities for printing Gel-MA constructs are also investigated. 
In Chapter 5 we assess the effect of incorporating photocrosslinkable HA 
and/or CS into Gel-MA hydrogels on chondrogenesis and matrix formation. In 
Chapter 6 we investigate in further detail how HA concentration influences the 
development of mechanical properties during culture. In Chapter 7 we have 
developed a process for functionalising tissue derived matrices with 
photocrosslinkable domains. Using chondrocytes and mesenchymal stromal 
cells (MSCs), we investigate if the addition of photocrosslinkable tissue 
matrices derived from three equine tissues, cartilage, meniscus or tendon, can 
enhance matrix production or chondrogenesis. The findings of this thesis are 
discussed in Chapter 8, along with potential avenues for future work. 
Following Chapter 8 the major findings are summarised in English and Dutch.  
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Abstract 
Hydrogels share many properties with cartilage, and chondrocytes were shown 
to respond favourably to encapsulation in hydrogels over 20 years ago. Early 
hydrogel studies typically used physically crosslinked, naturally derived 
hydrogels, such as agarose and alginate. Since the year 2000, the development 
of new hydrogel systems has been an active area of research, with many broad 
goals, such as the synthesis of new materials, increased mechanical strength, 
and reduced cell-toxicity. Of particular significance has been the emergence of 
photocrosslinkable hydrogels, which are covalently crosslinked by exposure to 
light. These materials can be produced from synthetic or naturally derived 
hydrogels, or a combination of both, and provide a versatile platform for further 
functionalisation and modification. Accordingly, a major avenue of cartilage 
research has been identifying bioactive molecules, such as peptides, proteins, 
polysaccharides, proteoglycans and growth factors that enhance chondrogenesis 
and matrix synthesis. Some photocrosslinkable hydrogels are now making early 
inroads into commercial translation to therapies for clinical cartilage repair. 
Recently, new photocrosslinkable chemical groups with improved kinetics and 
potentially reduced adverse cell effects have also been developed, along with 
new photoinitiators that allow the use of visible light to achieve crosslinking, 
overcoming the need to use potentially harmful ultraviolet light. 
Photocrosslinkable hydrogels offer many advantages over other materials, and 
their use in both cartilage tissue engineering research and clinical application are 
expected to grow in the future. 
Keywords: Hydrogels; photopolymerisation; cartilage; tissue engineering.  
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2.1   Introduction 
Biomaterials, cells and signalling factors form the three key components of 
tissue engineering. The study of biomaterials is a diverse field, ranging from 
metallic and ceramic materials used in bone applications, to pastes and gels used 
for soft tissue repair. For cartilage regeneration, hydrogels are a key subset of 
biomaterials being investigated and developed, since they share many properties 
with healthy cartilage. They are formed from crosslinked networks of water-
swollen polymers, and typically contain 80-99% water by mass. The high water 
content allows for diffusion of metabolites through the network, allowing cells 
to survive when encapsulated in the hydrogel. Following the early finding that 
dedifferentiated chondrocytes regain aspects of their original phenotype when 
encapsulated in agarose hydrogels [53], much effort has been directed at 
developing hydrogels that are specifically targeted for cartilage tissue 
engineering [54].  
One of the fundamental benefits of hydrogels for cartilage repair is that through 
in situ crosslinking of a cell suspension in solution of a precursor polymer, the 
cells can be encapsulated in a genuinely three-dimensional environment that 
promotes a rounded morphology. The commonly used alternative, seeding cells 
onto a preformed scaffold or matrix, also provides a three-dimensional 
environment on a larger scale, but if the pore sizes are large enough to allow 
cells to penetrate into the scaffold, then they are also large enough to allow cells 
within the scaffold to spread significantly. 
The objective of this literature review is to summarise the advances in 
photocrosslinkable hydrogel materials intended for cartilage tissue engineering, 
including functionalisation of hydrogels with bioactive motifs to improve the 
quantiy and quality for newly formed cartilage tissue.  
2.2   Mechanics of photocrosslinking 
There are two main requirements for a polymer solution to become covalently 
crosslinked when exposed to light. The first is a photoinitiator that produces 
radicals upon light exposure, and the second is that the polymer must contain 
reactive groups that undergo a crosslinking reaction in the presence of the 
photogenerated radical.  
Since the year 2000, cell encapsulation within photocrosslinkable hydrogels has 
been explored as a potential means for chondrocyte delivery [55]. Early studies 
focused primarily on PEG and PVA hydrogels, and crosslinking was almost 
exclusively achieved via photoinitiated radical polymerisation of polymers 
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functionalised with (meth)acrylate groups. These early studies showed that 
chondrocytes tolerated the photocrosslinking process, and were well suited for 
encapsulation within these bioinert hydrogels [55].  
2.2.1   Photoreactive chemical species 
The majority of polymers used in photocrosslinkable hydrogels systems are 
functionalised with acrylate or methacrylate groups. Polymers containing 
primary or secondary hydroxyl groups can be easily be modified to include 
acrylate or methacrylate groups using reactive derivatives of acrylic acid or 
methacrylic acid, respectively. Similarly, these reagents react with primary 
amines to form acrylamide and methacrylamide, which, due to resonance 
stabilisation, are less reactive than the corresponding (meth)acrylate groups. 
This simple and versatile chemical process has been used to functionalise a 
large number of synthetic and natural polymers with photocrosslinkable 
domains [56].  
Acrylate and methacrylate remain among the most widely chemical groups in 
photocrosslinked hydrogels, but more recently other systems with different 
crosslinking rates, mechanisms and conditions have been developed. These 
include the orthogonal systems, in which two different chemical groups are 
covalently bound during polymerisation. Usually, one of these groups is a thiol 
(S-H). The photogenerated radicals remove or abstract hydrogen from the thiol, 
leaving a reactive thiyl radical on the polymer chain. Thiyl radicals react readily 
with unsaturated groups containing double or triple bonds, termed thiol-ene and 
thiol-yne reactions, respectively. In addition, thiyl groups can react with acrylate 
and methacrylate, allowing different combinations of polymers to be 
incorporated into the hydrogel. There are several potential advantages of thiol-
systems compared to (meth)acrylate systems, and these are discussed in Chapter 
8.  
2.2.2 Photoinitiators and safety 
UV crosslinked biomaterials have been used in dentistry since the early 1970s, 
making dentistry an ideal field to review for insights into the safety of UV 
photopolymerisation. Polymer-based materials were developed to restore 
damaged or drilled teeth. These were applied as a viscous paste, shaped as 
required, then cured to form a solid upon exposure to light. Initially, light with a 
wavelength of approximately 365 nm was used and crosslinking was initiated 
using benzoin methyl ether [57]. The uptake of these systems was fast and 
widespread, but within a few years, concerns were raised regarding potential 
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biological damage to the oral mucosa of the patient and eyes of the physician 
[58]. This resulted in a rapid transition to visible light (400 – 550 nm) initiation, 
using the initiator camphorquinone together with amine accelerators [57]. 
Subsequently, potential risks to retinal damage from the lower regions of the 
visible spectra were identified [59], and if desired, physicians could use filters to 
remove wavelengths under 500 nm. This system has now proven itself over a 
long period, with visible light polymerisation using camphorquinone being a 
mainstay of dentistry for over 20 years.  
As previoiusly mentioned, photocrosslinking requires the presence of a 
photoinitiator. Photoinitiators can be classified as radical or cationic depending 
on their mechanism of action. Generally speaking, cationic initiators are 
incompatible with aqueous systems, so in situ polymerisation necessitates the 
use of radical initiators. When light is absorbed by a radical photoinitator, the 
molecule undergoes photolysis, forming two radicals. When they come into 
contact with unsaturated vinyl groups or other reactive moieties, these radicals 
initiate polymerisation and thus crosslinking occurs.  
Different photoinitiators are active at different wavelengths, and they are 
broadly grouped depending on whether they are active in the UV or visible 
region of the electromagnetic spectrum. The ultraviolet spectrum is further 
divided into three bands according to wavelength: UVA (320 – 400 nm), UVB 
(280 – 320 nm) and UVC (<280 nm) [60]. Solar radiation contains all of UVA, 
UVB and UVC, however not all of the UV radiation reaches the earth. UVC is 
almost completely absorbed by strathospheric oxygen, resulting in the 
production of ozone (O3), which in turn can absorb and filter UVB [61]. 
Consequently, UVA accounts for approximately 95% of the solar UV radiation 
falling on the Earth’s surface, with the majority of the remainder being UVB. 
UVA penetrates further into human skin than the shorter-wavelength UVB light, 
but importantly, has a lower energy. UVB has sufficient energy to cause direct 
DNA damage and mutations, and is the major cause of light-induced mutagenic 
DNA modifications [62], which effectively excludes UVB light from any 
photoinitiation systems involving cells. In comparison, DNA absorbs light only 
minimally in the UVA and visible regions; so direct damage to DNA upon UVA 
exposure is very limited [60]. Nevertheless, DNA damage through indirect 
mechanisms, such as reactive oxygen species (ROS), is still possible, and 
therefore safety concerns of UVA radiation cannot and should not be dismissed 
[61].  
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In addition to the potentially deleterious effects of UV radiation, there are a 
limited number of photoinitators that have acceptable toxicity for use in direct 
contact with cells. In order for a photoinitiator to be suitable, it must be water 
soluble, non-toxic (or minimally toxic) and active under either visible or UVA 
light. In addition, the photogenerated radicals must have an acceptable toxicity 
profile. The vast majority of photoinitiators have been developed for the 
chemical industry and are not soluble in water, which leaves a relatively small 
pool that may be suitable for hydrogel crosslinking.  
An early study on the biocompatibility of different photoinitiators compared 
five photoinitiation systems [63] which were either active under visible or UVA 
light. Of the five, Irgacure 2959 was demonstrated to have a considerably better 
cytotoxity profile than the others [63], and these findings led to the near 
universal and exclusive use of Irgacure 2959 for cell encapsulation in 
photocrosslinkable hydrogels [63]. Irgacure 2959 has an absorption peak at 
approximately 280 nm (Figure 8.4, in Chapter 8), but since this wavelength is in 
the UVB region, it is incompatible for with cells. As a compromise, the 
initiating light is often restricted to a safer wavelength of approximately 360-
365 nm, with a substantial drop in the molar extinction coefficient, and thus 
efficiency of the photoinitiating system [64]. Complete safety of this initiator 
has not yet been shown, and further studies, including long term in vivo studies, 
are required to obtain a clearer picture of the safety and risks of cell 
encapsulation with UVA light.  
Although photocrosslinking has a long history in dentistry, fundamental 
differences exist between using light to crosslink cell-free biomaterials 
compared to directly exposing cells to light during photocrosslinking. In 
addition, significant differences have been found between exposing cells in 
monolayer cultures to photointiated radicals compared to cells in hydrogels 
during crosslinking [65]. In a study using MSCs, UV exposure and Irgacure 
2959 had adverse effects on monolayer cultures, including reduced viability, 
reduced proliferation and reduced differentiation potential. During 
encapsulation, however, these negative effects were almost completely 
eliminated [65]. It was suggested that in monolayer cultures, in the absence of 
other reactive chemical species, the majority of the radicals formed react with 
cells. In contrast, during encapsulation, the radicals initiate crosslinking 
reactions, and are therefore less likely cause cell damage. This is a plausible 
explanation for the difference between the culture systems, but still suggests that 
optimising Irgacure concentration, UV exposure time and UV intensity are 
necessary for minimising cell harm. If radicals continue to be produced once 
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crosslinking is complete then presumably they would be likely to cause cell 
damage. Overall, the risks need to be evaluated for each hydrogel system and 
the process parameters need to be selected such that risks are minimised, at least 
to an acceptable level for clinical use. Further details and recent advances in 
photoinitiators are given in Chapter 8. 
2.2.3 Versatility  
One advantage that photocrosslinkable hydrogels have over other widely used 
systems, such as alginate or agarose, is that crosslinking can be triggered on 
demand. This gives a high level of spatial and temporal control over 
crosslinking. For example, spatial patterning can be achieved by placing a 
micro-fabricated template or stencil between the hydrogel and the light source. 
This has many possible applications, and as an example, surfaces can be 
selectively coated with different hydrogels, as shown in Figure 2.1 [66]. 
Photocrosslinkable hydrogels can potentially be used for injectable cell or drug 
delivery, and crosslinked by shining light through the skin [67].  
In addition, photocrosslinking is not heavily dependent on the size of the 
hydrogel, and the extent of crosslinking is typically relatively even throughout 
the hydrogel. In comparison, alginate hydrogels are crosslinked by diffusion of 
calcium ions into the gel, so the total time required for crosslinking rate is 
strongly dependent on hydrogel size, and the rate of crosslinking varies as 
crosslinking occurs, since calcium diffusion is slowed as crosslinking proceeds.  
 
Figure 2.1: Gel-MA micro-patterned onto a PEG substrate. Cells adhere strongly 
to regions coated with Gel-MA, but not surfaces coated with PEG. Scalebar 
represents 200 μm; Figure from [66]. 
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2.3   Hydrogels for cartilage tissue engineering 
The similarities between hydrogels and cartilage make hydrogels a natural 
choice for use in cartilage tissue engineering. Both are predominantly water by 
weight, and both maintain a swollen state by attracting water to the hydrophilic 
chemical groups. Hydrogels can be broadly categorised and naturally derived or 
synthetic, with each class having its own benefits and disadvantages. 
Depending on the materials, crosslinking mechanisms and functional groups, 
hydrogels can have a wide variety of properties. As expected, different 
properties are beneficial in different applications and the development of 
hydrogels that are inductive for cartilage repair is a key goal of many research 
groups and institutes. Several cartilage repair products that use 
photocrosslinkable hydrogel systems have progressed to human clinical trials, 
some of which use ‘off-the-shelf’ hydrogels such as fibrin, and others use 
hydrogels specifically developed for cartilage applications. Although it is too 
early to definitively evaluate the success of these products, some of the results 
have been promising. Further details are given in Chapter 8.  
2.3.1   Naturally derived hydrogels 
Many materials naturally form hydrogels, and these materials formed the basis 
for early hydrogel research. Common examples include alginate, agarose, gellan 
gum. One of the key challenges of handling chondrocytes is that they rapidly 
lose their characteristic phenotype when placed on two-dimensional surfaces, a 
process called dedifferentiation. A landmark study in 1982 identified that when 
dedifferentiated chondrocytes were encapsulated within agarose hydrogels the 
cells could regain aspects of their differentiated phenotype [53].  
Most natural hydrogels are non-covalently crosslinked, either through ionic or 
temperature dependent crosslinking. Some polymers, such as gellan gum, can be 
both ionically and/or thermally crosslinked. One disadvantage of ionic and 
temperature dependent crosslinking is that is it reversible: removing the 
crosslinking ions or reversing the temperature change will remove the 
crosslinks. To capitalise on the advantages of photocrosslinking, many natural 
materials have been modified with photocrosslinkable domains, allowing 
relatively robust, covalently crosslinked hydrogels to be synthesised. The most 
notable of these include alginate [56, 68], gelatin [52], hyaluronic acid (HA) 
[56, 69], chitosan [70], dextran [71], and gellan gum [72], along with mixtures 
of these.  
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HA is an important component of cartilage, and has been widely studied for 
cartilage repair. HA can be used in its natural, unmodified state [73, 74], or 
chemically modified to allow scaffolds [75] or hydrogels to be fabricated [69]. 
The synthesis of photocrosslinked hyaluronic acid methacrylate (HA-MA) 
hydrogels was first described in 2000 [56], along with an analogous method for 
producing alginate methacrylate (AL-MA). Several years later, chondrocytes 
were encapsulated in HA-MA and using an osteochondral defect model, were 
shown to be superior to empty defects [76]. In a later study, passage 0 and 1 
auricular chondrocytes encapsulated in HA-MA showed similar levels of 
neocartilage formation in a subcutaneous model [77], indicating that these cells 
could potentially tolerate a degree of monolayer expansion. HA-MA hydrogels 
provide a conducive environment for chondrogenic differentiation of 
mesenchymal [78] and embryonic stem cells [79], along with synthesis and 
retention of new cartilage matrix. Although differentiation is predominantly 
driven by potent soluble factors, such as transforming growth factor β (TGF-β), 
HA-MA hydrogels are nevertheless promising materials for cartilage repair.  
Alginate has a long history of use in cartilage tissue engineering research and 
has come to be regarded as a benchmark or gold standard for chondrocyte 
redifferentiation [80]. AL-MA has been investigated for nucleus pulpous tissue 
engineering [68], but little work has been done to evaluate AL-MA for 
engineering articular cartilage. 
Gelatin is a polymer of amino acids that is produced by hydrolysis of animal 
connective tissues. It has a long history of use in foodstuffs, and has more 
recently its potential for use as a biomaterial has been explored. The synthesis 
and properties of photocrosslinkable gelatin-methacrylamide (Gel-MA, also 
referred to as methacryloyl substituted gelatin, or occasionally as gelatin-
methacrylate) were first described in detail in 2000 [52]. In this original 
publication, no mention was made of the possibility to encapsulate cells within 
the gel. It was not until 10 years later that cell encapsulated was reported and 
this has sparked a rapid rise in the interest of Gel-MA hydrogels for various 
tissue engineering applications [66]. The use of Gel-MA hydrogels in cartilage 
tissue engineering research remains quite limited, and this application is the 
major focus of this thesis.  
2.3.2  Synthetic hydrogels 
Synthetic hydrogels are a different proposition to naturally derived hydrogels. 
Synthetic hydrogels can be designed and synthesised at a molecular level – 
allowing a huge degree of control over molecular weight, polymer structure, and 
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functionaltities. In addition, whereas natural polymers show a degree of batch-
to-batch variation and carry a small risk of disease or microbial transmission, 
synthetic polymers can theoretically be produced without these drawbacks.  
Polyethylene glycol (PEG) is by far the most common synthetic polymer used to 
produce hydrogels for cartilage tissue engineering. It can be synthesised in a 
wide range of molecular weights, with a number of different functional groups, 
and as either linear or branched polymers. One of the advantages of synthetic 
hydrogels is the opportunity to tailor the physical and biochemical properties. In 
particular, modern technology allows synthetic peptides that perform biological 
functions to be incorporated into hydrogels, thus synthetic hydrogel systems can 
act as a platform for producing tailored hydrogels with specific biological 
functionalities.  
2.3.3 Physical properties   
Appropriate physical properties are not only important for overall structure and 
stability, but also for cell-material interactions and ECM production. In load 
bearing applications, physical properties are often a limitation for hydrogels, 
which are, by their nature, generally soft and watery materials [81].  
There are a number of commonly measured physical properites for hydrogels, 
such as Young’s modulus, dynamic modulus, equilibrium modulus, fracture 
strength and fracture energy, each of which represents a slightly different aspect 
of the gel properties. The stiffness of a hydrogel is a measure of the force 
required to compress (or stretch) the hydrogel by a certain amount. The Young’s 
modulus is the most common measure of stiffness, and can be measured by 
stretching or compressing the gel. When measured under compression, the 
Young’s modulus is commonly referred to as the compressive modulus. It is 
measured by compressing the gel at a slow, constant rate and measuring the 
force exerted by the gel. It is a measure of both the compression of the solid 
phase of the gel and the resistance to fluid flow (which depends on the rate at 
which the gel is compressed). The dynamic modulus is usually measured by 
applying a sinusoidal waveform to the gel, typically at a higher strain rate than 
used to measure compressive modulus. Again it is a measure of both the force 
required to compress the gel and the resistance to fluid flow, but since the strain 
rate is higher, usually there is more impact of resistance to fluid flow. In 
addition, because it the waveform is repeated, it also shows the recovery of the 
gel after multiple compressions. The equilibrium modulus is measured by 
compressing the gel to a fixed strain (eg 10%), then waiting until the force 
exerted by the gel is effectively no longer changing, and recording this 
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equilibrium force. The strain is then increased (to say 15%), and again the 
equilibrium force is recorded. When the equilibrium force is converted to stress 
and plotted against strain, the slope of the stress strain curve gives the 
equilibrium modulus. Fracture strength (or failure strength) is usually measured 
by compressing the gel at a fixed rate until the gel fractures, then determining 
the stress at the point of failure. The fracture energy is the amount of energy 
required to require this point. Fracture strength is not necessarily related to 
stiffness, since some gels may tolerate 90% strain (or more) before they 
fracture, while others may fracture at 50% strain. 
Despite physical properties being a limitation for hydrogels, research has 
identified ways to control the physical properties of hydrogels over 
extraordinary ranges, and the stiffness of some hydrogels can approach or even 
exceed that of cartilage [82]. For example, by changing the molecular weight 
and concentration, PEG-DA hydrogels can be produced with dynamic 
compressive stiffness ranging from 55 kPa to 42 MPa [82]. An elegant way to 
improve the mechanical strength is through so-called double-network hydrogels, 
in which different polymers are combined in different ratios, and crosslinked at 
different times, to form an interpenetrated network with a mechanical strength 
that vastly exceeds that of either network individually [83]. Double network 
hydrogels are discussed further in Chapter 8. For both of these strategies, the 
challenge for tissue engineering is to encapsulate cells in these hydrogels while 
achieving high cell viabilities and providing an environment that is conducive to 
cartilage formation. 
The initial physical properties of a hydrogel are important for 2 main reasons. 
Firstly, the loads that the hydrogel can withstand are determined by these 
properties, and secondly, the extent to which cells are able to form a 
mechanically functional, interconnected tissue is dependent on the initial 
mechanical properties. The current hypothesis is that softer hydrogels have a 
larger mesh/pore size, and that the larger pore size allows for more diffusion, 
distribution and interconnectivity of the newly synthesised matrix throughout 
the hydrogel. Several studies have confirmed this pattern using hydrogels 
formed from PEG [80, 84], alginate [80] agarose [85] and HA-MA [78]. The 
initial mechanical properties must be chosen to select the optimal balance for 
this apparent conflict. The material must be sufficiently strong to withstand the 
mechanical loads that are applied, yet not so tightly crosslinked that it prevents 
the effective formation of new tissue.  
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2.3.4 Functionalisation and cell adhesion 
Functionalisation of hydrogels with biochemical moieties to increase cell-
biomaterial interactions, with the aim of enhancing differentiation and/or 
function has been a common theme of hydrogel research. For cartilage 
applications, both natural and synthetic hydrogels have been functionalised with 
a wide range of biomolecules, such as polysaccharides, peptides, cell adhesion 
motifs, degradation sites and growth factors. These functionalisations have 
generally resulted in incremental increases or decreases in chondrogenesis 
and/or matrix production, but revolutionary improvements have been limited. 
Often, as shown in Table 2.1 for HA, the results are highly dependent on the 
context in which the biomolecule is applied, making direct comparisons very 
difficult. For example HA may have quite different effects depending on the 
molecular weight, the cell type(s) used, the presence of other materials/growth 
factors, the nature and degree of modification, and whether it is supplemented 
into the media or incorporated into the gel. In addition, the significant challenge 
of biological or donor-to-donor variation adds further complexity. As a 
consequence, drawing general conclusions about the significance or benefit of a 
given functionalisation is at best difficult and requires care.  
Since most cell types require cell attachment in order to survive and function, 
cell adhesion domains have been one of the most commonly investigated 
hydrogel functionalisations. Cell attachment is often assessed by incorporating 
the fibronectin-derived adhesion peptide RGD (arginine-glycine-aspartic acid) 
[86] into the hydrogel, which allows cells to attach and spread. However, a 
distinguishing physical feature of chondrocytes is their rounded morphology, so 
the value of RGD functionalisation is unclear for chondrocytes, since cell 
attachment and spreading is typically detrimental to chondrogenesis. 
When chondrocytes are encapsulated in hydrogels functionalised with the cell 
adhesion peptide RGD they display spreading [80], dedifferentiation [87] and 
even apoptosis [88]. Collectively, these suggest that RGD has a negative effect 
for chondrocyte encapsulation. When encapsulated in a photocrosslinkable PEG 
hydrogel with a gradient in RGD concentration, chondrogenesis and matrix 
formation were reduced as RGD concentration increased [89]. These effects, 
however, can be reversed when combined with mechanical loading, with the 
combination of RGD functionalisation and mechanical loading in fact leading to 
enhanced chondrogenesis [90]. RGD has been identified as an important 
element of mechanotransduction in dynamically compressed cartilage constructs 
[91], so may be of some benefit when combined with mechanical loading. 
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In general, hydrogels that lack cell-adhesion domains, such as agarose, alginate, 
PEG and HA account for the majority of hydrogels used for chondrocyte 
encapsulation. However, although chondrocytes generally respond favourably to 
encapsulation in hydrogels that lack adhesion sites, other cell types, such as 
MSCs, do not, and over time viability and metabolic activity become reduced 
[92]. Thus for cells other than chondrocytes, RGD may be advantageous for 
maintaining survival and allowing the early stages of chondrogenic 
differentiation to occur. This has led to systems in which the presentation of 
RGD can be temporally controlled, for example by tethering the RGD peptide 
onto a degradable linkage [93]. Using this approach, chondrogenesis of MSCs 
can be enhanced when the RGD sequences are cleavable by MMP13 compared 
to non-cleavable RGD [93]. Thus like many functionalisations, a blanket 
conclusion cannot be drawn for RGD, since it may be beneficial in specific 
circumstances. 
Modification of hydrogels to allow enzymatic or hydrolytic degradation has also 
been widely investigated. For cartilage regeneration, the inclusion of enzymatic 
degradation sites in PEG hydrogels resulted in increased distribution of cell-
secreted matrix throughout the gel [94], which is highly beneficial. 
Hydrolytically degradable HA-MA hydrogels have been synthesised by 
synthesising a co-polymer of HA-MA and polycaprolactone [95]. The most 
notable outcomes were observed between the following two groups: 2% (w/v) 
HA-MA and 1% (w/v) HA-MA combined with 1% (w/v) of the HA-MA 
polycaprolactone copolymer. The hydrogels with a degradable component 
showed increased collagen type II and aggrecan gene expression compared with 
the 2% HA-MA gels, and also showed greater increases in compressive 
modulus during culture [95].  
In the same way that the peptide RGD has been identified as a functional 
sequence for cell adhesion, other short peptides of other matrix proteins and 
proteoglycans have been identified for other biological functions. The collagen-
derived sequence (Hyp-P-G)n has been shown to effectively mimic some of the 
features of collagen, including triple helical formation [96]. When incorporated 
into PEG-DA hydrogels, the peptide enhances the chondrogenic differentiation 
of MSCs, increases matrix production, and suppresses hypertrophy markers 
[97]. Similarly, the collagen binding peptide KLER, derived from the 
proteoglycan decorin, may also improve chondrogenic differentiation of MSCs 
and support matrix retention [98]. The collagen mimetic peptide GFOGER can 
also enhance chondrogenic differentiation of MSCs in PEG-based hydrogels 
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[99], however given the high level of cell spreading induced by this peptide, it is 
unlikely that chondrocytes would benefit substantially.  
This research area is still in its early stages. The limiting factor is the biological 
complexity, and the incomplete understanding we have over the biological roles 
of different molecules. As they key molecules are identified, the tools and 
methods to synthesise and incorporate them into hydrogels are well established. 
For other cell types and applications, Zhu et al. have reviewed in detail different 
peptide functionalisations of PEG hydrogels [100]. 
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Table 2.1: influence of hyaluronic acid on chondrogenic differentiation and 
matrix accumulation in vitro. 
Study Hydrogel/ scaffold Cell Details Notable Findings 
Allemann et 
al. (2001) 
[101] 
Lyophilised 
HA/collagen type 1 
sponges, with HA 
accounting for 0 or 
2% of dry weight. 
Juvenile, primary, bovine 
chondrocytes; 
3 or 5 million cells per 
sponge. Cultured for 7 
days with 10% FBS 
Fourfold higher collagen II 
expression and twofold higher 
aggrecan expression in sponges 
with HA. 
Grigolo et al. 
(2002) [102] 
HYAFF® 11 
scaffolds – benzyl 
ester of HA. 
Expanded (P3/4) human 
chondrocytes (non-OA); 
106 cells per scaffold.  
14 days culture with 10% 
FBS, 1 ng/mL TGF-β1,  
1 ng/mL EGF,  
10 ng/mL b-FGF 
Relative to day 0, collagen II 
expression increased in 4 out of 
4 patients; collagen I expression 
decreased in all patients; 
changes in aggrecan expression 
were mixed (2 up, 2 down). 
Liao et al. 
(2007) [103] 
Collagen I 
hydrogels with HA 
(3 MDa) accounting 
for 0, 1, 2, 5 or 10% 
of dry weight. [HA 
conc. in 10% gels = 
0.47 mg/mL]. 
Non-expanded porcine 
chondrocytes;  
3.5 × 106 cells/mL. 
Cultured for 14 days with 
10% FBS. 
Very slight increase in 
GAG/DNA in gels with 5% HA. 
Ko et al. 
(2008) [104] 
Collagen II sponges 
and sponges with 
HA and CS. 
Passage 3, non-OA 
human chondrocytes; 
1.5 × 106 cells per 
scaffold. Cultured for 14 
days 10 mg/mL TGF- β3 
(assumed 10 ng/mL) 
The inclusion of HA and CS 
strongly increased aggrecan 
expression and slightly 
increased collagen type II 
expression. Cells were not 
encapsulated. 
Angele et al. 
(2009) [105]  
Esterified HA with 0, 
5 or 30% (w/w) 
gelatin. Sterilised by 
beta irradiation. 
Human bone marrow 
MSCs isolated by 
adherence to plastic 
substrate; cell density not 
stated. Cultured for 28 
days with unspecified level 
of TGF- β1. 
Gelatin caused a significant 
increase in cell spreading on 2D 
films, and increased GAG/DNA 
ratios in hydrogels. 
Hwang et al. 
(2007) [106]  
10% PEG-DA or 
10% PEG-DA with 
0.25% HA 
Zonal chondrocytes from 
immature bovine joints; 2 
× 107 cells/mL. Cultured 
for 21 days with 10% FBS. 
HA increased aggrecan 
expression ~2 fold in superficial 
cells and decreased expression 
~2 fold in deep zone cells. 
Expression of collagen type II 
and link protein both unchanged. 
Hwang et al. 
(2011) [107] 
10% PEG-DA or 
10% PEG-DA with 
0.25% HA 
Bone marrow MSCs from 
adult goats; 
2 × 107 cells/mL. Cultured 
for 6 weeks with 10 ng/mL 
TGF- β1. 
HA significantly reduced GAG 
accumulation after 6 weeks. At 
day 5, HA appeared to reduce 
aggrecan expression and 
increase osteogenic markers. 
Skaalure et 
al. (2014) 
[74]  
15% PEG-LA-DA 
with 0.05% or 0.5% 
of 30 or 2,000 kDa 
HA 
Bovine chondrocytes from 
skeletally mature animals; 
20 × 107 cells/mL. 
Cultured for 29 days with 
10% FBS 
At day 8, all HA formulations 
increased the proportion of cells 
stained for collagen type II. 
Minimal impact of HA at day 29. 
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2.4 Photocrosslinkable hydrogels: Application in Bioprinting 
Photosensitive resins have been extensively used in stereolithography, an 
additive manufacturing technique in which light is used to cure a resin in a 
layer-by-layer approach, allowing precise control over scaffold architecture. In 
the rapidly developing field of bioprinting, early studies typically used a 
combination of two or more rheological properties or crosslinking mechanisms 
are used to print constructs with defined structures. During deposition, the 
printed hydrogel structure must somehow retain its shape until it is crosslinked. 
This step exploits the first rheological or crosslinking property, and, for 
example, can be provided by high viscosity or temperature dependent gelation. 
Subsequently, the construct is crosslinked to stabilise its shape and structure. 
Alginate has been commonly used for bioprinting since its rheological and 
crosslinking properties lend themselves make it somewhat suitable. During 
printing, its high viscosity maintains the desired structure, and once the finished 
structure has been printed, it is easily crosslinked by submersion in a solution of 
Ca2+. The fidelity of the printed structures is usually limited, since high 
viscosities are not sufficient to completely prevent flow of the printed construct.  
One of the challenges for bioprinting has been a lack of hydrogels that are 
appropriate for both cell culture and have the properties required for printing. 
When using alginate for cell culture, concentrations of 1-2% (w/v) are typically 
used, since these low concentrations support high cell viability and nutrient 
diffusion. For printing, though, higher concentrations give higher viscosity, 
making higher concentrations (4-10% w/v) most suited for printing. This had 
led to the popular concept of a bioprinting window – that is the working range in 
which a material can be both printed and be used as an effective biomaterial. So 
while alginate can be printed, it clear has some limitations for printing well-
defined or large structures. Other polymers, in comparison, such as lutrol and 
pluronic F127, are very well suited for printing, but are of limited practical use 
for cell culture [108].  
New materials are being developed and applied specifically for use in 
bioprinting. In particular, fluids with properties approaching those of Bingham 
fluids are ideal for temporarily holding the structure of the printed construct, 
since Bingham fluids usually do not flow under gravity alone. Gellan gum, for 
example, is a useful addition to Gel-MA for bioprinting, because it provides a 
yield stress at relatively low concentrations [109]. Photocrosslinking is a useful 
means to permanently crosslink the printed structure.  
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Alternative approaches that remove, or reduce, the requirement for viscosity or 
temperature sensitivity to maintain the initial structure have also been 
investigated. Skardal et al. have printed partially crosslinked mixtures of 
photocrosslinkable 1.2% (w/v) hyaluronic acid and 0.3% (w/v) gelatin [110]. 
Prior to printing, the hydrogel precursor solution, containing 25 × 106 cells/mL, 
was exposed to UV for two minutes. Following printing, the constructs were 
further UV crosslinked for one minute per layer. This provides additional 
support for the printed structure, but it is uncertain how this two-stage 
crosslinking would influence the network structure, mechanical strength and 
layer-to-layer integration.  
Cui et al. have used simultaneous inkjet printing and UV crosslinking to print 
PEGDA, which has a low viscosity and no thermal sensitivity [111]. In this 
way, the gel is crosslinked as it is deposited, which has the advantage that cells 
do not settle between printing and crosslinking. However, the objective was to 
entirely fill a cylindrical chondral defect, so the added value of printing, as 
opposed to a syringe or pipette, is unclear. Billiet et al. have modified a 
commercial printing system (Bioplotter, EnvisionTEC, Germany) to enable a 
high degree of control over the temperature at the needle outlet, which allows 
Gel-MA to be printed at the upper critical solution temperature (UCST) [112]. 
This study highlights the critical importance of temperature control if 
temperature sensitivity plays a substantial part of the printing process. 
2.5   Conclusion 
Photocrosslinkable hydrogels have been extensively evaluated for cartilage 
tissue engineering, but optimal materials have not yet been found. PEG 
hydrogels have provided a versatile and valuable platform for evaluating 
bioactive moieties, but have generally failed to match the level of 
chondrogenesis seen in naturally derived hydrogels. Recently, natural polymers 
that have been functionalised with photocrosslinkable domains have attracted 
increasing interest for cartilage tissue engineering, and HA in particular has 
generated significant research interest. Despite its widespread use, there is very 
little consensus on the impact of HA, which appears to depend on many other 
factors, such as the origin of the cells, the presence of other materials and 
growth factors, the HA concentration and molecular weight, and how the HA is 
crosslinked, if at all. Although the outcomes have been variable, many studies 
have shown promising effects of HA, which are expected to continue to create 
interest in this biopolymer.  
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A comparative study of photocrosslinkable hydrogels 
Abstract 
Hydrogels are promising materials for cartilage repair, but the properties 
required for optimal functional outcomes are not yet known. In this study, we 
functionalised four materials that are commonly used in cartilage tissue 
engineering and evaluated them using in vitro cultures. Gelatin, hyaluronic acid, 
polyethylene glycol, and alginate were functionalised with methacrylic 
anhydride to make them photocrosslinkable. We found that the responses of 
encapsulated human chondrocytes were highly dependent on hydrogel type. 
Gelatin hydrogels supported cell proliferation and the deposition of a 
glycosaminoglycan-rich matrix with significant mechanical functionality. 
However, cells had a dedifferentiated phenotype, with high expression of 
collagen type I. Chondrocytes showed the best redifferentiation in hyaluronic 
acid hydrogels, but the newly formed matrix was highly localised to the 
pericellular regions, and these gels degraded rapidly. Polyethylene glycol 
hydrogels, as a bioinert control, did not promote any strong responses. Alginate 
hydrogels did not support the deposition of new matrix, and the stiffness 
decreased during culture. The markedly different response of chondrocytes to 
these four photocrosslinkable hydrogels demonstrates the importance of 
material properties for chondrogenesis and extracellular matrix production, 
which are critical for effective cartilage repair.  
Keywords: cartilage; hydrogels; photopolymerisation; chondrogenesis; tissue 
engineering 
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3.1  Introduction 
Articular cartilage has a low capacity for self-repair, and treatment of cartilage 
defects remains a clinical and economic burden [49]. Current therapies such as 
microfracture and autologous chondrocyte implantation (ACI) frequently result 
in a fibrous repair tissue that is rich in collagen type I, and lacking the 
mechanical properties and zonal organisation of normal articular cartilage [113, 
114]. Cell-based cartilage tissue engineering aims to overcome the current 
limitations in cartilage therapies by restoring damaged tissue with hyaline 
cartilage that is rich in collagen type II and aggrecan [115]. 
Cell-based cartilage tissue engineering strategies most commonly use 
autologous chondrocytes that are harvested during a biopsy and expanded in 
culture [50]. A major limitation of this approach is that chondrocytes 
dedifferentiate during expansion, adopting a fibroblastic morphology, and 
replacing collagen type II expression with collagen type I expression [53, 116]. 
This dedifferentiation is likely responsible for repair tissue that is rich in 
collagen type I and mechanically inferior to the original cartilage. Thus, in order 
for the repair tissue to have similar structure and function as the original tissue, 
the chondrogenic phenotype of the cells must be restored [117]. One approach 
to achieve this goal is the development of biomaterials to direct the chondrocyte 
phenotype, and ultimately enhance the quality of the repair tissue. 
Dedifferentiated chondrocytes can regain their differentiated phenotype when 
cultured in three-dimensional hydrogels [53], which are water-swollen, 
crosslinked networks of hydrophilic polymers. The design of optimal hydrogel 
biomaterials to restore the chondrocyte phenotype and guide cartilage 
regeneration is a current challenge [118, 119], and there are a number of 
requirements that must be met. Ideally, the hydrogel should promote 
chondrogenesis, with the newly formed matrix resembling the original hyaline 
cartilage, which is rich in collagen type II and aggrecan [118]. Furthermore, the 
matrix should be spread throughout the hydrogel, rather than concentrated in the 
pericellular regions, and should facilitate the regeneration of the complex zonal 
organisation of native cartilage [118]. Finally, it must be practical to use it in a 
clinical setting: it must be sterilisable, easy to handle, and crosslink relatively 
rapidly. 
Photocrosslinkable hydrogels are covalently crosslinked by exposing a 
precursor polymer solution to light in the presence of a photoinitiator. The 
reaction proceeds relatively rapidly under physiological conditions, allowing in 
situ crosslinking and cell encapsulation with high viabilities [120]. In this study, 
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we compared four photocrosslinkable hydrogels with distinctly different 
properties to elucidate which cell-material interactions are likely to be beneficial 
for cartilage tissue engineering, and which are not. The hydrogels provided a 
wide range of functionalities (Table 3.1). Polyethylene glycol dimethacrylate 
(PEG-MA) is synthetic and highly hydrophilic, and since it is bioinert, it serves 
as a useful control. Like the matrix of native cartilage, alginate methacrylate 
(AL-MA) is negatively charged, and alginate hydrogels have frequently been 
used in chondrogenic differentiation models [80]. Hyaluronic acid-methacrylate 
(HA-MA) is based on a major component of articular cartilage that interacts 
with both chondrocytes, through CD44 receptors [20], and components of the 
extracellular matrix (ECM), such as aggrecan, via link protein [25]. Gelatin-
methacrylamide (Gel-MA) hydrogels are produced from hydrolysed collagen, 
retain cell adhesion domains, and are sensitive to cell-mediated degradation by 
matrix metalloproteinases (MMPs) [52, 66]. 
Table 3.1: Hydrogel source and properties. 
Hydrogel Source Properties 
Gel-MA ECM collagens Protein hydrogel, cell attachment domains, degradable 
PEG-MA Synthetic Bioinert, highly hydrophilic 
HA-MA Recombinant 
Direct interaction with chondrocytes through 
CD44 receptors, hydrolytically and 
enzymatically degradable 
AL-MA Seaweed Negatively charged, non-adhesive to cells, 
non-degradable 
 
3.2   Materials and Methods  
3.2.1   Macromer Synthesis 
Type A gelatin (molecular weight [MW] ~90 kDa), medium viscosity alginate 
(MW ~260 kDa [121]), PEG (MW 8 kDa), and methacrylic anhydride (MAAh) 
were purchased from Sigma Aldrich (St Louis, Mo). Hyaluronic acid (MW 860 
kDa) was generously provided by Novozymes. Polymers were modified to 
include photocrosslinkable groups by reaction with MAAh, based on previously 
published methods, which vary slightly between polymers to account for their 
different chemistries. Gelatin was dissolved in phosphate buffered saline (PBS, 
Invitrogen, Carlsbad, CA) at 100 mg/mL and reacted with 0.6 g MAAh per 
gram of gelatin for 1 h at 50 °C under constant stirring [52]. Alginate and HA 
were dissolved in distilled water at 20 mg/mL, and reacted with MAAh for 24 h 
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on ice [56]. For HA and alginate, five- and 10-fold molar excesses of MAAh to 
total hydroxyl groups were used, respectively, and the pH was regularly 
adjusted to 8 using 5 M NaOH. PEG was dissolved in dichloromethane (Thermo 
Fisher, Australia) at 300 mg/mL, and functionalised with MAAh (100% molar 
excess relative to hydroxyl groups) in the presence of triethylamine (25% molar 
excess). After reaction for 10 days at room temperature the PEG-MA was 
precipitated in diethyl ether (Merck, Darmstadt, Germany) and dried. For all 
other polymers, insoluble MAAh was removed by centrifugation, and remaining 
MAAh was removed by dialysis against distilled water (12 kDa molecular 
weight cut off cellulose dialysis membrane, Sigma). Functionalised polymers 
were lyophilised. 
Chemical modification of the hydrogel precursors was confirmed using proton 
nuclear magnetic resonance (1H NMR, spectra not shown) using a Bruker 
Avance 400 MHz instrument at room temperature. The 1H NMR spectra for all 
unmodified polymers in D2O (Sigma) showed no signal in the range 5.5–6.5 
ppm, whereas the spectra of the modified polymers gave peaks in this region, 
corresponding to the vinyl protons of the methacrylate or methacrylamide 
groups [56]. 
3.2.2   Cell Isolation and Expansion 
Cartilage was harvested from the macroscopically normal regions of the femoral 
condyles of a 72-year-old female patient undergoing knee replacement surgery. 
Chondrocytes were isolated as previously described [80]. The patient provided 
informed consent, and ethics approval was granted by Queensland University of 
Technology and the Prince Charles Hospital. Expansion media contained low 
glucose DMEM with 2 mM GlutaMAXTM (Invitrogen), supplemented with 10% 
fetal bovine serum (Lonza, Waverly Australia), 10 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid, 0.1 mM non-essential amino acids, 0.5 μg/mL 
amphotericin B (Fungizone), 50 U/mL penicillin G sodium, 50 μg/mL 
streptomycin (all Invitrogen), 0.4 mM L-proline and 0.1 mM ascorbic acid (both 
Sigma). 
3.2.3 Cell Encapsulation and Culture 
Cells were released from the tissue culture plastic by 5 minutes incubation in 
0.25% trypsin with 1 mM ethylenediamine tetraacetic acid (Invitrogen). Passage 
1 cells were washed, split equally into four groups, centrifuged, and 
resuspended at a density of 107 cells/mL in hydrogel precursor solutions in PBS 
containing 0.5 mg/mL Irgacure 2959 (BASF, Ludwigshafen, Germany). It was 
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necessary to vary the concentrations of polymer precursors according to 
solubility and hydrogel formation. For example, PEG-MA hydrogels are 
commonly formed from precursor solutions approximately 20% (w/v) PEG-
MA, which is above the solubility limit of many polysaccharides, such as 
alginate, which is commonly used at approximately 1–3% (w/v). Precursor 
concentrations for Gel-MA, PEG-MA, HA-MA, and AL-MA were 9%, 18%, 
2%, and 3%, respectively (w/v). Cylindrical hydrogels with an initial volume of 
100 μL, and height of 2 mm were crosslinked by 5 minutes exposure to 365 nm 
UV light at an intensity of 12 mW/cm2 (OmniCure®, Lumen Dynamics). 
Hydrogels were then cut into four even pieces, and were cultured for up to 4 
weeks in serum-free, high glucose DMEM (Invitrogen) differentiation media. In 
addition to the supplements in expansion medium, differentiation media 
contained ITS+1 (100 × dilution), 1.25 mg/mL bovine serum albumin (BSA), 
0.1 μM dexamethasone (all Sigma), and 10 ng/mL TGF-β3 (GroPep, Australia). 
Cultures were maintained at 37 °C in an atmosphere of 21% oxygen and 5% 
carbon dioxide. 
3.2.4 Viability assay 
Cell-hydrogel constructs were incubated in PBS containing 10 μg/mL 
fluorescein diacetate and 5 μg/mL propidium iodide (both Sigma), which stain 
living and dead cells green and red, respectively. Images were taken using a 
Nikon Eclipse fluorescence microscope. 
3.2.5 Mechanical testing 
Compressive testing was performed using an Instron 5848 microtester with a 5 
N load cell (Instron, Melbourne, Australia) in an unconfined arrangement. 
During testing, hydrogels were submerged in PBS at 37 °C. A displacement rate 
of 0.0025 mm/s was applied using a non-porous indenter. Constructs were 
weighed after testing using an analytical balance, and the cross-sectional area 
was determined as the ratio of wet weight to height. The compressive modulus 
was taken as the slope of the linear region of the stress-strain curve from 10 to 
15% strain, since comparable strain regions have been shown to be suitable for 
measuring similar hydrogel constructs [122-124]. 
3.2.6 Biochemical analyses 
For GAG and DNA analyses, hydrogel constructs were lyophilised and digested 
in proteinase K solution (Invitrogen) for 16 h at 56 °C. The concentration of 
GAGs in the digests was measured using the dimethylmethylene blue assay (pH 
1.5) in a 96 well-plate format [125]. GAG concentration in the conditioned 
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media was assayed at each media change. Results from the first media change 
were excluded because uncrosslinked alginate diffuses out of AL-MA gels 
during swelling. DNA concentration in the digests was measured using the 
Quant-iTTM PicoGreen® dsDNA quantification assay (Invitrogen). 
3.2.7 Immunofluorescence and Histology 
Immunofluorescence for aggrecan and collagen types I and II were performed 
on sections of fresh-frozen constructs, which were fixed by 10 min contact with 
ice-cold acetone. Sections were treated with 0.1% hyaluronidase (Sigma) in 
PBS for 30 min, then blocked in 2% BSA in PBS for 1 h. Antibodies for 
collagen type II (II-II6B3, DSHB, 1:200 dilution), collagen type I (I-8H5, MP 
Biomedicals, Australia, 1:300 dilution), and aggrecan (MA75A95, Abcam, 1:4 
dilution) were diluted in PBS with 2% BSA, and applied overnight at 4 °C. The 
secondary antibody (Alexa Fluor® 488, Invitrogen) was applied for 1 h in PBS 
with 2% BSA and 0.5 μg/mL DAPI. The secondary antibody alone was used as 
a negative control. Sulfated GAGs were stained with 0.5% Alcian blue (Sigma, 
pH 1) for 10 min at room temperature. 
3.2.8 Confocal microscopy 
Cell morphology was visualised using confocal microscopy in constructs 
cultured for 4 weeks. Constructs were fixed and permeabilised in 4% 
paraformaldehyde (Electron Microscopy Sciences, Hatfield, PA) with 0.2% 
Triton X-100 (Merck) in PBS, for 30 min at room temperature. Actin filaments 
and nuclei were stained for 1 h with 0.8 U/mL rhodamine-labeled phalloidin 
(Invitrogen) and PicoGreen® (1:200 dilution, Invitrogen), respectively. Images 
were acquired on a Leica SP5 confocal laser scanning microscope using a 20× 
objective. 
3.2.9 Gene expression 
Total RNA was isolated from cells prior to encapsulation in hydrogels (day 0), 
and from cell-hydrogel constructs on day 21. Cells or hydrogel constructs were 
homogenised in 1 mL of TRIzol reagent (Invitrogen) and frozen in liquid 
nitrogen. Total RNA was isolated according to manufacturer’s instructions. 
SuperScriptTM III First Strand Synthesis System (Invitrogen) was used to 
synthesise the first strand of complementary DNA (cDNA). DNase and RNase 
treatments (both Invitrogen) were included before and after cDNA synthesis, 
respectively. Real time-polymerase chain reaction was performed using 
SybrGreen® Mastermix (Invitrogen). B2M and RPL13a were selected as 
housekeeping genes. The primer sequences were either taken from the literature 
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for RPL13a [126] and COL2A1, COL1A1, COL10A1, ACAN and proteoglycan 
4 (PRG4) [127], or designed using Primer-BLAST (NCBI, Bethesda, MD) for: 
B2M (5’3’ F: ATGAGTATGCCTGCCGTGTGA,  
R: GGCATCTTCA-AACCTCCATGATG) and  
MMP13 (5’3’ F: ACTTCACGATGGCATTGCTG,  
R: CATA-ATTTGGCCCAGGAGGA). 
3.2.10  EPIC-μCT 
The distribution of fixed negative charges within the hydrogel constructs was 
visualised using equilibrium partitioning of an ionic contrast agent 
microcomputed tomography (EPIC-μCT) [128]. Cell-free hydrogels, and fixed, 
cell-laden constructs cultured for 4 weeks were incubated in a solution of 40% 
ioxaglate (Hexabrix®, Aspen, Australia) in PBS overnight at 37 °C. Constructs 
were imaged in a μCT 40 scanner (Scanco Medical, Switzerland) at 45 kV and 
177 μA, and analysed using Scanco μCT software. 
3.2.11  Statistics 
SPSS software (version 20, IBM corporation, Armonk) was used for statistical 
analyses. ANOVA and either Tukey’s or Dunnett’s T3 post hoc tests were used 
to determine significant differences between hydrogel groups for GAGs, day 1 
wet weights, and gene expression data, as appropriate. Independent samples t-
tests were used to compare day 1 and day 21 wet weights and moduli data for 
each hydrogel.  
3.3   Results 
Human chondrocytes showed distinctly different responses in the four 
hydrogels, indicating the importance of hydrogel properties for guiding cell 
processes and tissue regeneration. Most cells remained viable in all hydrogels 
after 4 weeks of culture (Supporting Information Fig. S3.1). 
3.3.1    Physical Properties  
Constructs had an initial wet weight of approximately 25 mg after crosslinking. 
The hydrophilic properties of PEG-MA caused much greater swelling on day 1 
compared to the other gel types (Figure 3.1A, Figure S3.2). The wet weight of 
HA-MA constructs decreased by almost half in 3 weeks, indicating relatively 
rapid degradation, while the wet weights of the other hydrogels were 
unchanged. 
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The compressive moduli of all constructs changed significantly during 21 days 
culture (Figure 3.1B). The stiffness of Gel-MA constructs was markedly higher 
on day 21 (54 kPa) than day 1 (1.5 kPa). Macroscopically, Gel-MA constructs 
were transparent on day 1, but white and opaque after 3 weeks (Fig. S3.2), 
indicating ECM accumulation. The compressive moduli of HA-MA constructs 
also increased during culture, although to a lesser extent than Gel-MA. PEG-
MA and AL-MA constructs became softer during culture. On day 1 there were 
differences in the compressive moduli of hydrogel constructs, due to differences 
in swelling and crosslink densities. Gel-MA and PEG-MA constructs were 
softer than HA-MA and AL-MA constructs (p < 0.05), and HA-MA constructs 
were softer than AL-MA constructs (Figure 3.1B, p < 0.05). 
 
Figure 3.1: Wet weights (A) and compressive moduli (B) of hydrogel-cell 
constructs on days 1 and 21. Bars and error bars show the means and standard 
deviations of five samples; stars indicate significant differences between days 1 and 
21 (* indicates p < 0.05, ** indicates p < 0.005). 
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3.3.2   Cell Proliferation and Morphology 
Hydrogel type was a strong determinant of cell morphology (Figure 3.2). Cells 
encapsulated in Gel-MA, which contains an abundance of cell adhesion 
domains, showed highly spread morphologies, indicative of dedifferentiated 
chondrocytes (Figure 3.2A). Cells were more highly spread on the surface of the 
gels than when encapsulated, but encapsulated cells also showed stretched actin 
filaments. Chondrocytes only proliferated in Gel-MA gels, with total DNA 
content increasing approximately three-fold during 3 weeks culture (Figure 
3.2E). Cells did not spread significantly in the other gels, although small cell 
extensions were seen spreading from cell clusters in PEG-MA hydrogels (Figure 
3.2B). 
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Figure 3.2: Confocal microscopy images showing organisation of actin 
filaments (green) and cell nuclei (blue) in Gel-MA (A), PEG-MA (B), HA-MA (C), 
and AL-MA (D) hydrogel-cell constructs after 4 weeks culture. Scale bars: 100 
μm. Total DNA content (E) showed that cells only proliferated significantly in Gel-MA 
constructs (p<0.005). Bars and error bars show the means and standard deviations 
of five samples.  
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3.3.3   Gene Expression 
The expression levels of key chondrogenic genes were measured to determine 
the degree of chondrogenesis in each of the hydrogels (Figure 3.3). Compared to 
day 0 levels, COL2A1 expression was upregulated in all hydrogels, but to the 
lowest extent in PEG-MA (Figure 3.3A). Aggrecan expression was upregulated 
only in HA-MA gels compared to day 0 (Figure 3.3B). Expression of the 
dedifferentiation marker COL1A1 was highly upregulated in Gel-MA, and 
unchanged from the day 0 level in other gels (Figure 3.3C). The superficial zone 
marker PRG4 was upregulated in all hydrogels, but to the highest extent in HA-
MA (Figure 3.3D), while expression of the deep zone marker COL10A1 was 
markedly upregulated in Gel-MA hydrogels (Figure 3.3E). MMP13 was also 
strongly upregulated in Gel-MA (Figure 3.3F), which together with COL10A1, 
indicates that cells in Gel-MA may be undergoing hypertrophy. 
 
Figure 3.3: Gene expression profile of chondrocytes after 3 weeks culture, 
normalised to day 0 expression levels. Expression of chondrogenic markers 
COL2A1 (A) and ACAN (B), the dedifferentiation marker COL1A1 (C), superficial 
zone marker PRG4 (D), deep zone marker COL10A1 (E), and hypertrophy marker 
MMP13 (F). Box plots show the mean, lower and upper quartiles, and range from five 
samples; different Roman numerals indicate statistically significant differences 
between groups (p < 0.05). 
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3.3.4   Matrix Production and Accumulation 
Total GAG production was determined as the sum of the GAGs retained in the 
hydrogel and GAGs secreted into the media. GAG production was highest in 
Gel-MA hydrogels, with two-fold more GAGs retained in Gel-MA compared to 
the other hydrogels (Figure 3.4A). The amount of GAGs retained was similar in 
PEG-MA, HA-MA, and AL-MA, with minor variations in the amounts secreted 
(Figure 3.4A). The fraction of total GAGs that were retained in the hydrogels 
was highest in AL-MA and HA-MA hydrogels, and lowest in PEG-MA 
hydrogels (Figure 3.4B). When normalised to the DNA content on day 21, 
GAG/DNA ratios were highest in Gel-MA and PEG-MA constructs (Figure 
3.4C). 
On day 1, HA-MA and AL-MA gels showed more Alcian blue staining than 
Gel-MA and PEG-MA, due to the negative charges on these polymers (Figure 
3.4D). After 21 days of culture, Alcian blue staining was strong and 
homogeneous in Gel-MA constructs. Conversely, staining was highly 
heterogeneous in HA-MA constructs, with intensely stained pockets of 
approximately 50 μm in diameter distributed throughout the construct, and 
overall less intense staining than in Gel-MA. 
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Figure 3.4: Production and retention of GAGs by chondrocytes encapsulated in 
the hydrogel constructs. Amount of GAGs secreted into the media or retained in 
the constructs during 21 days culture (A), the percentage of GAGs produced that 
were retained in the constructs (B), the total GAG normalised to the DNA content on 
day 21 (C), and sections of cell-hydrogel constructs stained for GAGs with pH 1 
Alcian blue (D). Bars and error bars show the mean and standard deviation of five 
samples. In A, * and ** indicate statistical significance for total (secreted + retained) 
GAG production (p < 0.05 and 0.005 respectively), ## indicates significance for 
GAGs retained (p < 0.005), and $$ represents significance for GAGs secreted (p < 
0.005). Scale bars: 100 μm. 
EPIC-μCT scans of cell-free hydrogels and cell-laden hydrogels after 28 days 
show intrinsic differences in the fixed negative charges in different hydrogels, 
as well as changes resulting from GAG deposition by encapsulated cells (Figure 
3.5). Attenuation values correlate with ioxaglate concentration, and are 
inversely correlated with the fixed negative charge in the construct, due to the 
negative charge of ioxaglate [128]. Clear differences were apparent between the 
four cell-free hydrogels (Figure 3.5A-D), with lower attenuation values recorded 
in the negatively charged gels. Changes were also apparent between cell-free 
gels and cultured constructs. In Gel-MA constructs, attenuation was strongly 
reduced in the cultured constructs as a result of the GAG accumulation in these 
gels (Figure 3.5), while the other gels, with lower GAG accumulation, showed 
less distinct differences. The perimeter of cultured HA-MA constructs showed 
regions of localised degradation (Figure 3.5G). 
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Figure 3.5: EPIC-μCT images of negative charge and charge distribution in cell-
free (circular cross-sections, A–D) or cell-laden (quarter-circle cross-sections, 
E-F) Gel-MA, PEG-MA, HA-MA and AL-MA hydrogel constructs, which were 
cultured for 4 weeks. Scale bars indicate 1 mm; different sizes result from 
differences in swelling between the constructs. The colour indicates the signal 
intensity (5,000 to 20,000) of the contrast agent ioxaglate. Higher ioxaglate intensity 
indicates lower fixed negative charge. 
Immunofluorescence was used to detect the presence of the chondrogenic 
markers collagen type II and aggrecan, and the dedifferentiation marker 
collagen type I (Figure 3.6). Collagen type II immunofluorescence was strong in 
Gel-MA and HA-MA constructs (Figure 3.6 A1, C1), however, was more 
evenly spread throughout Gel-MA constructs than in HA-MA constructs. In 
HA-MA constructs, both collagen II and aggrecan were intensely stained around 
cells and cell clusters. Aggrecan staining was strongest in HA-MA, with only 
low levels of staining in the other gels. Strong collagen type I 
immunofluorescence was observed in Gel-MA constructs (Figure 3.6 A3). 
Immunofluorescence showed relatively low levels of aggrecan, and collagen 
types I and II in PEG-MA and AL-MA constructs. 
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Figure 3.6: Immunofluorescence staining for collagen type II, aggrecan, and 
collagen type I in Gel-MA, PEG-MA, HA-MA, and AL-MA hydrogel constructs 
cultured for 21 days, with DAPI nuclear stain shown in white. Scale bars: 100 
μm. 
3.4   Discussion 
The aim of this study was to determine which hydrogel properties would be 
beneficial for cartilage tissue engineering. We found that Gel-MA hydrogels 
promoted a significant amount of ECM production, but chondrocytes had a 
mixed phenotype, whereas HA-MA hydrogels most effectively promoted 
chondrocyte redifferentiation. In comparison, the hydrogel properties in AL-MA 
and PEG-MA did not result is particularly notable outcomes. 
Gel-MA hydrogels are a promising biomaterial for engineering various tissues 
[66]. Here, we show that Gel-MA hydrogels promote encapsulated human 
chondrocytes to proliferate and form a GAG- and collagen-rich ECM. The ECM 
generated in Gel-MA constructs had significantly more mechanical functionality 
compared to the other hydrogels. Mechanical properties are a key metric for 
evaluating tissue-engineered cartilage [129], and has been a limitation of many 
attempts to date [130]. Although the final modulus of approximately 55 kPa is 
substantially lower than that of cartilage, it is a significant increase in a 
relatively short (3 week) in vitro culture period. However, the stretched cell 
morphologies and upregulation of COL1A1 and hypertrophy makers [131] 
indicate the cells are not undergoing classical chondrogenesis, and the matrix 
would not resemble the original hyaline cartilage. Based on these results, for 
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Gel-MA to be used in cartilage tissue engineering, additional strategies to guide 
chondrogenesis must be pursued in further studies. 
The apparent discrepancy between high GAG deposition and a lack of 
chondrogenic differentiation in Gel-MA may be accounted for by the lack of 
specificity of the GAG assay, Alcian blue, and EPIC-μCT, which are all 
measures of negative charge. Cartilage is a proteoglycan rich tissue, but more 
specifically, aggrecan accounts for 80% of total proteoglycans [34]. Other 
proteoglycans, for example, versican, decorin, and biglycan, which are not 
normally produced in cartilage, are upregulated during dedifferentiation [132]. 
In this study, the newly formed ECM in Gel-MA constructs was rich in GAGs, 
but immunofluorescence showed that very little aggrecan was produced. 
Similarly, while GAGs were produced in PEG-MA and AL-MA constructs, 
there was very little aggrecan staining in these constructs. From a practical 
perspective, these results highlight the need for multiple means of analyses in 
cartilage tissue engineering research, as the most widely used methods, GAG 
production and Alcian blue staining, do not necessarily correlate with 
chondrogenesis. 
Chondrogenic redifferentiation was most complete in HA-MA constructs. 
Expression levels of aggrecan were highest in HA-MA, and 
immunofluorescence for collagen type II and aggrecan were the strongest in this 
gel. PRG4 expression was also highest in HA-MA. Correlations between PRG4 
expression and chondrogenesis have been observed [127], so it may serve as a 
putative chondrogenic marker, but is also used as a marker of superficial zone 
chondrocyte phenotype. Together with HA, PRG4 is an important component of 
the lubricating system in synovial joints, and these molecules have been shown 
to have synergistic effects on lubrication and to interact in solution [133]. The 
addition of HA to alginate hydrogels also upregulated PRG4 expression in 
primary bovine chondrocytes undergoing dedifferentiation, indicating that HA 
may be more directly involved in PRG4 metabolism [134]. 
An important limitation of HA-MA hydrogels for tissue engineering was the 
lack of matrix distribution, as collagen type II and aggrecan were entirely 
limited to the pericellular space, and improvements in construct mechanical 
properties were significantly lower than in Gel-MA constructs. Increasing the 
cell density could result in better integration and functionality of the newly 
formed matrix [135], along with reducing the initial crosslink density in the 
hydrogel constructs [122]. HA-MA gels degraded relatively rapidly, with gels 
losing approximately 50% of their initial wet weight after 3 weeks culture, 
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whereas the wet weights of the other hydrogels remained unchanged. HA is 
susceptible to both hydrolytic and enzymatic degradation, making in vivo 
degradation times difficult to model precisely. It appears that enzymatic 
degradation was the predominant mechanism in our hydrogels, as cell-free gels 
did not change in shape or weight with time in culture (data not shown). 
Strategies to increase the stability of HA hydrogels have been developed, but 
some, such as esterification, appear to also alter its biological properties [69, 
136, 137]. 
Like HA-MA, AL-MA is a polysaccharide polymer with a fixed negative 
charge, however, is non-degradable. Cells responded very differently in these 
two gels, with only minimal matrix formation observed in AL-MA constructs. 
This could be a consequence of localised HA-MA degradation providing a more 
permissive environment for matrix deposition, or HA-MA promoting 
chondrogenesis through CD44 receptor mediated signaling [20]. It may also be 
a result of the differences in the initial crosslink densities and mesh sizes of the 
hydrogels. 
On day 1, significant differences existed in the compressive moduli, and hence 
crosslink densities and mesh sizes, of the different hydrogels. Other studies have 
shown that matrix properties are influenced by crosslink density, with increased 
matrix production and distribution occurring with lower crosslink densities 
[120, 122]. Matrix production was low in AL-MA constructs, and this could be 
partly attributable to these gels being the stiffest on day 1 [80, 122]. Similarly, 
the lower retention of GAGs in PEG-MA hydrogels may be a consequence of 
these gels being relatively soft on day 1. However, material properties appear to 
be of greater importance than crosslink densities. In a previous study in which 
PEG and alginate with different crosslink densities were compared, the 
differences between PEG and alginate were more pronounced than differences 
in crosslink densities for each material [80]. Nevertheless, the differences in the 
initial mechanical properties of the hydrogels are expected to have some 
influence over cell-fate and matrix production, and the role that initial 
mechanical properties and crosslink densities play is the subject of further 
studies in our laboratory. The impact of UV exposure on cells during hydrogel 
cross-linking is not fully understood [65], so we believe it is imperative that 
each group receives the same level of UV exposure. 
Biomaterials play a key role in next-generation ACI-based therapies. Different 
biomaterials have the capacity to influence the properties of the repair tissue. 
For example, differences in the repair tissue formed from cartilage therapies 
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using either HA or collagen-based materials were still detectable 2 years post 
operatively [114]. Thus, there is significant scope for material properties to 
influence outcomes of cartilage tissue therapies, and further research is required 
to develop and optimise these materials or their combinations for use in 
cartilage tissue engineering therapies. 
3.5  Conclusions 
Photocrosslinkable hydrogels have the potential to improve cell-based cartilage 
tissue engineering therapies. Here, we identified key differences in cellular 
response between several single-component hydrogel systems. Gel-MA 
hydrogels promoted the rapid formation of a cell-secreted, and mechanically 
functional ECM, thus reinforcing the interest in Gel-MA for tissue engineering 
applications. However, several measures showed that chondrocytes had a mixed 
phenotype in these gels. Meanwhile, HA-MA hydrogels promoted chondrogenic 
differentiation, but the limited matrix distribution and rapid degradation were 
clear limitations. As each material showed specific advantages and 
disadvantages, combinations of materials should be a focus in future attempts to 
recapitulate the composition, structure and function of articular cartilage. 
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Gel-MA hydrogels for bioprinting cartilage constructs 
Gelatin-methacrylamide (Gel-MA) hydrogels are shown to support chondrocyte 
viability and differentiation and give wide ranging mechanical properties 
depending on several cross-linking parameters. Polymer concentration, UV 
exposure time, and thermal gelation prior to UV exposure allow for control over 
hydrogel stiffness and swelling properties. Gel-MA solutions have a low 
viscosity at 37 °C, which is incompatible with most biofabrication approaches. 
However, incorporation of hyaluronic acid (HA) and/or co-deposition with 
thermoplastics allows Gel-MA to be used in biofabrication processes. These 
attributes may allow engineered constructs to match the natural functional 
variations in cartilage mechanical and geometrical properties. 
Keywords: additive manufacturing; cartilage; gelatin; hydrogels; tissue 
engineering 
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4.1   Introduction 
Regenerative medicine aims to restore or replace damaged tissues or organs, 
using a combination of cells, scaffolding materials, and growth factors. 
Scaffolding materials, acting as a temporary extracellular matrix, must both 
provide a support structure for the cells and at the same time provide a niche 
that allows the cells to deposit their specific extracellular matrix [5, 138]. 
Besides the material composition, structural characteristics, including 
architecture and mechanical properties will also affect its functionality. In native 
cartilage tissue, mechanical properties vary with distance from the surface. For 
example, stiffness increases with depth by more than an order of magnitude 
from the superficial to the deep zone [33]. The ability to regenerate articular 
cartilage with a zonal structure featuring different characteristics with changing 
depth would mark a significant advancement in the treatment of chondral 
defects [118]. Development of hydrogels with tunable mechanical properties is 
an important step toward this aim. 
Additive manufacturing techniques are recognised as promising innovative 
technologies in the emerging field of regenerative medicine, as they allow the 
fabrication of constructs of well-defined shape and internal structure, employing 
medical imaging and computer-aided design [139-141]. Bioprinting is a 
subclass of additive manufacturing techniques that involves the organised and 
specific placement of cells and materials, with or without a carrier material, to 
recreate the complex organisation of tissues and organs [142-144]. The 
possibility of combining different cell types and materials makes this approach 
particularly interesting for cartilage tissue engineering, since it can aid in the 
replication of the native zonal organisation of the tissue. 
In bioprinting, hydrogels are most often used as a cell carrier. These hydrogel 
materials need to meet a number of requirements in order to be suitable for 
bioprinting [145, 146]. First, the rheological properties of the material must 
enable the deposition of strands. Second, the material must have adequate 
mechanical properties to allow the construct to retain its shape after printing. 
Third, the gel must be cytocompatible and allow for differentiation of the 
encapsulated cells. Finally, the swelling characteristics of hydrogels must be 
known to predict the final shape and size of a bioprinted construct after 
swelling. 
Gelatin is a water-soluble protein obtained by the denaturation of collagen. Due 
to its biodegradability [147], biocompatibility [148], and ability to form 
hydrogels, gelatin plays a significant role in biomedical materials research and 
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specifically for three-dimensional (3D) cell culture models and tissue 
engineering applications. Aqueous solutions of gelatin form thermoreversible 
hydrogels below their upper critical solution temperature (UCST) of 25–35n°C 
[149, 150]. This thermo-responsive behavior could be employed in bioprinting, 
as thermal gelation would aid in retaining the shape of printed constructs [151]. 
Functionalisation of gelatin with unsaturated methacrylamide groups results in 
gelatin-methacrylamide (Gel-MA), which can form covalently crosslinked 
hydrogels under mild conditions [52, 152] and be cultured with encapsulated 
cells [153-155]. The addition of more viscous components, such as hyaluronic 
acid (HA), could potentially further improve properties important for printing of 
hydrogel systems [156]. Moreover, the presence of HA may be especially 
beneficial for cartilage tissue engineering given its abundance in native cartilage 
and its anabolic effect on extracellular matrix synthesis [157, 158]. 
In this work, we characterised how the macromer concentration, UV dose, and 
crosslinking temperature influence the mechanical and swelling properties of 
Gel-MA hydrogels. Subsequently, we investigated two strategies to allow Gel-
MA to be used as the ‘‘ink’’ in bioprinting. The first was to combine Gel-MA 
with HA to increase the viscosity, and the second was to utilise a thermoplastic 
polymer to provide structural support in printed hybrid constructs. Lastly, we 
assessed the suitability of Gel-MA for engineering of cartilaginous tissue by 
culturing encapsulated chondrocytes in photocrosslinked Gel-MA and Gel-
MA/HA hydrogels. 
4.2   Experimental Section 
4.2.1   Preparation of Gel-MA 
Gel-MA was prepared by reaction of type A gelatin (Sigma–Aldrich, St. Louis, 
Missouri, USA) with methacrylic anhydride (Sigma– Aldrich) at 50 °C for 1 h, 
as previously described [52]. Briefly, methacrylic anhydride was added 
dropwise to a 10% solution of gelatin in phosphate-buffered saline (PBS) 
(Invitrogen, Carlsbad, California, USA) under constant stirring. To achieve a 
high degree of functionalisation (DoF), 0.6 g of methacrylic anhydride was 
added per gram of gelatin [124]. The functionalised polymer was dialysed 
against distilled water for 3 d at 40 °C to remove methacrylic acid and 
anhydride, neutralised with 10% sodium bicarbonate (Merck, Darmstadt, 
Germany), freeze-dried and stored at ~20 °C before use. The DoF was 
determined as previously described [159], by using ninhydrin to quantify the 
concentration of residual free amine groups in the synthesised Gel-MA relative 
to the starting material. 
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4.2.2   Preparation of cell-free gels 
Unless otherwise stated, all concentrations given as a percentage are percent 
weight per volume (w/v). Hydrogel precursor solutions were prepared in PBS, 
with a final concentration of the photoinitiator Irgacure 2959 (BASF, 
Ludwigshafen, Germany) of 0.05% and photocrosslinked in a custom-built 
Teflon mold using 365 nm light at an intensity of 2.7 mW/cm2 in a UVP CL-
1000L crosslinker (UVP, Upland, California, USA). The mold produces gels 
with dimensions of 4 × 4 × 2 mm; n = 4 per condition. Gel-MA gels were either 
crosslinked as solutions at 37 °C, or allowed to form physically crosslinked gels 
at room temperature for 15 min, and then UV crosslinked. 
4.2.3   Physical Properties 
To determine the effective swelling, gels were weighed immediately after 
crosslinking and again after swelling overnight in PBS at 37 °C. The difference 
in wet weights was expressed as a percentage, and referred to hereafter as 
effective swelling. To assess the mass swelling ratio, swollen gels were 
weighed, then lyophilised to determine their dry mass. The mass swelling ratio 
was determined by the ratio of equilibrium wet weight to dry weight. The 
compressive moduli of swollen Gel-MA hydrogels were measured using an 
Instron 5848 microtester (Instron, Norwood, Massachusetts, USA) with a 5 N 
load cell. The hydrogels were tested in an unconfined arrangement while 
submerged in PBS at 37 °C. The gels were compressed at a displacement rate of 
0.01 mm/s between flat, non-porous surfaces. Gels were weighed after testing, 
and the cross-sectional area of each gel was calculated as the ratio of wet weight 
to height. The Young’s modulus was taken as the slope of the stress–strain 
curve from 10 to 15% strain. 
4.2.4   Bioprinting 
Three-dimensional (3D) models for the constructs were designed using Rhino 
3D software (McNeel, Seattle, Washington, USA), loaded via computer-aided 
manufacturing (CAM) software (PrimCAM, Einsiedeln, Switzerland), and 
constructs were printed using the BioScaffolder dispensing system (SYS + 
ENG, Salzgitter-Bad, Germany). Briefly, the BioScaffolder is a three-axis 
dispensing machine, which can build 3D constructs by coordinated motion of 
one or more syringe dispensers (for dispensing hydrogel) and a polymer 
dispenser, which deposit the polymer solution on a stationary platform. 
Manufacturing was performed at room temperature while keeping the hydrogel 
dispensing heads at 37 °C. 
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Printing of hydrogel-only constructs was attempted using 10% Gel-MA, 20% 
Gel-MA, and 20% Gel-MA supplemented with 2.4% HA (HA sodium salt from 
Streptococcus equi, Sigma–Aldrich). Hydrogel-only constructs were printed 
using a 27 G needle (inner diameter 210 μm), an XY-plane speed of 1,000 
mm/min, a spindle speed of 1.5 (arbitrary units), a strand distance of 1.5 mm, 
and a layer thickness of 0.3 mm. The spindle speed reflects the flowrate of the 
hydrogel precursor, and different materials require different XY-plane speeds 
and flow-rate parameters for printing. The optimal speed of the XY-platform 
and the flow-rate of the material were determined for each material used in this 
study. 
Hybrid constructs were printed with 10% Gel-MA plus 2.4% HA, alternated 
with e-polycaprolactone (PCL) (MW 70–90 kg/mol, Sigma–Aldrich) as 
previously described [160]. The PCL was dispensed through a 23 G metal 
needle (inner diameter 337 μm, DL Technology LLC, Haverhill, MA, USA) at 
160 °C and 0.5 MPa, at a deposition speed of 176 mm/min. Gel-MA/HA was 
dispensed between the PCL fibers at an XY-plane speed of 60 mm/min, spindle 
speed of 1.10 (arbitrary units), using an 18 G needle (inner diameter 838 μm). 
Since porosity was not required in these constructs, the XY-plane speed was 
significantly lower than for printing of hydrogel-only constructs. For 
visualisation, the hydrogel was stained using Fast Green or Basic Fuchsin 
(Sigma–Aldrich), or loaded with Dye-Trak ‘‘F’’ fluorescent blue or lemon 
beads (Triton technology, San Diego, CA, USA). After the construct was 
finalised, the Gel-MA was crosslinked by 5 min irradiation with a Superlite S-
UV 2001AV lamp (Lumatec, Munchen, Germany). Printed constructs were cut 
to 6 × 5 × 2 mm and analysed using fluorescence microscopy. 
4.2.5   Cell-laden Gelatin Hydrogel Constructs 
Full thickness healthy articular cartilage was harvested from the condyles and 
patellofemoral grooves of fresh equine cadavers (n=3, age 4–9 years) under 
aseptic conditions. The cells were obtained (with consent of the owners) from 
cadavers that died of natural causes in the clinic, and animals were thus not 
specifically sacrificed for this study. Cells from each donor were kept separate 
throughout the experiment. After digesting the tissue using 0.15% type II 
collagenase (Worthington Biochemical Corporation, Lakewood, New Jersey, 
USA) overnight at 37 °C, the cell suspensions were filtered (100 μm cell 
strainer, BD Falcon, Bedford, Massachusetts, USA) and washed three times in 
PBS. Cells were then resuspended in expansion medium (DMEM, Invitrogen) 
supplemented with 10% fetal bovine serum (FBS, Biowhittaker, Walkersville,
 Maryland, USA), 100 units/mL penicillin and 100 mg/mL streptomycin 
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(both Invitrogen), 25 mM HEPES (Invitrogen), and 10 ng/mL FGF-2 (R&D 
Systems, Minneapolis, Minnesota, USA) and counted using a hemocytometer. 
Chondrocytes were seeded at a density of 5000 cells/cm2 and expanded until 
90% confluency in monolayer cultures in expansion medium. 
After expansion, cells were detached using 0.25% trypsin (Invitrogen), washed 
with PBS, and P1 cells were resuspended in either a 10% Gel-MA solution or a 
mixture of 10% Gel-MA and 2.4% HA (Gel-MA/HA) (n = 3 per condition per 
donor). The Gel-MA hydrogel consisted of 10% Gel-MA and 0.05% Irgacure 
2959 (BASF). For the Gel-MA/HA, 2.4% HA was added to the Gel-MA 
solution, resulting in a highly viscous, translucent mixture. Cells were 
encapsulated at a density of 5 × 106 cells/mL for viability assays and at a density 
of 2 × 107 cells/mL for differentiation assays. Lower cell densities were used to 
more accurately visualise and quantify live and dead cells, while a higher cell 
density was used for increased matrix production in differentiation cultures. 
Constructs of 100 μL were fabricated using two sterilised glass slides and two 
PVC spacers of 2 mm height. The hydrogel-cell suspension was put on a glass, 
the spacers were placed, and the second glass was put on top of the gel, yielding 
a cylindrical construct. A Superlite S-UV 2001AV lamp (Lumatec) was used to 
cross-link the cell-laden hydrogel constructs for 5 min. Constructs were cultured 
in chondrogenic differentiation medium [DMEM supplemented with 0.2 mM 
ascorbic acid 2-phosphate (Sigma–Aldrich), 0.5% human serum albumin 
(Cealb, Sanquin, Utrecht, The Netherlands), 1% v/v insulin–transferrin–
selenium mixture (ITS-X, Invitrogen), 100 units/mL penicillin and 100 μg/mL 
streptomycin, and 5 ng/mL TGF-β2 (R&D Systems Abingdon, UK)]. Samples 
for viability assays were taken after 1 and 3 days. Samples for differentiation 
were cultured for 4 weeks; medium was refreshed twice per week. Samples (n = 
3 per donor) were cut in half, one half was processed for histology and the other 
half was used for quantitative assays. 
4.2.6   Viability Assay 
To visualise cell viability, a LIVE/DEAD Viability Assay (Molecular Probes 
MP03224, Eugene, Oregon, USA) was performed according to the 
manufacturer’s recommendations, as previously described [151]. The samples 
were examined using an Olympus BX51 light microscope and 
photomicrographs taken with an Olympus DP70 camera (both Olympus, USA). 
The excitation/emission filters were set at 488/530 nm to observe living (green) 
cells and at 530/580 nm to detect dead (red) cells. Live and dead cells were 
counted for three samples per time point, at four locations within each construct. 
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4.2.7   Histological, Immunohistochemical and Biochemical 
Assays 
For histology, samples were fixed in formalin, processed through graded alcohol 
series, and embedded in paraffin. Embedded samples were cut to yield 5 μm 
sections. Sections were stained with Weigert’s hematoxylin (Klinipath, Duiven, 
The Netherlands) for cells, fast green (Merck) for proteins, and Safranin-O 
(Merck) for proteoglycans. For immunolocalisation of cartilage marker collagen 
type II, endogenous peroxidase was blocked using a 0.3% H2O2 solution for 10 
min. Samples were washed with PBS/Tween (0.1%), followed by hyaluronidase 
and pronase antigen retrieval. Samples were blocked with 5% BSA in PBS for 
30 min and then incubated overnight with the monoclonal anti-collagen type II 
antibody [1:100, II-6B3II, Developmental Studies Hybridoma Bank (DSHB), 
Iowa City, IA, USA]. Samples were then incubated for 60 min with a 
horseradish peroxidase-conjugated goat anti-mouse antibody. Staining was 
visualised using DAB solution (Sigma–Aldrich) for 10 min. Counterstaining 
was performed with hematoxylin. The sections were examined using a light 
microscope. Isotype controls were performed by using mouse isotype IgG1 
monoclonal antibody at concentrations similar to those used for the staining. For 
biochemical analysis, samples were digested overnight at 56 °C in a solution 
containing 250 μg/mL papain (Sigma–Aldrich). Quantification of total DNA 
was performed by Quant-iT PicoGreen dsDNA kit (Invitrogen) using a 
spectrofluorometer (BioRad, Hercules, California, USA). The amount of 
glycosaminoglycans (GAGs) was determined spectrophotometrically after 
reaction with dimethylmethylene blue dye (DMMB, Sigma–Aldrich) [125], pH 
= 3.0.  
Intensity of color change was quantified immediately in a microplate reader 
(BioRad) by measuring absorbance at 540 and 595 nm. The amount of GAGs 
was calculated using a standard of chondroitin sulfate C (Sigma–Aldrich) and 
by calculating the ratio of absorbances. The tissue sections were examined using 
a light microscope and photomicrographs taken to assess the tissue thickness, 
the distribution of cells, and GAGs. 
4.2.8   Statistics 
All statistical analyses were performed using SPSS 15.0 software (IBM 
Corporation, Armonk, NY, USA). A one-way ANOVA and Tukey’s post hoc 
test were used for analysis of physical properties. To analyse viability between 
conditions, a one-way analysis of variance (ANOVA) was used, while for 
viability in time, a repeated measurements ANOVA was performed. For the 
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comparison between GAG and GAG per DNA, an independent samples t-test 
was used. All data are shown as mean values ± standard deviation. 
4.3  Results 
The synthesised and purified Gel-MA had a DoF of 75 ± 9%. Transparent Gel-
MA hydrogels with a wide range of mechanical and swelling properties were 
produced by varying the photocrosslinking duration and Gel-MA concentration. 
4.3.1   Effect of Macromer Concentration 
To investigate the effect of macromer concentration on swelling and mechanical 
properties, gels were produced by photocrosslinking 5, 10, 15, and 20% Gel-
MA solutions. All gels were photocrosslinked for 30 min to produce completely 
crosslinked gels. Other studies in our laboratory have shown that up to cell 
densities of 7 × 106 cells/mL, the physical properties of cell-free and cell-laden 
Gel-MA constructs are similar after crosslinking and swelling overnight 
(manuscript in preparation), and future studies will investigate how differences 
in the initial mechanical properties influence outcomes of cell-laden constructs 
after in vitro culture. Gel-MA concentration had a significant impact on 
hydrogel stiffness (Figure 4.1A) and equilibrium mass swelling (Figure 4.1B), 
but only a minor influence on the effective swelling (Figure 4.1B). The 
compressive modulus showed a strong power-law dependence on the Gel-MA 
precursor concentration. For Gel-MA concentrations between 5 and 20%, the 
modulus of gels crosslinked for 30 min was given by Equation 4.1, in which 
E100 is the modulus of a (hypothetic) undiluted gel (100% Gel-MA, no PBS), C 
is the Gel-MA concentration (% w/v), and n is the power constant. 
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Figure 4.1: Mechanical and swelling properties of Gel-MA hydrogels 
crosslinked for 30 minutes. (A) Compressive modulus shows a power law 
dependence on concentration (lower equation, solid line). The top equation and 
dashed line represent the overall model in which the exposure time is included as 
well (Equation 4.3). (B) Effective swelling (bars) and mass swelling ratio (dots) for 5–
20% (w/v) Gel-MA hydrogels. Differences in the initial Gel-MA concentrations are 
maintained after swelling, indicated by distinct mass swelling ratios between groups. 
Effective swelling (B) increases only moderately with Gel-MA concentration. All 
groups are statistically significantly different, as indicated by different Roman 
numerals (p<0.05). 
The low degree of effective swelling exhibited by the Gel-MA gels over a broad 
range of macromer concentrations is favorable for application in bioprinting, as 
excessive swelling would compromise printing accuracy. Even at the lowest 
Gel-MA concentration the weight change was only 12% (shrinkage in this case). 
This corresponds to a volume change of approximately 12% as well, which is 
less than 4% change in each dimension. Thus hydrogels with different 
macromer concentrations could potentially be combined in a single construct 
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with minimal interfacial stress, to obtain spatially defined mechanical properties 
as is the case in native cartilage [118]. 
Equation 4.1: Power law dependence of compressive modulus (E, kPa) on Gel-
MA concentration (C, % w/v) of gels crosslinked for 30 min. 
E =  E100 � C100�n 
4.3.2   Effect of UV exposure 
Total UV exposure is a sensitive parameter for controlling the stiffness and 
swelling of Gel-MA hydrogels. The compressive moduli of 20% Gel-MA 
hydrogels crosslinked for 30 min were over tenfold greater than those 
crosslinked for 5 min (Figure 4.2A), while hydrogels crosslinked for 10 min 
were over sixfold greater than those crosslinked for 5 min. The variation of 
modulus with UV time appeared to follow first order kinetics. Equation 4.2 
shows the model used to estimate the modulus of 10 and 20% Gel-MA 
hydrogels crosslinked for UV times ranging from 5 to 30 min. The modulus of 
the fully crosslinked hydrogels (at infinite exposure times) are given by E∞. A 
time shift (A, in min) was incorporated to account for retardation (consumption 
of formed radicals by reaction with dissolved oxygen prior to the onset of 
crosslinking of the methacrylamide groups) and to achieve the minimum 
crosslink density necessary for gel formation. The time constant τ (minutes), A 
and E∞ were determined using Solver in Excel to minimise the sum of squared 
errors. The values of these parameters for 10 and 20% Gel-MA hydrogels are 
shown in Table 4.1. For both Gel-MA concentrations, a time shift of 
approximately 4 min was found, which accounts for the large difference in 
moduli of hydrogels crosslinked for 5 or 10 min. The time constants, τ, were 9.4 
and 10.9 min for 10 and 20% Gel-MA hydrogels, respectively, indicating that in 
each case gels have attained approximately two thirds of their maximum 
modulus after approximately 10 min UV exposure.  
The effective swelling ratio is highly dependent on UV exposure, decreasing 
from 60% with 5 min exposure to negligible swelling after 25 or more minutes 
of UV exposure (Figure 4.2B). These data demonstrate that the UV exposure 
affects the mechanical properties of the hydrogel, but also define the kinetics of 
the reaction. Near-complete reaction of the functional groups is indicated by 
both the compressive modulus and the swelling parameters reaching steady-state 
at 25–30 min. It is important to keep in mind that the total UV exposure, not the 
UV time, that is the main parameter of importance, and that changing the UV 
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intensity would also change the necessary UV exposure times. Additionally, the 
DoF will affect the modulus, swelling parameters, and kinetics of the reaction as 
well. Preliminary experiments using Gel-MA with lower DoF (~40%) showed 
lower stiffness, along with swelling ratios up to 160% (data not shown). As 
these attributes are unsuitable for cartilage tissue engineering applications, all 
studies described here are based on the Gel-MA with a high DoF (75 ± 9%). 
 
Figure 4.2: Effect of UV exposure on the mechanical and swelling properties of 
20% (w/v) Gel-MA hydrogels. (A) Compressive modulus increases with UV 
exposure time in agreement with the exponential model (lower equation, solid line). 
The top equation and dashed line represent the overall model in which the Gel-MA 
concentration is included as well (Equation 4.3). (B) Effective swelling (bars) and 
mass swelling ratio (dots) decrease significantly with increased UV exposure. 
Statistically significant differences (p < 0.05) between groups are indicated by 
different Roman numerals. 
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Combining Equation 4.1 and Equation 4.2 gave a model for estimating the 
modulus of Gel-MA hydrogels with varying concentrations and 
photocrosslinking times (Equation 4.3). This equation was solved using the 
minimal sum of squared error method for all available combinations of 
concentration and exposure times, resulting in the generic best-fit parameters 
listed in Table 4.2. Here, the same parameters C and t and the same constants n, 
A, and τ are used as in Equation 4.1 and Equation 4.2. Emax combines the time-
dependent parameter E100 (Equation 4.1) and concentration-dependent E∞ 
(Equation 4.2) into one independent parameter, Emax, which represents the 
maximum modulus of a 100% Gel-MA gel at infinite exposure time. Its value of 
approximately 8 MPa is typical for rubbers, reinforcing that (Gel-MA) 
hydrogels are networks of rubbery polymer chains diluted by water. 
Equation 4.2: Model to approximate the compressive modulus (E, kPa) of Gel-
MA hydrogels with varying UV exposure time (t, min), for a given concentration 
of Gel-MA. E =  E∞�1− e−(t−A)/τ� 
Table 4.1: Best-fit parameters for the compressive modulus model (Equation 
4.2) using experimental data of 10 and 20% (w/v) Gel-MA hydrogels. 
Gel-MA Concentration 
 (% w/v) 
E∞ 
 (kPa) 
A  
(min) 
τ  
(min) 
10 36 4.0 9.4 
20 199 4.3 10.9 
 
The mathematical model can be used to guide the selection of concentrations 
and photocrosslinking times that should be used to give gels with a specific 
stiffness. It is only valid if other parameters used in this system, such as DoF, 
photoinitiator concentration, UV intensity, solvent type (PBS here), and 
crosslinking temperature remain constant. Changes to these conditions will 
affect the crosslinking kinetics and alter the values of parameters in Equation 3, 
although it is expected that the underlying model could be fitted to other 
conditions. 
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Equation 4.3: Model for estimating the compressive modulus (E, kPa) of Gel-
MA hydrogels based on Gel-MA concentration (C, % w/v) and UV exposure 
time (t, min). 
E =  Emax � C100�n �1− e−(t−A)/τ� 
     where   5 ≤ C ≤ 20 
       5 ≤ t ≤ 30  
Table 4.2: Best-fit parameters for the compressive modulus model (Equation 3) 
using experimental data of 5–20% (w/v) Gel-MA hydrogels. 
Emax (kPa) n A (min) τ (min) 
7995 2.28 4.2 11.5 
 
4.3.3 Effect of Temperature 
The state of Gel-MA polymer chains during crosslinking, and the mechanical 
properties of the resulting gels, is dependent on the gelation state during 
crosslinking (Figure 4.3). Gel-MA solutions that were maintained at 25 °C and 
were allowed to form thermal gels prior to UV exposure were significantly 
stiffer than those that were maintained at higher temperature (37 °C). The 
increased stiffness of gels which were photocrosslinked as physical gels (i.e., at 
25 °C) was maintained when the gels were swelled and mechanically tested at 
37 °C, indicating that the physical crosslinks that arise from thermal gelation are 
no longer temperature-responsive after covalent crosslinking. Moreover, gels 
crosslinked in solution at 37 °C also showed no difference in stiffness when 
tested at either 25 or 37 °C, confirming that these gels had also lost their 
temperature-responsiveness (data not shown). Gels crosslinked at 37 °C had 
similar equilibrium swelling ratios to those crosslinked at room temperature. 
The thermo-responsive properties of Gel-MA may be utilised during bioprinting 
to provide mechanical support prior to covalent photocrosslinking of the Gel-
MA network. By photocrosslinking the hydrogel in a thermal gel state, the Gel-
MA polymer chains maintain a triple helical conformation, and hence their 
biological relevance [161]. Photocrosslinking after printing and thermal gelation 
has the advantages of increased stiffness and stability, which is important for its 
potential application in tissue engineering. 
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Figure 4.3: Effect of crosslinking temperature on the stiffness of 10 and 20% 
Gel-MA hydrogels. Gels were crosslinked at 37 °C (white bars), or allowed to cool 
to room temperature then UV crosslinked (gray bars). All gels were tested at 37 °C; * 
indicates p < 0.05. 
4.3.4 Bioprinting of Gel-MA and Gel-MA/HA 
Bioprinting of Gel-MA was, despite the thermosensitive behavior of the 
material, hampered by its low viscosity. Upon ejection from the needle, droplets 
were formed that spread when contacting the building platform (Figure 4.4A, 
C). At lower temperatures the viscosity increased significantly, but at the cost of 
irregular flow rates and material inhomogeneity, resulting in blocking of the 
nozzle. The addition of 2.4% HA to 20% Gel-MA allowed the controlled, 
homogeneous deposition of hydrogel strands (Figure 4.4B). The strands fused to 
form mechanically robust porous constructs measuring ~20 × 20 × 1.2 mm and 
consisting of four stacked layers with a 0–90° lay-down pattern were fabricated 
according to the predefined size and shape (Figure 4.4D). The addition of HA 
increases the viscosity, and can facilitate the printing process and improve shape 
fidelity, as had been previously shown for dextran-based gels [156]. In this way, 
large and interconnected pores can be introduced, which is especially important 
when larger, clinically relevant constructs are to be manufactured [162-164]. 
Porosity can enhance nutrient transport and waste removal by decreasing 
diffusion distances [162]. This in turn leads to more homogeneous cell 
differentiation [163] and extracellular matrix deposition. The flexibility of 
printing allows constructs with various degrees of porosity to be fabricated, 
including non-porous (solid) constructs as is common when this fused 
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deposition modeling technique is employed for rapid prototyping purposes. The 
porosity and architecture of constructs will impact both the mechanical 
properties and diffusion, and the optimal parameters relevant for cartilage tissue 
engineering must be pursued in further research. 
To print well-defined, gel-only constructs, 20% Gel-MA with 2.4% HA had to 
be used. However, previous studies have shown that highly crosslinked gels 
inhibit the secretion and formation of new ECM, and that hydrogels with lower 
crosslinking densities provide a more permissive environment for matrix 
formation [94, 122, 165]. To overcome this limitation, Gel-MA could be 
combined with another material to enhance the rheological and mechanical 
properties, for instance with gellan gum [124] or fibrin [166]. The 
characterisation of Gel-MA/HA and other additives will be subject of future 
investigation, aiming at improving both printing accuracy and neocartilage 
formation. 
 
Figure 4.4: Bioprinting of Gel-MA with or without HA. Gel-MA on its own (20% 
w/v) formed droplets at the nozzle (A) and was deposited in flat lines that spread out 
on the surface (C). When 2.4% (w/v) HA was added, strands could be deposited 
from the nozzle (B), resulting in a construct of four layers (D). The scale bars in A–C 
represent 5 mm; the scale bar in D is 2 mm. 
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When constructs were fabricated using reinforcement with simultaneously 
deposited PCL fibers, the Gel-MA concentration could be lowered from 20 to 
10% (still supplemented with 2.4% HA). Combining the hydrogel with the 
thermoplastic polymer also made it feasible to print more layers on top of each 
other, creating rectangular scaffolds (6 × 60 × 1.98 mm), with separate Gel-
MA/HA hydrogel parts, in which different components could be incorporated. 
Figure 4.5 shows cross-sections of such hybrid structures in which separate 
layers of gel can be discerned by different colored fluorescent beads (Figure 
4.5A), or different coloured dyes (Figure 4.5B). The fabrication of distinct gel 
layers as shown here demonstrates the potential for capturing zone-specific 
components and material properties in printed constructs. The advantages of 
these hybrid constructs are two-fold: a wider range of hydrogels can be used for 
bioprinting, as shown here with a lower percentage of Gel-MA, and the stiffness 
of the resulting fiber-reinforced hydrogel is higher [160, 167] and hence better 
suited for musculoskeletal applications, in which the constructs bear 
considerable mechanical loads [160, 168-170]. The aim of this section of the 
study was to evaluate the potential to use Gel-MA or Gel-MA/HA mixtures in 
bioprinting, and the viability and differentiation of chondrocytes encapsulated in 
these materials. Although cell-laden, printed constructs were not fabricated in 
this study, cell viability has previously been shown to be similar in printed 
hybrid constructs and unprinted controls [144, 160], so similar cell viabilities 
would also be expected in printed, cell-laden constructs fabricated from these 
materials. 
Figure 4.5 shows that hydrogels can be organised into layered structures with a 
total height of less than 2 mm, which is comparable to the thickness of articular 
cartilage in the human knee or hip [171]. Thus using these bioprinting 
techniques, layered structures for the repair of articular cartilage can be 
fabricated [118]. Bioprinting enables researchers to combine different materials 
and different cell types into one construct, thus facilitating the replication of the 
complex architecture of tissues. This can be of value for both in vitro models 
and for the engineering of neotissues for implantation. The hybrid approach 
allows for a wider range of hydrogel materials to be used with this technology 
and therefore expands the possibilities for models and implantable tissues. 
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Figure 4.5: Hybrid bioprinting of Gel-MA/HA (10%/2.4%) resulted in rectangular 
scaffolds with two separate Gel-MA/HA hydrogel parts. Cross-sections of such 
constructs are shown, with incorporated blue and orange fluorescent beads (A) or 
basic fuchsin (pink) and fast green (B) to visualise the two Gel-MA hydrogels. The 
scale bars represent 2 mm. 
4.3.5 Cell-laden Gel-MA Hydrogel Constructs  
Chondrocyte viability in 10% Gel-MA was high, both with and without HA 
(Table 4.3). No significant differences were observed between days 1 and 3 of 
culture for either of the hydrogels (p = 0.320 for Gel-MA, p = 0.662 for Gel-
MA/HA). Between materials there was no significant difference at day 1 (p = 
0.946), but at day 3 the cell viability was significantly higher in Gel-MA/HA (p 
= 0.045). Viability was comparable to the values reported for the widely used 
calcium-crosslinkable [172] or photo-crosslinkable [173] alginate hydrogels, 
and at acceptable levels for both gel types. During photo-crosslinking, the 
radicals generated are quickly consumed in the crosslinking process, so cells are 
not adversely affected by UV exposure during crosslinking, whereas cells in 
monolayer cultures exposed to equivalent conditions are [65]. 
Table 4.3: Cell viability and glycosaminoglycans per DNA for Gel-MA and Gel-
MA/HA hydrogels. 
Hydrogel Viability day 1 ± SD (%) 
Viability day 3 
± SD (%) 
GAG/DNA 
day 28 (g/g) 
Gel-MA 83 ± 13 73 ± 2 7.1 ± 3.3 
Gel-MA/HA 79 ± 18 82 ± 8 * 10.5 ± 5.2 
 * Significantly different from Gel-MA day 3 (p = 0.045) 
Cartilaginous tissue was formed after 4 weeks in both materials, indicated by the 
presence of glycosaminoglycans using Safranin-O staining (Figure 4.6A, B) and 
DMMB assay (Table 4.3), along with the presence of cartilage marker collagen 
type II (Figure 4.6C, D). No significant difference in the amount of GAGs 
retained, normalised to DNA, was observed between the Gel-MA and Gel-
MA/HA hydrogels (p = 0.129). Previously, HA has been reported to enhance 
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chondrogenesis, but its effects appear to be concentration dependent. Several 
studies have reported HA to have chondrogenic properties at low 
concentrations, while at higher concentrations HA has no effect, or may even 
inhibit chondrogenesis [101, 174-176]. A relatively high concentration of HA 
was required to give sufficient viscosity for printing, and this may explain why 
GAG/DNA values were similar in the presence or absence of HA. Overall, the 
high cell viability and the formation of cartilaginous tissue confirm the 
suitability of both tested materials for cartilage tissue engineering purposes. 
However, the limited connectivity of the newly formed extracellular matrix 
(Figure 4.6C, D) makes it clear that further optimisation of these materials or 
cell culture conditions is required. 
 
Figure 4.6: Histology and immunohistochemistry of Gel-MA and Gel-MA/HA 
hydrogels after 4 weeks of culture. Cells are stained blue in both cases. Safranin 
O staining indicating glycosaminoglycan formation (red) in Gel-MA (A) and Gel-
MA/HA (B) hydrogels. Collagen type II immunostaining (brown) showing cartilaginous 
matrix production in Gel-MA (C) and Gel-MA/HA (D) hydrogels. The scale bar 
represents 200 μm and applies to all panels. 
Cell-based approaches in which chondrocytes are encapsulated in hydrogels 
have shown promise for cartilage regeneration [177], but must be able to 
withstand the harsh mechanical environment. As we have shown, hydrogels get 
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stiffer and stronger with increasing polymer content and crosslink density. 
However, for promoting the production of new matrix, polymer content and 
crosslink density should not be too high as this would impede the production 
and redistribution of extracellular matrix [120]. The crosslink density of 
polyethylene glycol gels has been shown to affect the distribution and 
composition of matrix deposited by encapsulated chondrocytes [120]. GAG 
distribution was homogeneous in loosely crosslinked PEG gels, with a modulus 
of 30 kPa, and localised to the pericellular regions in the more tightly 
crosslinked gels, with moduli of 360 and 960 kPa, respectively. Collagen type II 
deposition was also dependent on crosslink density, with the highest levels seen 
in the gels with an intermediate crosslink density (360 kPa). Thus a balance 
exists between optimizing gel properties for withstanding mechanical loads, and 
promoting synthesis and accumulation of new cartilage. 
4.4  Conclusion 
The physical properties of Gel-MA hydrogels can be controlled by manipulating 
the UV dose and concentration of Gel-MA in the precursor solution. Gels with 
compressive moduli in the range 5–180 kPa can be fabricated by varying the 
concentration of the precursor solution from 5 to 20%. Over this range of 
concentrations, the changes in gel dimensions caused by swelling are very 
small, facilitating the preparation of gel constructs with high shape fidelity. A 
mathematical model was developed that can be used to determine the 
concentration and UV exposure time required to give gels with a desired 
stiffness, as a useful tool for the development of Gel-MA-based hydrogel 
biomaterials in load bearing applications. The possibility to control the 
mechanical and swelling properties of the material, combined with the high cell 
survival and the formation of cartilaginous tissue make Gel-MA a candidate 
material for cartilage tissue engineering. When combined with viscosity-
enhancing additives such as HA and/or a reinforcing support structure, such as 
PCL, Gel-MA can be fabricated into layered hydrogel structures, which could 
aid in the engineering of human cartilage.  
Acknowledgements 
The authors would like to thank the Australian Research Council and the European 
Union (Marie Curie Fellowship (PIOF-GA-2010-272286 to Melchels)) for funding. The 
support of the Dutch Arthritis Foundation is gratefully acknowledged. The antibody 
against collagen type II, developed by T. F. Linsenmayer, was obtained from the 
DSHB developed under the auspices of the NICHD and maintained by The 
University of Iowa, Department of Biology, Iowa City, IA 52242. 
 
 71 
Chapter 4 
  
 72 
  
 
 
 
Chapter 5  
 
A biomimetic extracellular matrix for 
cartilage regeneration centered on photo-
curable gelatin, hyaluronic acid and 
chondroitin sulfate 
 
Peter A. Levett1,2, Ferry P. W. Melchels1,2, Karsten Schrobback1, Dietmar 
W. Hutmacher1,3, Jos Malda1,2 and Travis J. Klein1 
Acta Biomaterialia (2014), Vol. 10, No. 1, p. 214-223. 
1 Institute of Health and Biomedical Innovation, Queensland University of 
Technology, 60 Musk Ave, Kelvin Grove, QLD 4059, Australia 
2 Department of Orthopaedics, University Medical Center, Utrecht, P.O. Box 
85500, 3508 GA, The Netherlands 
3 George W Woodruff School of Mechanical Engineering, Georgia Institute of 
Technology, Atlanta, Georgia, USA 
  
 73 
Chapter 5 
Statement of Contribution of Co-Authors for 
Thesis by Published Paper 
The authors listed below have certified that: 
1. They meet the criteria for authorship in that they have participated in the conception, 
execution, or interpretation, of at least that part of the publication in their field of 
expertise; 
2. They take public responsibility for their part of the publication, except for the 
responsible author who accepts overall responsibility for the publication; 
3. There are no other authors of the publication according to these criteria that are not 
listed;  
4. Potential conflicts of interest have been disclosed to (a) granting bodies, (b) the editor or 
publisher of journals or other publications, and (c) the head of the responsible academic 
unit, and 
5. They agree to the use of the publication in the Peter Levett’s thesis and its publication on 
the QUT ePrints database consistent with any limitations set by publisher requirements. 
 
Chapter 5: A biomimetic extracellular matrix for cartilage tissue engineering 
centered on photocurablegelatin, hyaluronic acid and chondroitin sulfate, 
published in Acta Biomaterialia in October 2013. 
 
Contributor Statement of Contribution 
Peter A Levett 
Experimental design, polymer synthesis, hydrogel construct 
fabrication, cell culture, construct analyses, data analysis and 
manuscript preparation. 
8 March 2016 
Ferry. P. W. Melchels Experimental design, polymer synthesis and manuscript editing. 
Karsten Schrobback Experimental design, data analysis and manuscript editing. 
Dietmar. W. Hutmacher Experimental design and manuscript editing. 
Jos Malda Experimental design and manuscript editing. 
Travis J. Klein Experimental design, construct analyses, data analysis and manuscript editing. 
 
Principal Supervisor Confirmation  
I have sighted email or other correspondence from all co-authors confirming their certifying 
authorship. 
Travis Klein 8 March 2016 
Name Signature Date 
 
 74 
QUT Verified 
Signature
QUT Verified 
Signature
Gel-MA, HA-MA and CS-MA hydrogels for cartilage tissue engineering 
Abstract 
The development of hydrogels tailored for cartilage tissue engineering has been 
a research and clinical goal for over a decade. Directing cells towards a 
chondrogenic phenotype and promoting new matrix formation are significant 
challenges that must be overcome for the successful application of hydrogels in 
cartilage tissue therapies. Gelatin-methacrylamide (Gel-MA) hydrogels have 
shown promise for the repair of some tissues, but they have not been extensively 
investigated for cartilage tissue engineering. We encapsulated human 
chondrocytes in Gel-MA based hydrogels, and show that with the incorporation 
of small quantities of photo-crosslinkable hyaluronic acid methacrylate (HA-
MA), and to a lesser extent chondroitin sulfate methacrylate (CS-MA), 
chondrogenesis and mechanical properties can be enhanced. The addition of 
HA-MA to Gel-MA constructs resulted in more rounded cell morphologies, 
enhanced chondrogenesis as assessed by gene expression and 
immunofluorescence, and increased quantity and distribution of the newly 
synthesised ECM throughout the construct. Consequently, while the 
compressive moduli of control Gel-MA constructs increased by 26 kPa after 8 
weeks culture, constructs with HA-MA and CS-MA increased by 96 kPa. The 
enhanced chondrogenic differentiation, distribution of ECM, and improved 
mechanical properties make these materials potential candidates for cartilage 
tissue engineering applications. 
Keywords: cartilage tissue engineering; hydrogels; photopolymerisation; 
gelatin; hyaluronic acid 
  
 75 
Chapter 5 
5.1  Introduction 
Articular cartilage is a collagen- and proteoglycan-rich tissue. More specifically 
though, collagen type II accounts for over 90% of total collagen in the mature 
tissue [178], and together with proteoglycans, the large quantity of collagen type 
II provides the tissue with the mechanical properties required to absorb impacts 
and withstand significant loads. In the superficial zone of cartilage, lubricating 
molecules such as proteoglycan 4 (PRG4) allow for low-friction movement in 
articulating joints. However, cartilage is frequently damaged through trauma or 
disease, and has little to no capacity for self-repair. Without intervention, 
damaged cartilage continues to degenerate to the point where pain and impaired 
mobility result, and a joint replacement is typically required. Cartilage tissue 
engineering is a promising approach to repair damaged cartilage, thereby 
alleviating the prolonged degeneration and ultimate joint replacement, and to 
this end, regenerative medicine approaches for cartilage repair have been widely 
studied and tested for over two decades [50, 179]. 
One of the major limitations of regenerative cartilage therapies has been the 
inability to regenerate tissue with the original composition and structure of 
articular cartilage. In approximately 50% of cases, the repair tissue from 
autologous chondrocyte implantation (ACI) [50] resembles fibrocartilage and is 
rich in collagen type I, instead of collagen type II [180, 181]. This is most likely 
due to chondrocyte dedifferentiation during expansion in two-dimensional 
cultures. Consequently, the repair tissue often lacks the biomechanical 
properties required to persist in a loaded joint. These inconsistent ACI results 
have prevented ACI procedures from becoming the routine first line of 
treatment for cartilage defects [180]. Thus, for cartilage tissue engineering to be 
ultimately successful, it will be critical to control the phenotype of 
chondrocytes, and the composition and organisation of the extracellular matrix 
(ECM) they produce [117]. The design of biomaterials to promote chondrogenic 
differentiation and guide cartilage ECM synthesis is a key approach to improve 
cartilage tissue engineering outcomes, and has attracted significant research 
interest in the past decade [118, 182-184]. Various materials have also been 
tested in next-generation ACI procedures, in which cells are seeded onto 
biomaterials prior to implantation [185]. Gelatin–methacrylamide (Gel-MA) 
hydrogels have attracted attention for tissue engineering applications in recent 
years [66]; however, their potential for application in cartilage tissue 
engineering has not been widely investigated. 
Gelatin is produced by the hydrolysis of ECM-derived collagens, predominantly 
collagen type I. Gel-MA can be produced by chemical modification of gelatin, 
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allowing hydrogels to be covalently crosslinked in the presence of a 
photoinitiator and light [52]. During hydrolysis and chemical modification, 
some conformational structures are irreversibly altered, but Gel-MA hydrogels 
retain some properties of collagens and gelatin, such as cell adhesion domains 
[66], thermosensitivity [52] and enzymatic degradability [153]. Gel-MA 
hydrogels are gaining popularity as biomaterials, since they support the 
formation of new ECM, are enzymatically degradable, can be produced at low 
cost, are potentially injectable or printable, are easily crosslinked under 
physiological conditions, and show potential for cartilage tissue engineering 
[123]. 
In this study, we aimed to enhance chondrocyte behaviour in Gel-MA-based 
hydrogels by incorporating glycosaminoglycans (GAGs) into the hydrogels. 
Two of the most abundant GAGs in cartilage are hyaluronic acid (HA) and 
chondroitin sulfate (CS), and we incorporated these into Gel-MA hydrogels 
separately or together. We used methacrylated HA and CS (HA-MA and CS-
MA, respectively) to allow covalent and stable incorporation of these GAGs 
into the Gel-MA hydrogels. Table 5.1 shows the composition and notation used 
for the hydrogel groups tested in this study. 
5.2   Materials and Methods 
5.2.1 Macromer Synthesis 
Gelatin (porcine skin, type A), chondroitin sulfate A and methacrylic anhydride 
(MAAh) were purchased from Sigma Alrich (St Louis, MO, USA). Hyaluronic 
acid (molecular weight 0.86 MDa) was generously provided by Novozymes. 
Gel-MA, HA-MA and CS-MA were synthesised by reaction of gelatin, HA and 
CS, respectively, with MAAh, using protocols based on published methods [52, 
56]. Briefly, gelatin, HA and CS were dissolved in phosphate-buffered saline 
(PBS, Invitrogen, Carlsbad, CA, USA) at 10%, 1% and 25% w/v, respectively. 
Gelatin was reacted with 0.6 g of MAAh per gram of gelatin for 1 h at 50 °C 
[52]. CS and HA were reacted with MAAh for 24 h on ice, with the pH 
regularly adjusted to 8 with 5 M sodium hydroxide [56, 186]. For HA and CS 
the molar excess of MAAh over the hydroxyl groups was 5- and 10-fold, 
respectively. After the reaction period, insoluble MAAh was removed by 
centrifugation, followed by dialysis against deionised water to remove 
remaining unreacted MAAh and methacrylic acid. The pH of the dialysed 
polymer solutions was adjusted to 7.4, after which they were freeze-dried and 
stored at -20 °C. 
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Table 5.1: Composition and notation of hydrogels tested in this study. 
Hydrogel Notation Composition (% wt/vol) 
Gel-MA 10% Gel-MA 
G-HA 9.5% Gel-MA, 0.5% HA-MA 
G-CS 9.5% Gel-MA, 0.5% CS-MA 
G-HA-CS 9% Gel-MA, 0.5% HA-MA, 0.5% CS-MA 
 
5.2.2 Cell Isolation and Expansion  
The procedure for isolating zonal chondrocytes from cartilage has been 
described in detail elsewhere [187]. Briefly, zonal cartilage samples were 
excised from the macroscopically normal regions of the femoral condyle of a 
patient undergoing knee replacement surgery, with consent and ethics approval 
from the Prince Charles Hospital and Queensland University of Technology 
[187]. Chondrocytes were expanded in low-glucose Dulbecco’s Modified 
Eagle’s Medium (DMEM) with 2 mM glutamax (Invitrogen), supplemented 
with 10% fetal bovine serum (Lonza, Waverly Australia), 10 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 0.1 mM non-essential 
amino acids, 0.5 μg/mL amphotericin B (Fungizone®), 50 U/mL penicillin G 
sodium, 50 μg/mL streptomycin (all Invitrogen), 0.4 mM L-proline and 0.1 mM 
ascorbic acid (both Sigma). 
5.2.3 Cell Encapsulation and Culture 
All hydrogel precursor solutions were prepared in PBS, and contained 0.05% 
(w/v) of the photoinitiator Irgacure 2959 (BASF, Ludwigshafen, Germany). 
Passage 1 chondrocytes were suspended in one of the four precursor solutions 
(Table 5.1) at a density of 7 million cells/mL. Hydrogels were crosslinked by 15 
min exposure to 365 nm light at an intensity of 2.6 mW/ cm2 in a CL-1000 
crosslinker (UVP, Upland, CA, USA). The hydrogels were formed in a custom-
manufactured Teflon mold covered by a glass slide, which produces gels with 
dimensions of 4 × 4 × 2 mm. The cell–hydrogel constructs were cultured for up 
to 8 weeks in defined chondrogenic differentiation media (high-glucose DMEM 
with 2 mM glutamax (Invitrogen), 10 mM HEPES, 0.1 mM non-essential amino 
acids, ITS-G (100× dilution), 0.5 μg/mL amphotericin B (Fungizone®), 50 
U/mL penicillin G sodium, 50 μg/mL streptomycin (all Invitrogen), 1.25 mg/mL 
bovine serum albumin (BSA), 0.4 mM L-proline, 0.1 mM ascorbic acid, 0.1 μM 
dexamethasone (all Sigma) and 10 ng/mL TGF-β3 (GroPep, Adelaide, SA, 
Australia)). Cell-free hydrogels were cultured in high-glucose DMEM with 1.25 
mg/mL BSA, 0.5 μg/mL amphotericin B, 50 U/mL penicillin G sodium and 50 
μg/mL streptomycin. 
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5.2.4 Viability Assay 
Live and dead cells were visualsed with fluorescein diacetate (FDA) and 
propidium iodide (PI, both Sigma), respectively, at day 1, week 5 and week 8. 
Hydrogel constructs were washed in PBS, incubated in a solution of 10 μg/mL 
FDA and 5 μg/mL PI for 5 min at 37 °C, then washed twice in PBS. Images 
were captured using a Nikon Eclipse fluorescence microscope. 
5.2.5 Biochemical Analyses 
At each media change, the amount of GAGs secreted from cell-free and cell-
laden constructs into the culture media was measured using the dimethyl-
methylene blue (DMMB) assay (pH 1.5) [125]. Absorbances at 525 and 595 nm 
were measured, and the concentrations were calculated using the ratio of 
absorbances, compared to a quadratic standard curve prepared from chondroitin 
sulfate C (Sigma). Data from the first media change were excluded to allow for 
diffusion of unbound CS-MA from some gel groups. To quantify the retained 
GAGs and DNA, cultured constructs were weighed, frozen and freeze-dried. 
Dried constructs were digested overnight in 1 mg/mL hyaluronidase (Sigma) at 
37 °C, followed by overnight digestion with 0.5 mg/mL proteinase K 
(Invitrogen) at 56 °C. GAG concentration in the digests was measured in the 
same way as media. For both GAGs secreted and retained, amounts from cell-
free gels were subtracted from amounts from cell-laden constructs to determine 
the amount of GAGs produced by the cells. DNA concentration in the digests 
was measured using the Quant-iTTM PicoGreen® dsDNA quantification assay 
(Invitrogen). 
5.2.6 Physical Properties  
The compressive moduli of constructs were measured in an unconfined 
arrangement using an Instron 5848 microtester with a 5 N load cell. During 
testing constructs were submerged in PBS at 37 °C. A displacement rate of 0.01 
mm/s was applied using a non-porous indenter, and the modulus taken from the 
linear region of the stress–strain curve from 10 to 15% strain [123]. 
5.2.7 Immunofluorescence  
Constructs cultured for 8 weeks were frozen in Optimal Cutting Temperature 
compound (OCT, Sakura, Finetek, Tokyo, Japan) and sectioned. Sections were 
fixed by 10 minutes contact with ice-cold acetone, followed by antigen retrieval 
with 0.1% hyaluronidase (Sigma) for 30 min. Sections were blocked with 2% 
BSA in PBS for 1 h. Primary antibodies were diluted in 2% BSA in PBS, and 
applied overnight at 4 °C. Antibodies for collagen type II (II-II6B3, 
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Developmental Studies Hybridoma Bank (DSHB), Iowa City, IA, USA, 1:200 
dilution), collagen type I (I-8H5, MP Biomedicals, Seven Hills, Australia, 1:300 
dilution), aggrecan (MA75A95, Abcam/Sapphire Bioscience, Waterloo, 
Australia, 1:5 dilution) and CD44 (H4C4, DSHB, 1:200 dilution) were used. 
Cell membranes were visualised with CellMaskTM Orange plasma membrane 
stain (Invitrogen, 1:400 dilution). A mouse IgG isotype control antibody 
(Jackson ImmunoResearch, West Grove, PA, USA, 1:1000 dilution) and 
secondary antibody only were used as negative controls. Sections were washed 
twice for 5 min in PBS. The goat anti-mouse secondary antibody (Alexa Fluor® 
488, Invitrogen, 1:400 dilution) was diluted in 2% BSA in PBS containing 5 
μg/mL 4’,6-diamidino-2-phenylindole (DAPI, Invitrogen), and applied in the 
dark for 1 h. After rinsing and drying, sections were mounted with Prolong Gold 
(Invitrogen) and imaged using a Zeiss Axio microscope. 
To quantify fluorescence intensities in the inter-territorial areas (minimum 
distance of 50 μm from cell nuclei), five regions (each 50 × 50 pixels) were 
selected from each of four different histological sections. The mean grey scale 
intensity of each region was calculated using ImageJ software (National 
Institutes of Health, USA). The circularity of cells was quantified by tracing 
only well defined cell membranes (n > 30) shown in CD44 immunofluorescence 
images using ImageJ. 
5.2.8 Gene Expression  
Total RNA was isolated from freshly trypsinised cells and from hydrogel 
constructs that were cultured for 5 weeks. Cells or hydrogel constructs were 
homogenised in 1 mL of TRIzol reagent (Invitrogen), and RNA was isolated 
according to the manufacturer’s instructions. SuperScriptTM III First Strand 
Synthesis System (Invitrogen) was used to synthesise complementary DNA 
(cDNA). DNase and RNase digestions were performed before and after cDNA 
synthesis, respectively. Real-time polymerase chain reaction (PCR) was 
performed using SybrGreen® Mastermix (Applied Biosystems/Invitrogen). 
Expression of all genes was normalised to the housekeeping gene RPL13A 
[126]. The primer sequences (5’3’) used for PCR were as follows: 
RPL13A: F: CATAGGAAGCTGGGAGCAAG, 
R: GCCCTCCAATCAGTCTTCTG;  
COL2A1: F: GGCAATAGCAGGTTCACGTACA, 
R: CGATAACAGTCTTGCCCCACTT; 
COL1A1: F: CAGCCGCTTCACCTACAGC,  
R: TTTTGTATTCAATCACTGTCTTGCC;  
COL10A1: F: ACCCAACACCAAGACACAGTT-CT,  
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R: TCTTACTGCTATACCTTTACTCTTTATGGTGTA; 
ACAN: F: GCCTGCGCTCC-AATGACT,  
R: TAATGGAACACGATGCCTTTCA; 
PRG4: F: GAGTACCCAATCAAGG-CATTATCA, 
R: TCCATCTACTGGCTTACCATTGC;  
matrix metalloproteinase (MMP) 13:F: ACTTCACGATGGCATTGCTG, 
R: CATAATTTGGCCCAGGAGGA [188]. 
5.2.9   EPIC-μCT 
The distribution of fixed negative charges in the constructs was visualised using 
equilibrium partitioning of an ionic contrast agent microcomputed tomography 
(EPIC-μCT) [128]. Constructs were incubated in a mixture of 40% (v/v) 
ioxaglate (Hexabrix, Aspen, Australia) in PBS at 37 °C overnight on a moving 
plate. Constructs were imaged in a μCT 40 scanner (Scanco Medical, 
Brüttisellen, Switzerland) at 45 kV and analysed using Scanco μCT software. 
5.2.10   Macromer Synthesis 
Statistical analyses were performed using SPSS software (version 20, IBM 
Corporation, USA). Differences between groups were determined using analysis 
of variance and Tukey’s or Dunnet’s T3 post-hoc tests as appropriate, with a 
significance level of 0.05. Statistically significant differences are indicated in 
figures using Roman numerals or symbols. Any two groups labelled with the 
same Roman numeral are statistically similar, and groups without a like numeral 
are statistically different. 
5.3   Results 
Chondrocytes from the superficial and middle/deep zones responded to the 
different hydrogels in a similar manner. Thus, data from experiments using 
chondrocytes from the middle/deep zone, which represents the bulk of the 
cartilage volume, are presented here. 
5.3.1   Cell Numbers, Viability and Morphology 
High cell viabilities (80–90%) were observed in all constructs after 1 day, 5 
weeks and 8 weeks of culture, with no differences between groups. Images of 
live and dead chondrocytes after 8 weeks culture are shown in Figure 5.1A–D. 
The DNA content in all groups increased between day 1 and week 8 (Figure 
5.1I, all p < 0.05), although relatively modestly, with less than 2-fold increases 
in each group. 
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The cell membrane receptor CD44 was stained with an antibody to visualise the 
morphology of the encapsulated cells after 8 weeks culture (Figure 5.1E-H), and 
the average circularity values of at least 30 cells per condition are shown in 
Figure 5.1J. In Gel-MA and G-CS constructs, cell morphologies varied between 
irregular, stretched morphologies and rounded morphologies (Figure 5.1E, G). 
In gels containing HA-MA, cells had more rounded morphologies (Figure 5.1F, 
H), and the average circularity was higher in these constructs (Figure 5.1J). 
Similarly, the viability images in Figure 5.1 show that cells had more rounded 
morphologies with HA-MA. Although HA-MA influenced the morphology of 
encapsulated cells, all cells at the surface of all constructs had highly stretched 
morphologies, as shown by membrane staining (Fig. S5.1). 
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Figure 5.1 (previous page): Viability (A–D) and morphology (E-H) of 
chondrocytes cultured for 8 weeks. Total DNA content (I) after 1 day, 5 weeks and 
8 weeks culture, and circularity of cells after 8 weeks culture (J). In live/dead images, 
living cells appear green and dead cells appear red. In cell morphology images, 
immunoreactive regions to the membrane receptor CD44 are shown in green, and 
nuclei were counterstained with DAPI, shown in blue. Scale bars: 100 μm. For DNA 
quantification, bars and error bars show the mean and standard deviation of four 
samples, and # indicates that within each group, DNA content is different to the value 
at day 1 (p < 0.05). In (J), groups without a like Roman numeral are statistically 
different (p < 0.05). 
5.3.2   Matrix Production and Accumulation 
Gel-MA-based hydrogels supported the deposition of new matrix by 
chondrocytes; however, the composition and distribution of the cell-secreted 
matrix varied between hydrogels. Strong collagen type II and aggrecan 
immunoreactivity was observed in all gel constructs; however, in Gel-MA and 
G-CS constructs, strong staining was only observed in the regions close to cells, 
with very little immunoreactivity in the regions between cells (Figure 5.2A, C, 
E, G). In gels containing HA-MA, collagen type II and aggrecan were more 
homogeneously distributed (Figure 5.2B, D, F, H). The average fluorescence 
intensities of collagen type II and aggrecan in the inter-territorial regions were 
higher in constructs with HA-MA than those without (Figure 5.2M, N). In Gel-
MA and G-CS constructs, collagen type I antibodies reacted strongly (Figure 
5.2I, K). The intensity of collagen type I staining was markedly lower in gels 
with HA-MA (Figure 5.2J, L), and the intensity in the inter-territorial regions 
was also lower with HA-MA (Figure 5.2O). In sections treated with only the 
secondary antibody, the fluorescence intensities of inter-territorial regions were 
similar for all hydrogel formulations (data not shown). In addition, in constructs 
with HA-MA, inter-territorial intensities were higher for collagen type II and 
aggrecan, yet were lower for collagen type I, allowing us to conclude that 
differences were due to differential binding of the primary antibodies, rather 
than background or non-specific interactions. In all constructs, collagen type I 
staining was strong at the outer surface (Fig. S5.1). 
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Figure 5.2: Extracellular matrix production after 8 weeks culture. 
Immunoreactive regions for collagen type II (A–D), aggrecan (E–H) and collagen 
type I (I–L) appear green, and nuclei were counterstained with DAPI (blue). The 
fluorescence intensities in the regions between cells (inter-territorial regions) were 
quantified for collagen type II (M), aggrecan (N) and collagen type I (O). Scale bars: 
100 μm. Box plots show data from a total of 20 regions from four different histological 
sections. Groups without a common Roman numeral are statistically different (p < 
0.05). 
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5.3.3   GAG Production 
Figure 5.3 shows GAG production after 8 weeks culture, with all values 
corrected using cell-free gels. GAG content prior to correction with cell-free 
gels is shown in Figure S5.2, and GAG secretion profiles are shown in Figure 
S5.3. The amount of GAGs retained and secreted (both normalised to wet 
weight) was higher in G-HA constructs compared to Gel-MA (Figure 5.3A). 
The fraction of the total GAGs that were retained was 60-70% in all constructs, 
and was not influenced by the presence of HA-MA or CS-MA. When 
normalised to DNA content, the amount of GAGs retained was also higher in G-
HA constructs compared to Gel-MA (Figure 5.3B). 
 
Figure 5.3: GAG synthesis in hydrogel constructs after 8 weeks culture, with all 
values corrected using cell-free gels. Total GAG production (A) after 8 weeks, 
shown as GAGs retained in the construct or GAGs secreted into the media. The 
GAGs retained in the constructs were normalised to the DNA content (B) after 8 
weeks culture. Bars and error bars show the means and standard deviations of four 
samples, respectively. Groups without a common Roman numeral are statistically 
different (p < 0.05). In (A), lower- and uppercase letters are used for GAGs secreted 
and retained, respectively. 
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5.3.4   EPIC-μCT 
Cell-free and chondrocyte-laden constructs were scanned using EPIC-μCT [25] 
after 2, 5 and 8 weeks culture, using the negatively charged contrast agent 
ioxaglate. The intensity of the ioxaglate signal is inversely proportional to the 
concentration of groups with a fixed negative charge in the constructs. Figure 
5.4 shows the scans of Gel-MA and G-HA constructs with middle/deep cells at 
2, 5 and 8 weeks, and cell-free constructs at 2 weeks (images from all groups 
and time points are shown in Figures S5.5–S5.7). Attenuation levels in cell-free 
Gel-MA constructs are higher than in G-HA constructs (Figure 5.4A, E), due to 
the repulsion of ioxaglate by the negative charges of HA-MA. With increasing 
culture time, the difference in attenuation levels between Gel-MA and G-HA 
constructs becomes more pronounced, as a result of enhanced GAG synthesis 
and deposition in G-HA constructs. Thus EPIC-μCT is a viable tool to visualise 
differences in fixed negative charges between different cell-free hydrogels, and 
matrix accumulation in tissue-engineered constructs. 
 
Figure 5.4: EPIC-μCT scans of cell-free hydrogel constructs (A, E) or cell-laden 
constructs (B–D, F–H). Constructs were scanned after 2 weeks (A, B, E, F), 5 
weeks (C, G) or 8 weeks culture (D, H). Constructs were Gel-MA (A–D) or G-HA (E–
H). The scale bar in G is 2 mm and the scale is the same for all panels. The 
attenuation scale in (H) ranges from 10,000 (blue) to 22,000 (red), and applies to all 
panels. Figures S5.5–S5.7 show the images for all constructs at the time points 
evaluated. 
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5.3.5   Gene Expression 
The expression levels of chondrogenic marker genes were highly dependent on 
the hydrogel composition, with greater chondrogenesis occurring in constructs 
containing HA-MA (Figure 5.5). COL2A1 expression was 9-fold higher in G-
HA constructs compared to Gel-MA (Figure 5.5A). Addition of CS-MA to Gel-
MA had a smaller (3-fold increase), but significant effect on COL2A1 
expression. ACAN expression was upregulated by the addition of either HA-
MA or CS-MA, or both, compared to Gel-MA alone (Figure 5.5B), while 
COL1A1, a dedifferentiation marker, was expressed at lower levels in gels with 
HA-MA (Figure 5.5C). Expression of the superficial zone marker PRG4 was 
higher in gels containing HA-MA (Figure 5.5D). PRG4 expression in G-CS gels 
was intermediate, and statistically similar to both the Gel-MA controls and 
constructs containing HA-MA. The addition of HA-MA, CS-MA or both 
lowered the expression of COL10A1 compared to Gel-MA controls (Figure 
5.5E). Expression of the hypertrophy marker MMP13 was lower in gels 
containing HA-MA, and expression in these gels was unchanged from day 0 
(Figure 5.5F). CS-MA had no influence of MMP13 expression compared to 
Gel-MA controls, and expression was upregulated in these groups compared to 
day 0. 
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Figure 5.5: Relative expression levels of collagen type II (A), aggrecan (B), 
collagen type I (C), PRG4 (D), collagen type 10 (E) and MMP13 (F) at day 0 and 
after 5 weeks culture. Expression of each gene was normalised to the Gel-MA 
control, and presented on a log2 scale. Box plots show data from four samples, and 
groups without a common Roman numeral are statistically different (p < 0.05). 
5.3.6   Physical Properties 
Gel-MA hydrogels are sensitive to MMP degradation, yet significant gel 
degradation was not observed in either the cell-free or cell-laden constructs. 
Hydrogel constructs were easy to handle at each time point, and swelling after 
crosslinking was negligible. 
The addition of HA-MA increased the stiffness of cell-free gels, and cell-laden 
gels on day 1 by ~10–15 kPa, while the addition of CS-MA had no effect on day 
1 (Figure 5.6A, B). However, HA-MA had a much greater impact on the change 
in stiffness of cell-laden hydrogels after 8 weeks culture (Figure 5.6A, B). After 
8 weeks culture, the moduli of Gel-MA constructs increased by 26 kPa, whereas 
G-HA constructs increased by 96 kPa (Figure 5.6B). The addition of CS-MA 
had a smaller, but significant effect on stiffness, with G-CS constructs 
increasing by 47 kPa. The largest change in the stiffness was seen in G-HA-CS 
constructs, which increased by 114 kPa during 8 weeks culture. 
HA-MA also had an impact on the changes in the wet weights and swelling 
ratios of constructs during culture (Figure 5.6C, D; Figure S5.4). The increase in 
the wet weights of G-HA and G-HA-CS were lower than those of Gel-MA and 
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G-CS constructs. Similarly, during culture, the swelling ratio of Gel-MA 
constructs increased by more than G-HA and G-HA-CS constructs, while the 
increase in swelling ratio of G-CS constructs was similar to Gel-MA. Thus after 
8 weeks, Gel-MA and G-CS constructs tended to be softer and more highly 
swollen than those containing HA-MA. 
 
Figure 5.6: Compressive moduli (A, B) and wet weights (C, D) of cell-free 
hydrogels (A, C) and cell-laden hydrogel constructs (B, D). Compressive moduli 
and wet weights are shown after 1 day, 5 weeks and 8 weeks of culture. Bars and 
error bars show the mean and standard deviation of four samples, respectively. At 
day 1 and week 8, statistically significant differences between the hydrogel groups 
are indicated by different Roman numerals, using lower and upper case, 
respectively. At week 8, # indicates a significant difference from day 1, while * 
indicates that the change during culture is significantly different to the change in the 
corresponding Gel-MA constructs. 
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5.4   Discussion 
HA and CS are abundant GAGs in cartilage ECM, and they have been 
incorporated into hydrogels and scaffolds with the intention of creating a 
biomimetic environment to enhance chondrogenesis [54]. However, there is no 
clear consensus on the effect that incorporation of GAGs in hydrogels has on 
chondrogenic differentiation and matrix production. Gel-MA, derived from 
collagen type I, was the main component in each of the hydrogels used in this 
study, accounting for at least 90% of the polymer content by mass. This study 
shows that, when used alone, Gel-MA does not support complete 
chondrogenesis in vitro. However with the addition of small quantities of HA-
MA, and to a lesser extent CS-MA, Gel-MA-based hydrogels can provide a 
supportive environment for the deposition of cartilage-like extracellular matrix. 
HA is implicated in a vast number of biological processes, including cell 
proliferation, attachment, migration, differentiation, and tissue homeostasis [18, 
189]. The influence of HA on chondrogenesis appears to be dose or 
concentration dependent, with several studies showing that low concentrations 
of HA promote chondrogenesis, while higher concentrations have no effect or 
even inhibit chondrogenesis [101, 174-176]. Despite these complications, HA 
incorporation into hydrogels has promoted chondrogenesis in several promising 
studies [190-192], and it remains a key material in cartilage tissue engineering 
research and clinical application. In this study, gene expression, protein 
deposition and cell morphology collectively demonstrated that HA-MA 
significantly enhanced chondrogenesis in the predominantly Gel-MA hydrogels 
tested. The benefits of HA-MA were exhibited in three ways: promoting the 
chondrocyte phenotype; increasing matrix accumulation; and enhancing matrix 
distribution. 
Chondrocytes are highly differentiated cells with a distinct phenotype and cell 
morphology. The rounded morphology observed in healthy cartilage appears to 
be intrinsically linked to cell phenotype [53]. When placed on two-dimensional 
surfaces coated with ECM molecules, sub-populations of rounded and spread 
cells can be observed [193]. While rounded cells continue producing 
predominantly collagen type II, spread cells produce collagen type I and 
fibronectin [193], suggesting that reacquiring a rounded morphology may be 
essential for redifferentiation. 
HA has been shown to play a critical role in cell attachment to the surrounding 
matrix [189, 194, 195]. During mitosis and cell migration, cells secrete a thin 
layer of an HA-rich matrix that mediates detachment and cell rounding [195]. In 
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cartilage, CD44 cell receptors bind HA, which results in the chondrocytes being 
surrounded by a gel-like layer [196]. Removing this layer rapidly alters the 
homeostasis of the tissue [196], indicating that HA is critical for regulation of 
biosynthesis and MMP production. In this study, inclusion of HA-MA 
supported rounded cell morphologies, and cell morphology correlated well with 
other measures of chondrogenic differentiation. We hypothesise that the 
enhanced chondrocyte morphology in constructs containing HA-MA may be the 
result of an intrinsic mixing incompatibility between the two polymers. 
Mixtures of gelatin and HA are cloudy, and, if left to settle in a solution state, 
eventually phase separate. The phase separation phenomenon may make cell 
adhesion sites on gelatin less available to cells, resulting in the rounded 
morphologies. 
In G-HA constructs, the main chondrogenic marker, COL2A1, was upregulated 
9-fold, whereas the main dedifferentiation marker, COL1A1, was down-
regulated compared to Gel-MA constructs. While collagen type I staining was 
markedly reduced in constructs containing HA-MA, two cell subpopulations 
with different phenotypes were observed. Encapsulated cells had a 
predominantly rounded morphology and produced only low amounts of collagen 
type I, while cells at the surface had a fibroblast-like morphology, and secreted 
high levels of collagen type I. Fibroblastic morphologies and high levels of 
collagen type I were observed at the surface of all constructs, regardless of 
hydrogel composition (not shown). Thus at the surface, which is effectively a 
curved two-dimensional environment, chondrocytes adopt a dedifferentiated 
phenotype and produce collagen type I, as they do when cultured on tissue 
culture plastic [116]. This in vitro result is particularly relevant when compared 
to some current clinical practices, such as matrix-induced autologous 
chondrocyte implantation (MACI®), in which chondrocytes are seeded onto a 
collagen scaffold [197]. These cells attach to the scaffold, thus effectively being 
at a surface, rather than encapsulated in a three-dimensional environment. This 
may partly account for the limited success of cartilage tissue engineering 
attempts to date, in which predominantly fibrous cartilage, rather than the 
desired articular cartilage, is regenerated in the joint. 
Incorporation of HA-MA resulted in increased accumulation of cartilage matrix 
molecules and increased compressive modulus. In addition to higher expression 
of cartilage-specific genes COL2A1 and ACAN, total GAG production and the 
GAG/DNA ratio were higher in constructs with HA-MA, indicating that HA-
MA promoted increased biosynthesis of cartilage-specific matrix molecules. HA 
interacts with components of the ECM, particularly aggrecan and hyaladherins 
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[198], which may play a role in matrix retention [199], but HA-MA did not 
appear to impact matrix retention in these gels. Of the total amount of GAGs 
produced during 8 weeks of culture, 60–70% were retained in all constructs, 
with no significant effect of HA-MA (or CS-MA) on GAG retention. This may 
be due to the methacrylate modification of HA-MA, which is further discussed 
in Chapter 8. 
Mechanical properties are a critical metric to assess the quality of tissue-
engineered cartilage. Cartilage from bovine femoral condyles has a Young’s 
modulus of approximately 0.3 MPa [200], and by attracting water, GAGs 
account significantly for the compressive stiffness of the tissue [14]. However, 
in this study, higher GAG levels did not fully account for changes in mechanical 
properties. After 8 weeks culture, differences in compressive moduli were much 
more pronounced than differences in GAG content. For example, the 
concentration of GAGs in G-HA constructs was 43% higher than in Gel-MA 
constructs, while, the increase in compressive moduli of G-HA constructs was 
270% greater than the increase in Gel-MA constructs. 
An explanation for the discrepancy in construct modulus and GAG content may 
lie in the third beneficial effect of HA-MA: enhancing matrix distribution. In 
addition to GAGs, the collagen network is also expected to contribute to the 
stiffness of the constructs, and thus GAG content alone is not always an 
accurate predictor of mechanical properties. HA-MA enhanced the distribution 
of collagen type II and aggrecan, shown by the higher levels of these 
components in the inter-territorial regions of constructs with HA-MA. As a 
result, the mechanical properties of constructs with HA-MA increased 
significantly more during culture than those without. The newly synthesised 
matrix is expected to be more interconnected in constructs with HA-MA, and 
hence provide greater mechanical reinforcement. 
The mechanisms by which HA-MA enhanced the distribution of new matrix and 
improved the mechanical properties are not clear, but we hypothesise that the 
microscale phase separation of Gel-MA and HA-MA helped facilitate 
distribution of the ECM. In Chapter 3, in which hydrogels were prepared from 
either Gel-MA or HA-MA, we found that collagen type II and aggrecan were 
highly localised to the pericellular regions of HA-MA, suggesting that HA-MA 
alone does not facilitate larger-scale matrix distribution [188]. Similarly, other 
studies have shown that HA-MA hydrogels alone do not necessarily promote 
matrix distribution, but lower crosslink densities, and hence larger pore sizes, do 
allow for more matrix diffusion [122]. Futher discussion about the potential 
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microstructure of these hydrogels can be found Section 8.2. 
Both the hydrogel biomaterial and the cell-secreted ECM are sensitive to 
enzymatic degradation [201], so the changes in mechanical properties of the 
constructs during culture are a result of the balance between anabolic and 
catabolic factors, combined with hydrolytic degradation. The compressive 
moduli of all cell-laden constructs increased during culture, whereas cell-free 
constructs decreased slightly or were unchanged. The increase in stiffness of 
cell-laden constructs can therefore be attributed to the matrix deposited by the 
cells, suggesting that in all gels, regardless of composition, there was a net shift 
in favour of anabolic processes. 
Constructs with HA-MA expressed lower levels of MMP13 than those without. 
MMP13, also called collagenase-3, is a marker of chondrocyte hypertrophy 
[202, 203], and is up-regulated in osteoarthritis, where it is a key mediator of 
cartilage degradation [204]. In this study, constructs with elevated MMP13 
expression levels were also softer and more swollen; thus cell-mediated 
degradation of both the gelatin, as well as the newly produced ECM, may be a 
key factor limiting matrix accumulation and mechanical property development 
in these constructs. Exposure to collagen types I and II can upregulate MMP13 
production via integrins or discoidin domain receptor 2 (DDR2) [205, 206], but 
exposure to denatured collagens and gelatin do not have the same effect [205]. 
Thus, although the cause of MMP13 upregulation in Gel-MA and G-CS 
constructs is unknown, it could be a result of the high levels of collagen type I 
that are produced in these gels. 
The initial mechanical properties of hydrogels are dependent on the crosslink 
density, and hence pore size, of the hydrogel, and as expected, larger pore sizes 
facilitate more diffusion of newly secreted matrix [80, 122, 207]. Therefore, 
hydrogels that are initially the softest can become the stiffest after a period of in 
vitro culture, while hydrogels that are initially very stiff may impede the 
formation and distribution of new ECM [80, 122]. Interestingly, in this study the 
opposite trend was observed, with the stiffness increasing more in the gels that 
were initially stiffer, showing that HA-MA was facilitating matrix organisation 
by other means. When optimising the initial crosslink density for the purposes 
of cartilage repair, it is important to consider both the initial and developed 
mechanical properties, along with the overall strategy for cartilage repair. 
The incorporation of CS-MA had fewer and less significant effects on 
chondrocyte and construct properties than HA-MA. This could be because CS 
does not participate in cell–matrix interactions to the same extent as HA. It 
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could also be because mixtures of gelatin and CS-MA are fully miscible, thus if 
the phase separation phenomenon observed for HA-MA was indeed important, 
it would be expected that chondrocytes would respond differently to CS-MA 
and HA-MA. The solubility limit of CS is substantially higher than that of HA, 
so much higher concentrations of CS-MA could potentially be incorporated into 
Gel-MA hydrogels. Thus although the effects of CS-MA were comparatively 
minor at 0.5%, higher concentrations may elicit stronger chondrocyte responses, 
and further studies should evaluate the concentration-dependent influence of 
CS-MA. 
The incorporation of CS-MA increased COL2A1 and ACAN gene expression 
compared to Gel-MA controls; however, COL1A1 and MMP13 expression 
levels were unchanged. Previous studies using polyethylene glycol-based 
hydrogels have shown CS-MA to have variable effects on bovine chondrocytes. 
In one study, CS-MA was shown to strongly upregulate the expression of 
collagen type II and aggrecan [106], while in another study, CS-MA reduced 
proteoglycan synthesis by bovine chondrocytes by 22–50%, depending on CS-
MA concentration [186]. 
When both HA-MA and CS-MA were included in the hydrogel construct, cells 
showed a similar response to those in G-HA constructs, indicating that HA-MA 
was a more potent modulator of differentiation and physical properties than CS-
MA. The greatest increase in stiffness was seen in G-HA-CS constructs, 
suggesting that there may be advantages including both GAGs in the hydrogels. 
Mesenchymal precursor cells (MPCs) have been widely investigated as a 
potential cell source for the repair of cartilage defects. Since G-HA hydrogels 
promote the chondrogenic redifferentiation of expanded chondrocytes, further 
studies could evaluate the potential for these hydrogels to be used to guide 
chondrogenic differentiation of MSCs. In addition, further studies should 
validate whether the in vitro results shown here can be translated to enhanced 
quality of repair tissue in vivo. 
5.5   Conclusion 
This study highlights the potential for multiple-component photocrosslinkable 
hydrogels based primarily on Gel-MA to be used in cartilage tissue engineering. 
Encapsulated chondrocytes remain viable for up to 8 weeks in culture, and 
produce a significant amount of ECM. Incorporation of a relatively small 
proportion of HA-MA into these hydrogels significantly enhances 
chondrogenesis and facilitates matrix distribution, with corresponding 
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improvements to mechanical properties. Incorporation of CS-MA enhances 
some aspects of chondrocyte redifferentiation, though to a lesser extent than 
HA-MA. 
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HA enhances the properties of tissue engineered cartilage 
Abstract 
There is a need for materials that are well suited for cartilage tissue engineering. 
Hydrogels have emerged as promising biomaterials for cartilage repair, since, 
like cartilage, they have a high water content and they allow cells to be 
encapsulated within the material in a genuinely three-dimensional 
microenvironment. In this study, we investigated the mechanical properties of 
tissue-engineered cartilage constructs using in vitro culture models 
incorporating human chondrocytes from osteoarthritis patients. We evaluated 
hydrogels formed from mixtures of photocrosslinkable gelatin-methacrylamide 
(Gel-MA) and varying concentrations (0-2%) of hyaluronic acid methacrylate 
(HA-MA). Initially, only small differences in the stiffness of each hydrogel 
existed. After 4 weeks of culture, and to a greater extent 8 weeks of culture, 
HA-MA had striking and concentration dependent impact on the changes in 
mechanical properties. For example, the initial compressive moduli of cell-laden 
constructs with 0 and 1% HA-MA were 29 and 41 kPa, respectively. After 8 
weeks culture, the moduli of these constructs had increased to 66 and 147 kPa 
respectively, representing a net improvement of 69 kPa for gels with 1% HA-
MA. Similarly the equilibrium modulus, dynamic modulus, failure strength and 
failure strain were all improved in constructs containing HA-MA. Differences in 
mechanical properties did not correlate with glycosaminoglycan content, which 
did not vary greatly between groups, yet there were clear differences in 
aggrecan intensity and distribution as assessed using immunostaining. Based on 
the functional development with time in culture using human chondrocytes, 
mixtures of Gel-MA and HA-MA are promising candidates for cartilage tissue-
engineering applications. 
Keywords: Hydrogels, gelatin, hyaluronic acid, cartilage, tissue engineering 
  
 99 
Chapter 6 
6.1   Introduction 
Articular cartilage is a load bearing tissue. In articulating joints, cartilage 
provides low friction surfaces for efficient movement, and effective impact 
absorption and load dissipation. Unfortunately, cartilage is susceptible to 
damage, and has a very limited capacity to heal. To address this clinical need, 
researchers and clinicians have developed methods to potentially regenerate or 
tissue-engineer new cartilage, but currently there remains a shortage of materials 
that are well suited for guiding effective regeneration of high quality, hyaline 
cartilage [54].  
The mechanical properties of cartilage are crucial to its ability to withstand the 
compressive and shear loads to which it is routinely subjected in the joint 
environment. It has been noted elsewhere that the importance of mechanical 
properties in tissue-engineered cartilage is often overlooked [129], and has even 
been suggested that mechanical properties should be viewed as the most 
important metric for assessing the quality of tissue-engineered cartilage [129]. 
Studies to identify materials for cartilage tissue engineering commonly 
characterise the mechanical properties of cell-free scaffolds or hydrogels, but 
frequently do not examine how the mechanical properties change with time 
[208]. While the optimal mechanical properties for a cartilage scaffold or tissue 
engineered cartilage are not known, healthy cartilage is a common reference, 
which has an equilibrium compressive modulus in the order of 0.1 – 2 MPa, 
varying significantly with depth from the articular surface [82]. Implanting a 
construct that has matured for four weeks in vitro showed better integration with 
the surrounding cartilage compared to implanting a freshly crosslinked construct 
[209], which may be partially a result of the mechanical properties developed 
over four weeks culture protecting the construct from damage once implanted. 
The mechanical properties of tissue-engineered cartilage can be considered in 
two distinct elements. Firstly, the biomaterial has some inherent mechanical 
properties, and generally the mechanical properties of the newly formed 
construct will be derived from these inherent properties. Secondly, over time, 
the mechanical properties of the construct will change, due to material 
degradation, production of proteins and assembly of extracellular matrix via the 
cell machinery, and matrix remodelling.  
The first element, the initial mechanical properties, is relatively simply altered 
by changing the materials used, the way in which they are constructed, or the 
way in which they are held together. For example, thermoplastic polymers can 
be used to produce very stiff constructs, which can easily match the stiffness of 
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articular cartilage [210], but fail to adequately match the low friction properties 
and shock absorption characteristics. Hydrogels, meanwhile, have been 
extensively investigated for cartilage repair, but the mechanical properties of 
these typically soft and highly water-swollen materials have limited their 
clinical impact. To overcome the limitation of the mechanical properties, 
strategies to enhance the mechanical properties of hydrogels have been keenly 
investigated. For example, double network hydrogels have been developed that 
have excellent compliance, high water content and remarkable failure strengths 
[83], however the process for producing these gels is not easily adapted for cell 
encapsulation and the strength is reduced upon repeated loading [211]. Very 
stiff and strong hydrogels can also be produced from polyvinyl alcohol, and 
promising short term clinical results have been reported [212], but these 
materials replace cartilage, rather than regenerate the original tissue. Similarly, 
polyethylene glycol diacrylate (PEGDA) hydrogels formed from a high 
concentration (40% w/v) of low molecular weight PEGDA (508 Da) have 
mechanical properties that are comparable to cartilage [82], but the potential to 
successfully encapsulate cells in such stiff gels remains uncertain, and exposure 
to low molecular weight PEG may also limit cell compatibility. Yet another 
approach has been to combine soft, cell compatible hydrogels with stronger 
materials, such as thermoplastic polymers [123, 213], to produce constructs in 
which the hydrogel contributes negligibly to the overall mechanical properties.  
In parallel, research efforts have also been directed towards developing 
materials that allow an increase in the mechanical properties of tissue-
engineered constructs with time, usually mediated by the deposition of 
extracellular matrix from embedded or invading cells. For hydrogels, one 
common method to allow for greater increases in mechanical properties has 
been to lower the initial stiffness of the gels, usually be lowering the 
concentration of polymer [80, 122]. The basic principle is that reducing the 
polymer concentration results in a hydrogel that is not only softer, but also has 
larger pores, therefore allowing more diffusion of extracellular matrix into and 
throughout the hydrogel, which ultimately accounts for the bulk of the 
mechanical strength. 
Hyaluronic acid (HA) is a ubiquitous component of extracellular matrices, and 
performs important functions in cartilage. By binding and immobilising 
aggrecan, HA mediates the formation of massive aggregates of fixed negative 
charge that retain water and is a critical extracellular matrix (ECM) component 
for cartilage mechanical properties. Meanwhile, the collagen network acts to 
resist this swelling tendency and provides tensile strength. In this study, we 
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evaluated hydrogels formed from mixtures of photocrosslinkable derivatives of 
gelatin and HA (gelatin-methacrylamide (Gel-MA) and HA-methacrylate (HA-
MA), respectively). In particular, we aimed to investigate in detail the role of 
HA-MA in the developed mechanical properties of engineered cartilage 
constructs using chondrocytes from four human patients. Based on our previous 
studies [214], we hypothesised that HA-MA would significantly enhance the 
mechanical properties of cultured constructs, and that the influence would be 
concentration dependent. 
6.2   Materials and Methods 
6.2.1   Study Design 
The main aim of this study was to evaluate the importance of a hyaluronic acid 
derivative on the impact of developed mechanical properties of tissue-
engineered cartilage constructs, and can be considered in two parts. The 
objective of the first part was to characterise the mechanical properties of cell-
free hydrogel constructs after 1 and 28 days in culture, including compressive 
modulus, swelling ratio, and also the release profile of non-covalently bound 
HA from Gel-MA hydrogels. The objective of the second part was to 
encapsulate human chondrocytes in Gel-MA/HA-MA constructs and evaluate 
the impact of HA-MA on the change in mechanical properties and matrix 
production. For the cellular experiments, the compressive modulus and swelling 
ratio were tested on days 1, 28 and 56, and failure strength was measured after 
63 days. ECM production was assessed in constructs cultured for 28 days. 
6.2.2   Macromer Synthesis 
Gelatin and methacrylic anhydride (MAAh) were purchased from Sigma 
Aldrich (St Louis, MO, USA). Hyaluronic acid was purchased from Novozymes 
Biopharma (Bagsvaerd, Denmark). Irgacure 2959 was purchased from BASF 
(Ludwigshafen, Germany). Gelatin-methacrylamide (Gel-MA) and hyaluronic 
acid methacrylate (HA-MA) were synthesised using protocols based on previous 
methods [52, 56, 188]. Unless otherwise stated, all concentrations are given as 
percentage weight per volume (% w/v). Gelatin was dissolved in phosphate 
buffered saline (PBS, Invitrogen, Carlsbad, CA, USA) at 10% and reacted with 
0.6 g MAAh per gram of gelatin for 1 hour at 50 °C under constant stirring. 
After the reaction period, excess MAAh was removed by centrifugation, and the 
Gel-MA was exhaustively dialysed against distilled water at 40 °C. The pH of 
the dialysed Gel-MA solution was adjusted to 7.4, and Gel-MA was recovered 
by lyophilisation. HA was dissolved in distilled water at 2% and reacted with 
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MAAh on ice for 8 hours under constant stirring. HA-MA was precipitated in an 
excess of cold 100% ethanol, redissolved, then exhaustively dialysed against 
distilled water. The pH of dialysed HA-MA was adjusted to 7.4, and HA-MA 
was recovered by lyophilisation. Following lyophilisation, HA-MA was washed 
with acetone and allowed to dry overnight in a biological safety cabinet to 
ensure sterility. Each polymer was dissolved separately at 10 mg/mL in 
deuterium oxide (Sigma) and proton nuclear magnetic resonance spectra were 
recorded on a Mercury 300 MHz instrument (Varian Associates Inc., CA, USA). 
6.2.3   Ethics Statement 
Ethics approval was granted from the Queensland University of Technology and 
the Prince Charles Hospital (both Brisbane, Australia). 
6.2.4   Cell Isolation and Expansion 
Human chondrocytes were isolated and expanded as described in detail 
elsewhere [187]. Cartilage with a macroscopically normal appearance was 
excised from the femoral condyles of four osteoarthritis (OA) patients that had 
undergone knee replacement surgery. The cartilage was diced with a scalpel and 
digested overnight with 0.15% collagenase type II (Worthington, NJ, USA) in 
high glucose Dulbecco’s modified eagle medium (DMEM, Invitrogen). 
Chondrocytes from the four patients were kept separate for the entirety of the 
study, and were expanded in low-glucose DMEM with 2 mM glutamax 
(Invitrogen), supplemented with 10% fetal bovine serum (Lonza, Waverly 
Australia), 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
(HEPES), 0.1 mM non-essential amino acids, 0.5 µg/mL amphotericin B 
(Fungizone), 50 U/mL penicillin G sodium, 50 µg/mL streptomycin (all 
Invitrogen), 0.4 mM L-proline and 0.1 mM ascorbic acid (both Sigma). 
6.2.5   Hydrogel Formation 
All hydrogels were crosslinked in a custom made Teflon mould by 15 minutes 
exposure to 2.6 mW/cm2 365 nm light (UVP CL-1000, Upland, CA, USA). All 
gel precursor solutions had a total polymer concentration of 10% and contained 
0.05% of the photoinitiator Irgacure 2959. Passage one chondrocytes were 
released from monolayer culture by 5 minutes incubation with 0.25% trypsin 
(Invitrogen). The cells were washed with DMEM containing FBS, then washed 
a further two times with serum-free DMEM. The cells were counted using a 
hemocytometer, and encapsulated by combining one millilitre of gel precursor 
solution with 107 cells and photocrosslinking. Initially gels had dimensions of 
approximately 4 × 4 × 2 mm. Cell-hydrogel constructs were cultured for up to 9 
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weeks in defined chondrogenic differentiation media (high-glucose DMEM with 
2 mM glutamax (Invitrogen), 10 mM HEPES, 0.1 mM nonessential amino 
acids, ITS-G (100 × dilution), 0.5 µg/mL amphotericin B (Fungizone), 50 U/mL 
penicillin G sodium, 50 µg/mL streptomycin (all Invitrogen), 1.25 mg/mL 
bovine serum albumin (BSA), 0.4 mM L-proline, 0.1 mM ascorbic acid, 0.1 µM 
dexamethasone (all Sigma) and 10 ng/mL TGF-β3 (GroPep, Adelaide, 
Australia)). Cell-free hydrogels were cultured in high-glucose DMEM with 1.25 
mg/mL BSA, 0.5 µg/mL amphotericin B, 50 U/mL penicillin G sodium and 50 
µg/mL streptomycin. 
6.2.6   Viability Analysis 
After 28 days culture, cell-laden hydrogel constructs were halved with a scalpel, 
incubated in a solution of 10 μg/mL fluorescein diacetate and 5 μg/mL 
propidium iodide (both Sigma) in PBS for 10 minutes, and imaged using a Zeiss 
Axio microscope. The cut face of each hydrogel construct was imaged to 
visualise the cell viability in the centre of the construct. 
6.2.7   Mechanical Testing 
All hydrogels were tested in an unconfined arrangement between non-porous 
platens while submerged in PBS at 37 °C, using an Instron 5848 microtester 
(Instron, Melbourne, Australia). The compressive modulus was determined by 
compressing gels at 0.01 mm/s, and calculating the slope of the stress-strain 
curve between 10-15% strain. The cross-sectional area of each gel was 
calculated from the ratio of wet weight to height. After testing, the gels were 
lyophilised to determine the dry weight. The (mass) swelling ratio was 
determined as the ratio of wet weight to dry weight. The following procedure 
was used to determine the equilibrium modulus, dynamic modulus, failure 
strength and failure strain for each gel, using a displacement rate of 0.01 mm/s. 
Gels were compressed to 5% strain, held for 10 minutes, compressed to 10% 
strain, and held for 10 minutes. Fifty cycles of a sinusoidal waveform with an 
amplitude of 2% and frequency of 1 Hz was applied, centred about 10% strain. 
Gels were then compressed to 15% strain, held for 10 minutes, and compressed 
to 20% strain and held for 10 minutes. The load was released completely, and 
the gels were compressed until failure using a displacement rate of 0.01 mm/s. 
For each gel, the equilibrium modulus was determined from the slope of the 
residual stress-strain curve between 10 and 15% strain. The dynamic modulus 
was determined as the slope of the stress strain curve between 9 and 11% strain 
during dynamic compression. The failure force and displacement were taken as 
the point of a clear discontinuity of the force-displacement curve, from which 
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failure strength and strain were calculated based on cross-sectional area and 
height. 
6.2.8   Immunofluorescence 
Constructs were snap frozen in Optimal Cutting Temperature (OCT) compound 
(Sakura, Finetek, Tokyo, Japan) and sectioned. Sections were fixed with ice-
cold acetone for 10 minutes, and washed in PBS. Antigen retrieval was 
performed for collagen type II, using 0.1% hyaluronidase (Sigma) for 30 
minutes at room temperature. All sections were blocked with 2% bovine serum 
albumin (BSA, Sigma) in PBS for 1 hour at room temperature. Primary 
antibodies were diluted in 2% BSA in PBS and applied overnight at 4 °C. 
Antibodies for aggrecan (969D4D11, Invitrogen, 1:300 dilution), collagen type 
II (II-II6B3, Developmental Studies Hybridoma Bank (DSHB), Iowa City, IA, 
USA, 1:200 dilution), CD44 (H4C4, DSHB, 1:200 dilution) and collagen type X 
(Abcam, polyclonal in rabbit, 1:100 dilution) were used. Slides were washed 
three times in PBS for 5 minutes each. The goat anti-mouse secondary antibody 
(Alexa Fluor488, Invitrogen, 1:400 dilution) was diluted in 2% BSA in PBS 
containing 5 μg/mL 4,6-diamidino-2-phenylindole (DAPI, Invitrogen), and 
applied in the dark for 1 hour. For collagen type X, the secondary antibody was 
Cy3 conjugated anti rabbit IgG (Abcam, 1:500 dilution). Slides were washed a 
further 3 times in PBS for 5 minutes each, and after drying, mounted with 
Prolong Gold (Invitrogen) and imaged using a Zeiss Axio microscope. Confocal 
microscopy was used to image the morphology of encapsulated cells and cells at 
the surface of constructs. Whole constructs were incubated in PBS containing 5 
μg/mL DAPI and 0.8 U/mL rhodamine phalloidin for 1 hour then washed three 
times in PBS. Images were captured on a Leica SP5 laser scanning confocal 
microscope. 
6.2.9   Biochemical Analyses 
GAG content was measured quantitatively using the dimethylmethylene blue 
(DMMB, Sigma) assay and a standard curve of chondroitin-6-sulfate (Sigma) 
and the ratio of absorbance at 525 nm to 590 nm. For HA/HA-MA retention 
experiments the assay was performed at pH 3.0, and for cell culture experiments 
pH 1.5 was used, since unsulfated GAGs bind with DMMB at a pH of 3.0 but 
not 1.5 [125]. For the retention experiments, cell-free gels were incubated in 
PBS at 37 °C for up to two weeks. At each time point, four gels were removed 
from PBS, weighed, and digested with papain (250 μg/mL, Sigma) at 60 °C 
overnight. GAG content was measured in cell-laden constructs after 1 and 28 
days culture. The constructs weighed, lyophilised, weighed again, and digested 
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with 0.5% hyaluronidase (Sigma) in PBS at 37 °C for 48 hours, followed by 
digestion with proteinase K (Invitrogen) overnight at 56 °C. DNA content in the 
digests was measured using the Quant-iTTM PicoGreen® dsDNA assay 
(Invitrogen). 
6.2.10   EPIC-μCT 
Equilibrium partitioning of an ionic contrast agent (EPIC) microcomputed 
tomography (μCT) was used to visualise the concentration and distribution of 
negative charge, as a measure for proteoglycan content in hydrogel constructs 
[128, 215]. This technique uses a negatively charged contrast agent to indicate 
the amount and distribution of fixed negative charge in the hydrogel construct. 
Since cartilage ECM is negatively charged, gels with a higher amount of ECM, 
and therefore a higher negative charge, have a lower signal strength of contrast 
agent. Gels were incubated in a mixture of 40% Ioxaglate (Hexabrix, Aspen, 
Australia) in PBS at 37 °C overnight with constant mixing, and imaged using a 
Scanco μCT 40 scanner (Scanco Medical, Brüttisellen, Switzerland). 
6.2.11   Statistical Analyses 
All statistical analyses were performed using SPSS v20 (IBM corporation, 
Armonk), with a statistical significance level of 0.05. Differences between 
hydrogel groups (0-2% HA-MA) were determined using ANOVA. Tukey’s 
posthoc test was used in instances where the p-value for Levene’s test was 
greater than 0.05, and Tamhane’s T2 posthoc test was used where the p-value 
for Levene’s test was less than 0.05. Statistically significant differences from the 
appropriate posthoc test are indicated in Figures using Roman numerals. 
Independent samples t-tests were used for comparisons within groups or 
between days, and statistically significant differences were indicated in figures 
using the symbols *, # and †. 
6.3   Results 
6.3.1   Retention of HA 
When unmodified HA was incorporated into Gel-MA hydrogels, a portion 
diffuses out of the gels over the first 1-3 days, but some HA is stably 
incorporated (Figure 6.1). HA-MA content could not be quantified using the 
DMMB assay after papain digestion, since after digestion of gels containing 
HA-MA, a soft, yet stable hydrogel remained, most probably a crosslinked 
network of HA-MA. This nevertheless provides reasonable evidence that HA-
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MA is stably incorporated, and in all studies with chondrocytes, HA-MA was 
therefore, used. 
 
Figure 6.1: Retention of HA in cell-free Gel-MA hydrogels over 14 days. HA 
content per wet weight, determined using a quantitative GAG assay at a number of 
time points. The retention of HA-MA was not measureable, since the HA-MA appears 
to become crosslinked, and does not dissolve after proteinase K or papain digestion. 
Each point represents the mean of four samples, and error bars show standard 
deviations. 
6.3.2   Viability and Cell Morphology 
Cell viability was not dependent on HA-MA concentration, and was high in all 
groups after 28 days (Figure 6.2A). The morphologies exhibited by cells in all 
gels fell into one of two major categories: encapsulated cells displayed a 
predominantly rounded morphology, while cells at the surface of constructs had 
highly spread, fibroblastic morphologies (Figure 6.2B, C). Some encapsulated 
cells showed slight deviations from rounded morphology, with some non-
circular actin structures and cell membrane extensions observed, particularly in 
constructs with 0% HA-MA. 
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Figure 6.2: Viability and morphology of chondrocytes after 28 days culture in 
Gel-MA hydrogels with 0-2% HA-MA. (A) Viability images from the centre of 
hydrogel constructs, in which living cells appear green (stained with fluorescein 
diacetate) and dead cells appear red (stained with propidium iodide). (B) Confocal 
microscopy showing actin filaments (green) and nucluei (blue) showing the 
morphology of encapsulated chondrocytes inside the gels and at the surface of the 
gels (insets for 0 and 2% HA-MA). (C) CD44 immunostaining (green) and nuclei 
(blue) showing the cell membrane morphology of encapsulated cells. The scalebar in 
(A) represents 500 μm, and scalebars in (B) and (C) represent 100 μm. 
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6.3.3   Physical Properties 
On day 1, HA-MA had a relatively minor, but statistically significant impact on 
the compressive modulus of cell-free and cell-laden hydrogels (Figure 6.3A). 
For HA-MA concentrations up to 1%, compressive modulus increased with HA-
MA concentration. Constructs with 2% HA-MA were softer than those with 1% 
HA-MA, which was driven by substantially greater swelling in the 2% HA-MA 
hydrogels (Figure 6.3C). On day 1, all cell-laden hydrogels were softer than 
their cell-free counterparts (Figure 6.3A), but the effect was not a consequence 
of differential swelling. On day 1, swelling ratios of cell-free and cell-laden gels 
were generally similar, with only a few small, but statistically significant 
differences (Figure 6.3C).  
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3 (next page): Physical properties of cell-free and cell-laden gels after 
1 and 28 days culture in vitro. (A) Compressive modulus of cell-free and cell-laden 
gels on day 1; (B) swelling ratio of cell-free and cell-laden gels on day 1; and (C) 
change in swelling ratio between days 1 and 28 of culture. Bars and error bars 
represent the mean and standard deviation of data from four patients. The symbol # 
indicates a significant difference between cell-free and cell-laden gels. In (C), a value 
of 2 represents an increase in swelling ratio, for example from 8 on day 1 to 10 on 
day 28, and * represents a difference from day 0. 
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After 28 days culture, cell-free gels with 0-0.5% HA-MA were softer than on 
day 1, while 1% HA-MA gels were unchanged, and 2% HA-MA increased in 
stiffness (Figure 6.3B). The increase of gels with 2% HA-MA was consistent 
with a notable reduction in the swelling ratio, whereas the swelling ratios of 
other hydrogels either increased or were unchanged (Figure 6.3D). For each 
group with HA-MA, the change in swelling ratio during culture was the same 
for cell-free and cell-laden gels. For the Gel-MA only group, however, the cells 
caused the swelling ratio to increase significantly more during culture than the 
cell-free gels.  
The most striking effect of HA-MA was apparent for the changes in the 
compressive moduli of cell-laden gels during culture. HA-MA had a strong and 
concentration dependent effect on the developed mechanical properties after 28 
and 56 days culture (Figure 6.4). The stiffness of all groups increased during 
culture, but the increases were substantially greater in constructs containing HA-
MA, and generally, the change in modulus increased as HA-MA concentration 
increased (Figure 6.4C). After 56 days culture, the compressive modulus of Gel-
MA only constructs (0% HA-MA) increased by an average of 37 kPa, whereas 
constructs with 2% HA-MA increased by an average of 129 kPa during the 
same period.  
 
 
 
 
 
 
Figure 6.4 (next page): Compressive modulus of cell-free and cell-laden gels 
throughout in-vitro culture. (A) The compressive modulus of cell-free gels on days 
1 and 28; (B) compressive modulus of cell-laden gels on days 1, 28 and 56; and (C) 
change in modulus between day 1 and day 28 and day 1 and day 56. Bars and error 
bars represent the mean and standard deviation of data from four patients. The 
compressive modulus increased in all gels with culture time, and HA-MA had a 
significant impact on the rate of increase. The symbol * indicates a difference 
between days 1 and 28, and † indicates a difference between days 28 and 56. In 
each panel, groups without a like Roman numeral are significantly different, and 
upper and lower cases should be considered separately. 
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After 63 days culture, the dynamic and equilibrium moduli of cell-laden 
constructs were measured (Figure 6.5A, B). Both dynamic and equilibrium 
moduli tended to increase with HA-MA concentration, although for higher HA-
MA concentrations, the differences were smaller and less likely to be 
statistically significant. The presence of clear differences in the equilibrium 
moduli confirms that the differences in compressive and dynamic moduli are not 
just a result of increased resistance to fluid flow, but also stem from increased 
rigidity of the network. For hydrogel materials, the compressive modulus 
measured at a given strain will always be equal to or higher than the equilibrium 
modulus at the same strain. On day 63, the equilibrium modulus of gels with 1% 
HA-MA was 86 kPa, significantly higher than the compressive modulus of the 
same gels on day 1 (41 kPa), which also confirms that a substantial component 
of the equilibrium stiffness can be attributed to the cell-secreted extracellular 
matrix.  
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Figure 6.5: Physical properties of cell-laden gels after 63 days of culture. (A) 
Dynamic and (B) equilibrium moduli (B); (C) failure strength and (D) failure strain. An 
example stress-strain curve for a compression-to-failure test is shown in (E). Bars 
and error bars represent the mean and standard deviation of data from four patients. 
Differences between groups are indicated using Roman numerals; groups with a 
common numeral are significantly similar, and groups without a common numeral are 
significantly different. 
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HA-MA also had a significant impact on the failure properties of cell-laden 
constructs on day 63, but unlike the moduli measurements, was not strongly 
dependent on HA-MA concentration (Figure 6.5C). On average, the failure 
stress of gels with any concentration of HA-MA was 63 kPa, which represents a 
substantial increase from the failure strength of gels without HA-MA (23 kPa). 
Failure strains followed a similar pattern to failure strength, although not all 
differences were statistically significant (Figure 6.5D). 
6.3.4   Matrix Production 
After 4 weeks of culture, immunofluorescence was used to visualise the 
presence and distribution of the major cartilage matrix components aggrecan 
and collagen type II. For all hydrogel compositions, the intensity of both 
aggrecan and collagen type II immunofluorescence was greater towards the 
outer regions of the construct than in the centre (Figure 6.6). HA-MA appeared 
to influence the distribution of aggrecan, with more staining in the ECM as 
opposed to the pericellular matrix in constructs with HA-MA. Hydrogel 
composition appeared to have only minor impacts on the staining patterns of 
collagen type II, and the staining patterns of collagen type II and aggrecan were 
quite distinct.  
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Figure 6.6: Aggrecan and collagen type II immunofluorescence in constructs 
after 28 days of culture. Aggrecan and collagen type II are shown in green, and 
nuclei are shown in blue. Regions at the edge and centre of each construct are 
shown. The scalebar represents 100 µm and applies to all panels. 
Collagen type 1 immunofluorescence was strong at the outermost edge of the 
constructs (Figure 6.7), consistent with the stretched chondrocyte morphologies 
observed on the surface of all gels. Collagen type I was also more strongly and 
widely stained in gels without HA-MA, especially compared to those with 0.5% 
and 1% HA-MA (Figure 6.7). Collagen type X was present throughout the 
cultured constructs (Figure 6.7), indicating that cells may be undergoing 
hypertrophy and potential for the ECM to be partially mineralised. 
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Figure 6.7: Collagen type I and type X immunofluorescence in constructs after 
28 days of culture. Collagen type I and type X are shown in green and nuclei are 
shown in blue. Regions at the edge and centre of each construct are shown. The 
scalebar represents 100 µm and applies to all panels. 
6.3.5   GAG Production 
The amount of GAGs that accumulated in the constructs over 28 days culture 
was quantified, and DNA content was quantified on days 1 and 28. In all gels, 
DNA content increased by a similar amount during 28 days culture (Figure 
6.8A). Total GAG content was statistically similar in all groups (Figure 6.8B), 
and GAG content normalised to dry weight was also similar in all groups 
(Figure 6.8C). When normalised to the total GAG content to the 0% HA-MA 
group for each patient to account for inter-patient variability, a modest increase 
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is apparent in gels with 0.5% HA-MA compared to Gel-MA only gels (Figure 
6.8D). 
 
Figure 6.8: (A) DNA content of constructs on days 1 and 28. (B) Total GAG 
content in each hydrogel construct after 28 days of culture; (C) GAG content 
normalised to dry weight, and (D) GAG content normalised to the GAG content for 
0% HA-MA hydrogels for each patient (D). Bars and error bars represent the mean 
and standard deviation of four patients. Groups without a like Roman numeral are 
significantly different, and those with a like numeral are statistically similar. In (A), * 
indicates a significant difference in the DNA content in a hydrogel group between 
days 1 and 28. 
6.3.6   EPIC-μCT 
EPIC-μCT was used as a tool to visualise and semi-quantify differences in GAG 
content between hydrogels. In cell-free gels, the intensity of the negatively 
charged contrast agent Ioxaglate varies with HA-MA (Figure 6.9A). For 
example, 0% HA-MA gels show considerably more red colouration than 2% 
HA-MA gels. EPIC-μCT can also give an indication of charge distribution, with 
more red coloration generally visible in the center regions of cell-laden 
constructs, where matrix synthesis was observed to be much lower (Figure 
6.9B). 
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Figure 6.9: EPIC-μCT scans of cell-free (A) and cell-laden (B) constructs after 
28 days culture. The scans show intensity of the negatively charged contrast agent 
Ioxaglate, and attenuation range in each panel is from 5,000 (blue) to 22,000 (red). 
The 2 mm scalebar applies to all panels. 
6.4   Discussion  
Hyaluronic acid (HA) is one of the most commonly studied biomaterials in 
cartilage tissue engineering, yet we are still discovering aspects of its 
significance for cartilage biology. In healthy cartilage, aggrecan is non-
covalently bound to HA to create massive aggregates of fixed negative charge 
which provide compression resistance and swelling properties, both of which 
are key to its mechanical properties [12]. Many biomaterials for cartilage tissue 
engineering have been produced partly or wholly from HA or HA derivatives, 
some of which have progressed to clinical trials [73, 122, 216]. In addition, 
lightly crosslinked HA is an effective viscosupplementation agent for diseased 
or damaged joints, including those with OA [217].  
In this study, a photocrosslinkable HA derivative has been shown to be a 
valuable addition to gelatin-based hydrogels, and specifically, has shown that 
the addition of HA-MA results in a substantial improvement in the developed 
mechanical properties, as measured using a number of different parameters. 
This is relevant for tissue-engineered cartilage in vivo, which must routinely 
withstand considerable stresses. After 9 weeks of culture, construct dynamic and 
equilibrium moduli significantly increased in a HA-MA concentration-
dependent manner. After this time in culture, the majority of the compressive 
modulus was due to cell-secreted ECM. Additionally, inclusion of HA-MA 
increased failure strength relative to Gel-MA constructs, but strength was 
independent of HA-MA concentration over the range 0.25-2%. Although the 
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failure strength of cell-free gels was not measured, it is likely that the cell 
secreted ECM is also a major factor in determining the failure strength of the 
cell-hydrogel constructs.  
While it is clear that the mechanical properties of the constructs in this study 
improve with time in culture, the exact mechanism for this improvement is not 
clear. GAG content in articular cartilage is correlated with compressive 
properties [218, 219] and GAG content is the most commonly used method to 
measure the functional development of tissue-engineered cartilage. However the 
importance of total GAG content for the mechanical properties of tissue-
engineered cartilage is unclear, and an important distinction was observed in 
this study. In contrast to the role of GAGs in cartilage, the total GAG content 
had very little, if any, correlation with mechanical properties of the tissue-
engineered constructs in this study. GAG content was relatively similar for each 
patient and hydrogel composition, with no significant differences in total GAG 
content or GAG/dry weight. When normalised within each patient, a slight 
increase in GAG/dry weight was observed for gels with 0.5% HA-MA, which is 
roughly in line with previous results from a single patient [214]. Other studies 
have shown that in pure HA-MA hydrogels, the correlation between mechanical 
properties and GAG content was also highly non-linear [122]. This must be 
considered when assessing the quality of tissue-engineered cartilage throughout 
the literature, where GAG content has been measured but not mechanical 
properties. Along with GAGs, the collagen network is also important for 
providing cartilage with mechanical strength. Total collagen content was not 
measured in this study, but it is likely that both the collagen content and its 
distribution throughout the gels contribute substantially to the mechanical 
properties. The hydroxyproline assay is the most common technique to measure 
total collagen content, but this is not practical for gels containing such a large 
amount of gelatin.  
Cell viability was high after 28 days, indicating that the crosslinking process is 
well tolerated and that cells receive sufficient nourishment by diffusion through 
the gel. The crosslinking process has been previously shown to yield high cell 
viabilities [63, 65], but no study has definitely shown that no adverse cell 
outcomes occur. Meanwhile, photoinitiators that are active in the visible region 
of the spectrum are being investigated to further remove the potential for UV or 
radical induced cell damage [220].  
Immunofluorescence analysis showed that aggrecan distribution was enhanced 
in gels with HA-MA, particularly towards the outer edges, and in the 1% HA-
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MA group, in which an almost continuous aggrecan staining can be observed. 
This enhanced ECM distribution may be responsible for the increases in 
mechanical properties when HA-MA was included. Less staining was 
consistently observed in the centre of the constructs, and this is most likely a 
consequence of lower nutrient concentrations due to diffusion gradients within 
the gels. Constructs with 2% HA-MA appeared to inhibit the diffusion of OCT 
into the tissue; this adversely affected the quality of the sections from gels with 
2% HA-MA, and as such, limited emphasis should be placed on images from 
these gels. Cell viability, however, was not reduced in the centre regions of all 
tested gels, perhaps unsurprisingly, since chondrocytes habitually withstand 
hypoxic conditions in native cartilage. Mechanical stimulation using bioreactors 
or perfused medium culture systems could be used to increase mass transfer 
throughout these constructs, potentially further improving mechanical properties 
[122]. Mechanical stimulation may also simultaneously enhance chondrogenesis 
and matrix synthesis by mimicking the natural strains that are applied to 
cartilage [187], and further studies should investigate bioreactor systems to 
progress these materials towards regenerative medicine applications.  
Collagen type X was observed in all hydrogels in this study, which could 
potentially be a consequence of prolonged TGF-β3 exposure or the presence of 
reactive oxygen species during crosslinking. Other studies have indicated that 
reactive oxygen species may promote hypertrophy and collagen type X 
production [221, 222], thereby reducing the quality of the resulting tissue. 
Importantly, using alternative chemical groups for photocrosslinking can reduce 
hypertrophy and collagen type X production. Thiol groups, for example, can 
quench reactive oxygen species during crosslinking, whereas acrylate-based 
chemistries cannot [222]. HA can be modified with thiol groups using simple 
procedures [223] or purchased, and could be used instead of HA-MA [224]. 
Such a study would also provide insight into the importance of network 
topology on the developed mechanical properties and cell responses [222], since 
a substantial proportion of the crosslinks would be expected to occur between 
HA and Gel-MA macromers. In addition, oxygen inhibition results in a several-
minute delay in the onset of crosslinking of acrylate (and methacrylamide) 
systems [123, 224]. By using thiolated HA this delay is effectively removed, 
which would greatly reduce the required UV exposure [222] and make the 
process safer. 
Biological variation, or donor-to-donor variation, presents a significant 
challenge for biomedical research. Previously, it has been identified that HA-
MA can improve the stiffness of cultured Gel-MA/HA-MA constructs, but these 
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results were obtained using chondrocytes from a single patient [214], and thus 
uncertainty remained over how applicable the findings were to cells from other 
patients. In the present study, we used chondrocytes from four patients to 
measure the importance of donor-to-donor variation. The similar response of 
each patient to these materials confirms that material composition has a 
significant influence on construct maturation. It is reasonable to expect that the 
differences observed here using in vitro methods would also translate to 
substantial differences in an in vivo setting, but this remains to be verified.  
Cell source is an important consideration for cartilage repair, and a number of 
different clinically driven routes have been explored. Therefore, this study also 
provides further evidence of the potential to use chondrocytes from elderly 
patients and OA joints. Initially, expanded autologous chondrocytes were used 
for cartilage repair [50], but since then allogeneic chondrocytes [225] and 
mesenchymal stem cells [226] have been investigated. Cells from young donors 
are thought to be more biologically active and have greater potential for 
regeneration, and thus cartilage from juvenile donors has been preferred for 
some clinical treatments [227]. Although we have no comparative data from 
juvenile patients, in this study all cells were isolated from elderly patients with 
OA, and the cells from all patients were able to secrete ECM that significantly 
increased the construct stiffness. This reinforces the potential for using 
autologous chondrocytes even in elderly patients in combination with 
biomimetic hydrogels. 
The hydrogels formed in this study are crosslinked using two very similar 
chemistries. The gelatin component is modified with predominantly 
methacrylamide groups, while HA is modified with methacrylate groups. Both 
groups are crosslinked via the reaction of unsaturated vinyl bonds however the 
reactivity of methacrylamide is reduced by resonance stabilisation with the 
adjacent nitrogen. Theoretically, methacrylamide can crosslink with 
methacrylate, and this has recently been demonstrated using Gel-MA and 
methacrylate functionalised polycaprolactone [228]. Should no preference exist, 
Gel-MA – HA-MA gels would be randomly inter-crosslinked on a molecular 
level. However, it is possible that the methacrylate groups preferentially 
crosslink with other methacrylate groups, or that due to their higher reactivity, 
methacrylate groups are favoured, particularly during the early stages of 
crosslinking. In this case, the network would resemble a double-network 
hydrogel, in which the first network is formed by crosslinked HA-MA, and the 
second network is crosslinked Gel-MA.  
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The degradation characteristics lend some weight to the hypothesis that two 
distinct networks may exist. For example, if the gelatin component of a gel with 
a composition of 9.5% Gel-MA, 0.5% HA-MA is removed by papain or 
proteinase K digestion, an intact, stable network of crosslinked HA-MA 
remains. The existence of a stable HA-MA network, even when HA-MA 
accounts for only one twentieth of the total dry mass indicates that the HA-MA 
network exists independently of the Gel-MA network. Of course this is also 
facilitated by the high molecular weight of the HA used here, increasing the 
likelihood and occurrence of HA chains overlapping.  
The extent of mixing between Gel-MA and HA-MA is temperature dependent. 
Mixtures of these polymers have a degree of turbidity, which increases as 
temperature is reduced, probably as a result of the thermal gelation response of 
Gel-MA (Figure S6.1). This suggests that the network structure of crosslinked 
Gel-MA – HA-MA hydrogels may be temperature dependent, and possibilities 
may exist to further improve mechanical property development by adjusting the 
crosslinking temperature.  
An important question also remains about the functionality of HA-MA 
compared to HA, and the mechanism by which HA-MA improves the 
mechanical properties. In cartilage, for instance, the non-covalent interaction 
between aggrecan and HA is stabilised by link protein [25], and HA turnover is 
mediated by enzymatic degradation by hyaluronidase and replacement with high 
molecular weight HA [229]. Preliminary data from our research (not shown) 
indicates that HA-MA is much less readily degraded by hyaluronidase than HA, 
and that link protein does not strongly bind to or recognise HA-MA. The 
reduced susceptibility of HA-MA to hyaluronidase has been noted in other 
studies, and appears, as one might expect, to depend on the degree of 
functionalisation [230]. Thus if HA-MA has altered functionality to HA, the 
mechanisms by which HA-MA improves the matrix organisation and function 
when added to Gel-MA gels requires further research.  
There is a strong need for improved materials for cartilage tissue engineering, 
and biomimetic materials are a promising strategy to deliver these 
improvements. Currently, fibrin glue is one of the most commonly used gels to 
deliver cells to cartilage defects [51]. This usage is based on the familiarity of 
fibrin glue to orthopaedic surgeons and existing regulatory approval, rather than 
solid evidence demonstrating the suitability of fibrin glue for cartilage repair. 
Individually, Gel-MA and HA-MA are both interesting materials for tissue 
engineering [66, 129, 188], and here and elsewhere, mixtures of these two 
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materials have been identified as having particularly intriguing properties [123, 
201, 214]. The crosslinked hydrogels appear to be quite stable in PBS, with cell-
free gels of all compositions maintaining their shape and structure for at least six 
months at room temperature (data not shown). The gels are susceptible to 
enzymatic degradation, which can be manipulated by varying the relative 
amount of HA-MA [201] or incorporating polymers that are not susceptible to 
enzymatic degradation, such as PEG [231]. Further research should consider the 
mechanisms by which HA-MA exerts an impact on developed mechanical 
properties, possibilities to enhance diffusion throughout the gel, and direct 
comparisons between these gels and existing clinically used materials in large 
preclinical animal models. 
6.5   Conclusion 
In summary, combinations of Gel-MA and HA-MA are promising candidates 
for cartilage tissue engineering. Encapsulated chondrocytes display a 
predominantly rounded morphology, and secrete extracellular matrix that 
increases the compressive modulus by up to three-fold over 8 weeks culture. 
Importantly, different patients respond similarly to HA-MA, and cells from all 
patients were capable of substantially increasing the stiffness of Gel-MA – HA-
MA hydrogels. 
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Hydrogels derived from cartilage, meniscus and tendon 
Abstract 
Decellularised tissues have proven to be versatile matrices for the engineering of 
tissues and organs. These matrices usually consist of collagens, matrix-specific 
proteins, and a set of largely undefined growth factors and signaling molecules. 
Although several decellularised tissues have found their way to clinical 
applications, their use in the engineering of cartilage tissue has only been 
explored to a limited extent. We set out to generate hydrogels from several 
tissue-derived matrices, as hydrogels are the current preferred cell carriers for 
cartilage repair. Equine cartilage, meniscus, and tendon tissue was harvested, 
decellularised, enzymatically digested, and functionalised with methacrylamide 
groups. After photo-crosslinking, these tissue digests were mechanically 
characterised. Next, gelatin methacrylamide (Gel-MA) hydrogels were 
functionalised with these methacrylated tissue digests. Equine chondrocytes and 
mesenchymal stromal cells (MSCs) (both from three donors) were encapsulated 
and cultured in vitro up to 6 weeks. Gene expression (COL1A1, COL2A1, 
ACAN, MMP-3, MMP-13, and MMP-14), cartilage-specific matrix formation, 
and hydrogel stiffness were analysed after culture. The cartilage, meniscus, and 
tendon digests were successfully photo-crosslinked into hydrogels. The addition 
of the tissue-derived matrices to Gel-MA affected chondrogenic differentiation 
of MSCs, although no consequent improvement was demonstrated. For 
chondrocytes, the tissue-derived matrix gels performed worse compared to Gel-
MA alone. This work demonstrates for the first time that native tissues can be 
processed into crosslinkable hydrogels for the engineering of tissues. Moreover, 
the differentiation of encapsulated cells can be influenced in these stable, 
decellularised matrix hydrogels. 
Keywords: Decellularised tissues cartilage, chondrocytes, hydrogels 
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7.1  Introduction 
In tissue engineering, there is a rationale for designing [232, 233] biomimetic 
materials that recreate the native cell niche. Tissue-derived matrices, for 
example, can provide structural and biological support for matrix formation by 
embedded or invading cells [234]. Native tissues that have been decellularised 
while maintaining the natural growth factors and signaling molecules may thus 
provide the ultimate biomimetic environment [235]. Despite the clinical 
translation of decellularised materials for the repair of skin, bone, heart valves, 
and so on, the application in the field of cartilage regeneration has only been 
explored to a limited extent [236, 237]. 
There is a strong need for novel biomaterials for cartilage tissue engineering 
[46, 54]. Hydrogels are good potential candidates, since they can support the 
chondrogenic morphology and simultaneously serve as a temporary scaffold for 
matrix formation. Moreover, hydrogels are easily delivered to a cartilage defect 
and allow for engineering of advanced cartilage constructs [211]. Currently, 
fibrin glue is the clinical standard for cell delivery to cartilage defects [51]. 
However, this gel is relatively unstable with a high degradation rate and is thus a 
delivery vehicle rather than a support structure for cartilage matrix formation 
[238, 239]. Therefore, several new hydrogels are being designed, in which 
ideally the degradation rate is balanced with active cartilage matrix formation, 
and biochemical cues are incorporated to direct the behavior of encapsulated 
cells [184, 240]. Hydrogels derived from natural tissues are interesting 
candidates to meet these requirements, as they may form a potential scaffold for 
cells and include the appropriate biochemical cues. To this end, native matrix 
gels have been acquired from several tissues through digestion with pepsin 
enzymes [241-243]. These hydrogels allowed the invasion of cells and 
subsequent matrix deposition. However, tissue-derived matrix gels so far have 
only been physically cross-linked resulting in low shape stability, which is a 
serious drawback. 
In this study, decellularised matrices were derived from cartilage, meniscus, and 
tendon tissues. Cartilage has a high level of collagen II and glycosaminoglycans 
(GAGs); meniscus has an intermediate level of GAGs, and a mixture of collagen 
types I and II, whereas tendon is predominantly composed of collagen type I 
and a small amount of GAGs [244]. Decellularised cartilage tissue may contain 
the biochemical cues that are present in the native chondrocyte niche. 
Intuitively, a collagen type II scaffold would be the scaffold of choice for 
cartilage engineering, whereas there are indications that this type of collagen 
induces catabolic pathways in cultured chondrocytes [245-247]. On the other 
 128 
Hydrogels derived from cartilage, meniscus and tendon 
hand, collagen type I scaffolds have proven efficacy in the regeneration of 
cartilage tissue [248, 249]. Therefore, both types of collagen and a mixed 
composition (meniscus tissue) were evaluated here. The tissue-derived matrices 
were used for the functionalisation of gelatin methacrylamide (Gel-MA) 
hydrogels. Gel-MA has been identified as a stable, versatile hydrogel for tissue 
regeneration [66, 228, 250]. It can be synthesised at low cost and gelatin is 
widely available as a substrate; cell adhesion sites are abundant and cells are 
allowed to migrate through the hydrogel and remodel the newly formed tissue. 
We previously showed that functionalising Gel-MA with GAGs can 
substantially improve cartilage matrix formation in in vitro models [214]. In this 
study, cartilage, meniscus, and tendon tissues were processed into hydrogels that 
were covalently crosslinked to Gel-MA hydrogel. The potential of these 
matrices to enhance cartilage tissue formation by chondrocytes and 
mesenchymal stromal cells (MSCs) in vitro was evaluated. 
7.2  Materials and Methods 
7.2.1   Development of crosslinkable tissue-derived matrix 
hydrogels 
Stifle joints (n = 8; age 3–10 years) were obtained from horses that had 
died or were euthanised due to nonorthopedic ailments. Consent was obtained 
from the owner before tissue harvest and tissue was only obtained from 
macroscopically healthy joints. The stifle joints were dissected and the full-
thickness cartilage was harvested from the entire femoral condyles. Also, both 
complete menisci and the patellar tendons were harvested, 0.5 cm from their 
anchoring site in the bone. The tissues were dissected into small pieces (5×5×5 
mm for meniscus and tendon, and 5×5×2 mm for cartilage tissue) and all donors 
were pooled. Three random samples were taken from each tissue type to 
measure the GAG and DNA content. The obtained values will thus reflect the 
variability between donors and sample location (e.g., cartilage from the medial 
or lateral condyle). Then the tissues were separately milled in liquid nitrogen 
(A11 basic analytical mill; IKA). The cartilage fragments were subsequently 
sieved through pores of 710 μm. Cells were removed from the tissues by 
treatment with 10 mM Tris/1% triton on a roller bench for 24 h; sonication for 2 
h at 55 ± 10 kHz and a nuclease solution consisting of 1 U/mL 
deoxyribonuclease and 1 U/mL ribonuclease in phosphate-buffered saline (PBS) 
on a roller bench for 72 h at 37 °C. The resulting matrices (from cartilage, 
meniscus, and tendon tissue) were freeze-dried and digested with pepsin 
(Sigma-Aldrich) in a 0.01 M hydrochloric acid solution at 37 °C on a roller 
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bench, until clear suspensions were obtained. The pH of the solutions was raised 
to 9.0 for 1 h (using 1 M NaOH), to irreversibly inactivate the remaining pepsin 
enzymes [251], before adjustment to 7.5 (using 1 M HCl). Next, methacrylic 
anhydride (Sigma) was added dropwise (2.5 mL/g matrix) and was allowed to 
react with the matrices under constant stirring for 1 h. The methacrylated tissue-
derived matrices (CartMA, MenMA and TendMA) were dialysed against 
distilled water for 7 days at 40 °C to remove unreacted methacrylic acid and 
anhydride. After freeze-drying, the tissue digests were dissolved in PBS 10% 
(w/v), containing photoinitiator Irgacure 2959 (0.1% [w/v], Ciba; BASF). A 
schematic overview of the experimental set-up is presented in Figure 7.1. 
 
Figure 7.1: Experimental setup of the study. Col, collagen; GAG, 
glycosaminoglycans; IHC, immunohistochemistry; MES, mesenchymal stromal cells; 
n, the number of analysed samples per donor; NMR, nuclear magnetic resonance; 
PCR, polymerase chain reaction. 
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7.2.2   Characterisation of tissue derived matrices 
Collagen type I (rat tail; BD Biosciences), collagen type II (from chicken sternal 
cartilage; Sigma), meniscus, tendon, and cartilage digests (not methacrylated) 
were electrophoresed on a Bolt 4–12% BisTris Plus gel (Novex; Life 
Technologies) under reducing conditions (1.25% 2-mercaptoethanol). The 
proteins were visualised with Page Blue (Thermo Scientific) and compared to a 
multicolour High Range protein ladder (Thermo Scientific). Images were 
recorded using an Epson perfection 4490 Photo scanner. 
 
The success of the methacrylation procedure was evaluated using proton nuclear 
magnetic resonance (1H NMR). 1H NMR spectra of 10 mg/mL solutions of 
decellularised cartilage, meniscus, and tendon tissue digests, and their 
methacrylated equivalents (respectively cartMA, menMA, and tendMA), were 
recorded on a Mercury 300 MHz instrument (Varian Associates, Inc.; NMR 
Instruments). Chemical shifts were recorded in ppm with reference to the 
solvent peak (d = 4.8 ppm for D2O). 
7.2.3   Blending of tissue digests with Gel-MA 
For cellular differentiation experiments, the methacrylated tissue digests 
(cartMA, menMA, and tendMA), were separately blended with Gel-MA at 37 
°C, and will be referred to as the cartilage, meniscus, and tendon group, 
respectively. Gel-MA was synthesised by reaction of type A gelatin (Sigma) 
with methacrylic anhydride as described previously [52, 123]. The final 
composition of the hydrogels was 8% Gel-MA and 2% tissue digest in 1×PBS 
with 0.1% photoinitiator (all w/v). Gel-MA (10% w/v) was used as a control.  
7.2.4   Photocrosslinking of hydrogels 
Photocrosslinking of all hydrogels was performed for 15 min in a custom-made 
Teflon mold (width × height = 4×2 mm) using 365 nm UV light in a UVP CL-
1000L cross-linker (UVP). The crosslinked samples were stored overnight at 37 
°C in PBS before analysing the compressive modulus. 
7.2.5   Compressive mechanical testing 
The compressive modulus of all three uncrosslinked and crosslinked (-MA) 
tissue digests was measured, and compared to crosslinked Gel-MA gels (all n = 
5). The compressive modulus was also measured at day 1 and week 6 of in vitro 
culture for all experimental groups (cross-linked cartilage, meniscus, tendon, 
and Gel-MA gels, all n = 5). Measurements were performed by uniaxial 
unconfined compression in air at room temperature. Hydrogels and hydrogel-
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cell constructs were compressed to ~20% strain in 2 min using a Dynamic 
Mechanical Analyser (DMA 2980; TA Instruments). The compressive modulus 
was calculated from the linear derivative of the stress/strain curve at 10–15% 
strain. 
7.2.6   Isolation of equine chondrocytes and multipotent 
stromal cells 
Full-thickness cartilage was harvested under sterile conditions from the stifle 
joint of fresh equine cadavers (n = 3, age 3–10 years) with macroscopically 
healthy cartilage and with consent of the owners. After overnight digestion in 
0.15% type II collagenase (Worthington Biochemical Corp) at 37 °C, the 
suspension was filtered, stored at -196 °C, and encapsulated in the hydrogels at 
passage 1, according to a previously described protocol [228]. 
With approval of the Institutional Animal Ethical Committee, bone marrow 
aspirates were obtained from the iliac crest of healthy horses under general 
anesthesia (n = 3). The mononuclear fraction was isolated according to a 
previously described protocol [252]. The cells were stored at -196 °C and 
encapsulated in the hydrogels at passage 3–4. The multi-lineage potential of 
cells cultured from the bone marrow aspirates was confirmed by a three-way 
differentiation assay as previously described [252, 253]. 
7.2.7   Viability assay 
To evaluate the effect of the addition of the methacrylated tissue digests to Gel-
MA on embedded cells, the viability of chondrocytes and MSCs (both three 
donors) was analysed on day 1. The cells had been encapsulated in the cartilage, 
meniscus, tendon, and Gel-MA hydrogels at a concentration of 5×106 cells/mL. 
A LIVE/DEAD Viability Assay (Molecular Probes MP03224) was performed 
according to the manufacturer’s instructions. Live and dead cells were counted 
for three samples per time point, at four locations within each construct. 
Viability was calculated as follows: (live cells/total cells) ×100. 
7.2.8   Cellular differentiation experiments 
Equine chondrocytes and MSCs (both three donors, 15×106 cells/mL) were 
embedded in the cartilage, meniscus, tendon, and Gel-MA groups. The gels 
were cultured in vitro for up to 6 weeks in chondrogenic differentiation medium. 
For chondrocyte-laden hydrogels this consisted of Dulbecco’s modified Eagle’s 
medium (DMEM) (41965; Invitrogen) supplemented with 0.2 mM l-ascorbic 
acid 2-phosphate, 0.5% human serum albumin (SeraCare Life Sciences), 1×ITS-
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X (Invitrogen), 100 U/mL penicillin, 100 mg/mL streptomycin, 25 mM 4-(2-
hydroxyethyl)-1-piperazineethanesulfonic acid (Invitrogen), and 5 ng/mL 
transforming growth factor β-2 (TGF-β2, R&D Systems). MSC-laden samples 
were cultured in DMEM (31966; Invitrogen) supplemented with 0.2 mM l-
ascorbic acid 2-phosphate, 1×ITS + premix (BD Biosciences), 0.1 μM 
dexamethasone, 100 U/mL penicillin and 100 μg/mL streptomycin, and 10 
ng/mL TGF-β2 (R&D Systems). Cell-free hydrogels cultured for 6 weeks 
served as a negative control group. 
7.2.9   Histology, immunohistochemistry and biochemistry 
After 4 and 6 weeks of culture (three and five replicates respectively), the DNA 
and GAG content was quantified for all donors and groups. To this end, the 
samples were digested overnight in papain solution (200 μL per sample [0.01 M 
cysteine, 250 μg/mL papain, 0.2 M NaH2PO4, and 0.01 M 
ethylenediaminetetraacetic acid] at 60 °C). Total DNA was quantified using the 
Picogreen DNA assay (Invitrogen) according to the manufacturer’s instructions. 
Total GAG content was determined by photospectrometry at 525 and 595 nm, 
after reaction with dimethylmethylene blue using a microplate reader (Biorad). 
The ratio of both absorbances was calculated and the GAG content was 
quantified using a chondroitin sulfate (Sigma) standard. The concentrations of 
GAG and DNA in each papain digest were normalised per donor to the 4-week 
Gel-MA control group. GAG/DNA was calculated to display the single cell 
synthetic activity for the production of cartilage-specific matrix. 
After 6 weeks of culture, three samples from each donor were taken for 
histology and immunohistochemistry. Samples were dehydrated through a 
graded ethanol series, cleared in xylene, and embedded in paraffin. The samples 
were sectioned into 5 μm slices and a triple stain of hematoxylin (Klinipath 
BV), fast green and Safranin-O (Merck) was applied to identify GAG 
deposition. The stained sections were examined using a light microscope 
(Olympus BX51). 
Collagen type II was stained by immunohistochemistry after deparaffinisation 
and rehydration of the sections, according to a previously described protocol 
[228] (primary antibody: 1:100, monoclonal mouse, II-II6B3; Developmental 
Studies Hybridoma Bank (DSHB); secondary antibody: 1:200, P0447; Dako). 
Isotype controls were performed by using mouse isotype IgG1 monoclonal 
antibody at concentrations similar to those used for the stainings. 
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7.2.10   Gene expression 
After 6 weeks of culture, the samples were homogenised in TRIzol reagent 
(Invitrogen). The best-performing chondrocyte and MSC donors were selected 
for polymerase chain reaction (PCR) analysis, based on a safranin-O staining of 
the Gel-MA control groups at week 6. The RNA was isolated according to the 
manufacturer’s guidelines (chloroform was substituted by 3-bromo-
chloropropane [254]). RNA was cleared of any DNA contamination by DNase 
digestion. Total RNA yield was determined spectrophotometrically (NanoDrop 
ND1000; Isogen Life Science) and 500 ng total RNA per sample was reverse 
transcribed into complementary DNA (cDNA) using Superscript III (Invitrogen) 
and random primers. SybrGreen quantitative real-time PCR was subsequently 
performed on an iQ-5 real time PCR detection system (Bio-Rad Laboratories). 
Each sample was run in duplicate and a three-fold serial dilution of pooled 
cDNA was used as a standard curve. 
Primers were designed using computer software (primer BLAST, 
www.ncbi.nlm.nih.gov/tools/primer-blast) and obtained from Eurogentec. The 
specific genes of interest were collagen type IA1 (COL1A1), collagen type IIA1 
(COL2A1), aggrecan (ACAN), matrix metalloproteinase-3 (MMP-3), MMP-13, 
and MMP-14. Hypoxanthine-guanine-phosphoribosyltransferase 1 (HPRT-1) 
and signal recognition particle 14 kDa (SRP-14) were selected as reference 
genes. Following fold-change calculation using the standard curve method, the 
geometric mean of these two reference genes was used to calculate the 
normalised mRNA expression of each target gene. Primer sequences of selected 
genes are provided in Supplementary Table S7.1.  
7.2.11   Statistical analyses 
An independent samples T-test, assuming unequal variances, was performed to 
compare the DNA and GAG content of the tissues before and after the 
decellularisation protocol and also to compare the stiffness of cross-linked and 
uncrosslinked cell-free hydrogels. A Univariate Analysis of Variance with a 
Tukey HSD post hoc test was performed to compare GAG, DNA, GAG/DNA, 
and the compressive modulus between the groups of the cell culture 
experiments. Because the level of matrix formation differed significantly 
between the cell donors, a randomised block design was used, correcting for 
donor effects. GAG and DNA were normalised to the Gel-MA control group at 
week 4 for each separate cell donor; the compressive modulus was normalised 
to Gel-MA day 1. The statistical analyses were done using SPSS statistics (IBM, 
version 20). For the PCR data, Kruskal Wallis and Dunn’s multiple comparison 
 134 
Hydrogels derived from cartilage, meniscus and tendon 
post hoc tests were used to test differences between experimental conditions for 
each primer pair using Graphpad software (Graphpad Prism version 5.2 for 
Windows). Differences were considered significant when p < 0.05 for all tests.  
7.3   Results 
7.3.1   Decellularisation procedure 
The DNA content of the cartilage, meniscus, and tendon tissues significantly 
decreased after decellularisation, to values below 50 μg/mg dry weight (Figure 
7.2A). The DNA content was unaltered by the subsequent dialysis. The GAG 
content of all three tissues showed large variations between donors and/or 
sample location (Figure 7.2B). Yet, the variation and the absolute GAG content 
decreased considerably after the decellularisation procedure and remained 
unaltered after dialysis. About 58 – 10% of methacrylated and decellularised 
material could be obtained from the original tissues (expressed in dry weight). 
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Figure 7.2: The effect of the decellularisation protocol on DNA and 
glycosaminoglycan (GAG) content of equine cartilage, meniscus and tendon 
tissues. (A) The DNA content of all tissues was significantly reduced by the 
decellularisation protocol. (B) The GAG content of all tissues directly after harvesting 
from the knee joint (before decell) shows large standard deviations, caused by donor 
and location variations. The subsequent decellularisation procedure significantly 
reduced and standardised the GAG contents.  
7.3.2   Characterisation of tissue derived matrices 
The decellularised cartilage, meniscus, and tendon matrices were successfully 
digested with pepsin enzymes until clear or close to clear solutions were 
obtained. Short treatment of the tissue particles (cartilage) or fibers (meniscus 
and tendon) with pepsin resulted in viscous substances, whereas overnight 
treatment resulted in low-viscosity solutions. Overnight digestion was used to 
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facilitate the methacrylation procedure. Gel electrophoresis showed that all 
digested tissues consisted of polymers with a molecular weight predominantly 
in the range of 130–300 kDa (Figure 7.3A). The profile of the collagen I 
solution reflects the collagen monomers (two subunits), dimers (two subunits), 
and trimers. This typical profile can also be observed in the tendon and 
meniscus digests. The collagen type II control only displays monomers with one 
subunit. This single unit monomer can also be found in the cartilage digest. 
Successful methacrylation of the solutions was confirmed with NMR by the 
double peak that emerged between 5 and 6 ppm after methacrylation of all three 
tissue digests (Figure 7.3B-G). Comparing the stiffness of methacrylated tissue 
digests (cartMA, menMA, and tendMA) with Gel-MA and nonmethacrylated 
tissue digests revealed significant variations (Figure 7.4). CartMA was stiffer 
than all other groups (66.2 – 11.9 kPa, p < 0.05) and Gel-MA was stiffer (33.8 – 
6.5 kPa, p < 0.05) compared to menMA (15.1–5.4 kPa) and tendMA (11.4–0.6 
kPa). The non-methacrylated tissue digests remained low-viscosity solutions 
after treatment with UV light and, therefore, their stiffness could not be 
determined. Considering the variable degree of stiffness and to functionalise the 
existing Gel-MA hydrogel platform, the methacrylated tissue digests were 
blended with Gel-MA for the cellular differentiation experiments.  
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Figure 7.3: Characterisation of tissue-derived matrices. (A) Protein gel of tissue 
digests, collagen type I and II. (B-D) Nuclear Magnetic Resonance (NMR) of the 
tissue digests shows an inhomogeneous tissue profile after the decellularisation 
procedure, reflecting the natural polymers. (E-G) The two peaks that appeared after 
methacrylation (shaded area, between 5-6 ppm) show the presence of vinyl protons, 
and confirm the success of the methacrylation procedure. 
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Figure 7.4: Compressive modulus of photocrosslinked 10% hydrogels. Non-
methacrylated tissue digests were not crosslinkable and hence their compressive 
modulus could not be determined (ND). The compressive modulus of crosslinked 
tissue digests (cartMA, menMA and tendMA) and Gel-MA varied significantly. 
7.3.3   Viability and cartilage matrix formation by embedded 
chondrocytes 
Encapsulation of chondrocytes resulted in high viability at day 1 in all tissue-
derived matrix hydrogels (Figure 7.5A). During in vitro culture, the tendon 
samples rapidly disintegrated for all chondrocyte donors and could, therefore, 
not be included in the differentiation analysis. Gel-MA gels had a higher 
stiffness 1 day after cell encapsulation compared to the cartilage, meniscus, and 
tendon groups (Figure 7.5B). A comparable pattern was observed after 6 weeks 
of culture. The DNA and GAG content and GAG/DNA of hydrogels was 
comparable for all groups after 4 weeks, but it was significantly higher in the 
Gel-MA group compared with cartilage and meniscus after 6 weeks (Figure 
7.5C-E). The absolute GAG content in the Gel-MA control samples was 1.17 – 
0.28 μg/mg wet weight after 4 weeks and increased to 2.73 – 2.13 μg/mg after 6 
weeks of culture. GAG and DNA in all experimental groups were significantly 
higher than the cell free control samples. The superior cartilage-specific matrix 
formation after 6 weeks in the Gel-MA group was confirmed by histology for 
GAGs (Figure 7.5F) and immunohistochemistry for collagen type II (Figure 
7.5G). The differences between the experimental groups at week 4 were 
comparable to week 6. Therefore, only week 6 data were presented for both cell 
types. The cell free cartilage gels contained no significant traces of GAGs and 
collagen type II after 6 weeks. 
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Figure 7.5: Survival and chondrogenic differentiation of chondrocytes 
embedded in the tissue-derived matrix gels. (A) The cartilage, meniscus and 
tendon gels were not cytotoxic for embedded chondrocytes; (B) the stiffness of the 
tissue-derived hydrogels was lower than Gel-MA directly after encapsulation (day 1) 
and after 6 weeks of culture; (C-E) the DNA, GAG and GAG/DNA values after 6 
weeks of culture were lower in both experimental groups compared to the Gel-MA 
group; (F) GAG formation (red) and (G) collagen type II content (brown) were 
superior in the Gel-MA group after 6 weeks. The tendon group disintegrated during 
culture of chondrocytes and is therefore not displayed for GAG and DNA content. 
The DNA, GAG and GAG/DNA content were normalised per donor to Gel-MA week 
4; sample stiffness was normalised to Gel-MA day 1. All scale bars are 200 µm; “cell 
free” sample is cartilage gel. 
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7.3.4   Viability and cartilage matrix formation by embedded 
MSCs 
MSCs in all experimental groups retained a high viability 1 day after 
encapsulation in the hydrogels (Figure 7.6A). The stiffness of Gel-MA gels was 
highest 1 day after encapsulation of the MSCs (Figure 7.6B). Gel-MA and 
tendon gels showed superior stiffness after 6 weeks of cell culture. The DNA 
content was higher in the tendon and Gel-MA gels compared to the cartilage and 
meniscus gels, both after 4 and 6 weeks of culture Figure 7.6C). A comparable 
amount of GAG was measured for all groups; only the cartilage gels had a 
statistically lower amount than the Gel-MA group (Figure 7.6D). The absolute 
GAG content in the Gel-MA control samples was 3.48 – 3.62 μg/mg wet weight 
after 4 weeks and 3.82 – 4.38 μg/mg after 6 weeks of culture. The GAG/DNA 
values for the cartilage and meniscus gels were larger than found in the Gel-MA 
group (due to a lower DNA content in cartilage and meniscus gels), although 
these differences were not statistically significant. Staining of GAGs and 
collagen type II showed abundant cartilage-specific matrix formation by MSCs 
in all groups (Figure 7.6F, G). 
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Figure 7.6: Survival and chondrogenic differentiation of MSCs embedded in the 
tissue-derived matrix gels. (A) The cartilage, meniscus and tendon gels were not 
cytotoxic for embedded MSCs; (B) directly after encapsulation of the MSCs (day 1), 
the stiffness of Gel-MA samples was highest; after 6 weeks of culture, Gel-MA as 
well as the tendon group were stiffer; (C-D) differences were observed in the DNA 
and GAG content of the experimental groups; (E) GAG/DNA content was higher in 
the cartilage and meniscus gels, although this difference was not statistically 
significant; (F) GAGs (red) and (G) collagen type II (brown) localisation in all groups 
after 6 weeks. The DNA and GAG content were normalised per donor to Gel-MA 
week 4; sample stiffness was normalised to Gel-MA day 1. All scale bars are 200 
µm; “cell free” sample is cartilage gel. 
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7.3.5   Gene expression levels 
The poor interaction of the chondrocytes with the various tissue cultures (Figure 
7.5) led to insufficient RNA yields in the cartilage and meniscus groups (the 
tendon group having disintegrated and not being available for that reason), so 
that the chondrocytes were excluded from the gene expression analysis. In 
contrast, the RNA yields of MSCs were sufficient for all samples. ACAN, and 
COL2 expression was similar for all experimental groups (Figure 7.7). The 
expression of COL1A1 was significantly lower in meniscus than in cartilage 
gels. Catabolic enzyme MMP-13 and MMP-14 expression was significantly 
lower in the tendon group compared with Gel-MA and the cartilage group 
respectively. These were the only target genes for which a significant difference 
existed between the experimental conditions. 
 
Figure 7.7: Gene expression by MSCs in tissue-derived matrix gels. Gene 
expressions for aggrecan and collagen type II were similar in all hydrogels cultured 
with MSCs. Collagen I expression was higher in the cartilage hydrogel compared to 
meniscus. MMP-3 expression was similar in all cultures, whereas expression of 
MMP-13 and MMP-14 was lower in tendon gels compared to Gel-MA and cartilage 
respectively. Separate data points were presented (n=5) including the median and 
interquartile range. 
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7.4   Discussion 
In this study, crosslinkable hydrogels were created, based on matrix derived 
from cartilage, meniscus, and tendon tissues. These substrates allowed the 
biological functionalisation of the existing Gel-MA hydrogel system, in which 
they influenced the quantity and quality of matrix produced by embedded cells. 
All tissue types negatively influenced outcomes for chondrocytes, whereas 
encapsulated MSCs exhibited variable differentiation patterns, depending of the 
type of tissue the matrix gel was derived from. 
To our knowledge, this is the first report in which decellularised tissues are 
covalently cross-linked into stable hydrogels. Previously, the Badylak group has 
derived hydrogels from the extracellular matrix of the dermis, urinary bladder, 
and the central nervous system [241, 242, 255]. These hydrogels allowed the 
infiltration and adhesion of cells and influenced their differentiation. In addition, 
hydrogels derived from heart, cartilage, and adipose were recently shown 
capable of supporting tissue formation by embedded cells [243]. Analogous to 
our work, the hydrogels were obtained by pepsin digestion of the respective 
tissues. However, only physical crosslinking of the natural polymers was 
accomplished, resulting in considerable contraction of the hydrogel constructs 
during culture. This behavior is comparable to other natural polymer networks 
like collagen gels and fibrin glue [239, 254, 256]. The resulting shape 
instability, however, is unfavourable for the sustainable filling and regeneration 
of a tissue defect, especially for load-bearing tissues such as cartilage. We have 
now successfully overcome this issue by covalent cross-linking of the matrix-
derived hydrogels through the addition of methacrylamide groups. These 
substrates were subsequently incorporated into Gel-MA hydrogel, because we 
aimed to further develop this versatile hydrogel, which was proven efficient for 
cartilage matrix formation by embedded cells [123, 214, 228]. The 
methacrylation procedure resulted in a very substantial increase in the 
compressive modulus, which was largest in the cartilage-derived matrix and of 
the same order of magnitude as occurring in the Gel-MA reference matrix. The 
methacrylation procedure can hence be considered as an important asset in the 
production of extracellular matrices for tissues that have to withstand 
biomechanical forces. 
The chondrogenic potential of MSCs in extracellular matrix gels was greater 
than that of chondrocytes. MSCs have previously shown capable of forming a 
cartilage specific matrix in 3D-hydrogel systems [257]. The quality and quantity 
of cartilaginous tissue formed by MSCs was found comparable to that of 
chondrocytes, although dependent on the type of hydrogel [258]. From our work 
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we can conclude that equine MSCs thrive relatively well in Gel-MA gels. 
Nevertheless, chondrocytes from the different donors did show less donor 
variation than the MSCs, which is a known phenomenon for the latter cell type 
[259]. Still, MSCs are of great interest as an allogeneic cell source for the 
single-stage repair of cartilage tissue [260]. A limitation for the application of 
MSCs in vivo is that they require the addition of growth factors to be directed 
toward the chondrogenic lineage [253]. Recently, chondrocytes have shown 
they are capable of guiding MSC differentiation, and therefore, a coculture of 
MSCs and chondrocytes holds promise for the repair of cartilage tissue [260]. 
The absolute GAG production by chondrocytes embedded in the Gel-MA 
hydrogels is similar to the amounts reported in previous in vitro studies [123, 
214]. However, a consistent negative effect of the incorporation of all three 
tissue derived components was observed on the differentiation of chondrocytes. 
This is in line with previous reports on the culture of chondrocytes on collagen 
matrices [245-247]. Collagen type II matrix induces catabolic pathways in 
cultured articular chondrocytes, including the upregulation of MMP-3, MMP-
13, and MMP-14 [246, 247]. In addition, earlier work from our group showed 
poor GAG production of chondrocytes cultured on decellularised cartilage 
matrix scaffolds (collagen type II) and even accelerated degradation of the 
scaffolds [245]. In the current work, scaffold (i.e., hydrogel) disintegration was 
observed only for the tendon hydrogels (collagen type I), which may be a result 
of the catabolic activities of the chondrocytes, analogous to those observed in 
osteoarthritis [261, 262]. Unfortunately, we were unable to analyse MMP 
expression by chondrocytes, since the tendon gels had disintegrated and RNA 
yield was too low in the cartilage and meniscus groups. In contradiction to these 
findings, successful cultures of chondrocytes were shown on synthetic collagen 
type I and II matrices [263-266]. The literature is thus inconclusive about the 
effect of collagen matrices onchondrocyte behavior, although the upregulation 
of inflammatory pathways has been clearly indicated. 
In interpreting cell–matrix interactions, the difference between pure collagen 
scaffolds and tissue-derived matrices should be taken into account. In the latter, 
other matrix components, growth factors and/or signaling molecules may 
contribute to effects on cell behavior [233, 235]. For example, it was shown that 
several growth factors were retained in decellularised bladder submucosamatrix 
[267] and small intestinal submucosa matrix [268]. The decellularisation 
protocol in this study was relatively mild compared to previous studies [237]. 
Therefore, a panel of growth factors is likely to be retained within the matrix, 
although this was not specifically studied here. The main components of the 
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tissue-derived matrices were shown to be collagens type I and II, the proportions 
depending on the original tissue. However, the exact biochemical composition 
of the polymers, for example, the amount of available reactive amines to be 
methacrylated, remains unknown. As a result, the degree of methacrylation of 
the tissue-derived matrices was not controlled, and will hence vary between 
tissue types and tissue donors. This limitation should be taken into account 
during the interpretation of the responses of embedded cells. 
The absence of trypsin as a protein-cleaving enzyme in the current protocol lead 
to the preservation of some of the GAGs (~10%, compared to 0% when treated 
with trypsin [245]) while the DNA content could be decreased to acceptable 
standards, that is, below 50 μg/mg dry tissue [237]. Chondrocytes probably 
benefit more from GAG than collagen components in hydrogel cultures [123, 
214]. Therefore, the current outcomes could be improved by a modified 
decellularisation protocol, preserving still more GAGs. 
For the chondrogenic differentiation of MSCs, our results show a slight 
preference for a collagen type I rich matrix (tendon gels) over collagen type II 
(cartilage gels). For example, MSCs proliferated more in tendon and Gel-MA 
gels and the sample stiffness was higher after culture, compared to meniscus and 
cartilage gels. In addition, MSCs in the tendon gels showed reduced expression 
of MMP-13 and MMP-14, although gene expression of cartilage-specific matrix 
genes was similar. Recently, Yang et al. also analysed the effects of tendon-
derived matrix on MSCs and found a reduced expression of collagen type I, 
which is considered a marker for inferior fibrocartilage formation [256]. The 
lowest GAG production by MSCs was observed in the cartilage matrix gels, 
along with a higher gene expression of collagen type I. Previous research, 
however, revealed a stimulatory effect of cartilage matrix on the chondrogenic 
differentiation of MSCs in vivo [269, 270]. In addition, other work showed that 
chondrogenesis of bovine MSCs was slightly enhanced in collagen type II 
compared with collagen type I gels [271]. It appears that certainly collagens 
influence the differentiation of MSCs, yet the optimal collagen composition still 
needs to be unraveled and will require specific tailoring for the target tissue to 
be engineered. 
Further research should identify the specific biological cues in native tissues that 
are favorable to cells in tissue engineering. Unfortunately, the specific factors 
responsible for the cell behavior in decellularised tissues are still largely 
unknown. A better understanding of the native cell niche can guide the process 
of producing biomimetic materials.  
 146 
Hydrogels derived from cartilage, meniscus and tendon 
7.5   Conclusion   
Crosslinkable hydrogels were created from cartilage, meniscus, and tendon 
tissue through a process that included enzymatic digestion and methacrylation. 
The methacrylation procedure successfully increased the stiffness of these 
matrices, which is a critical factor in the manufacturing of scaffolds for use in 
musculoskeletal tissue repair. Moreover, a stable hydrogel platform was created 
by covalent incorporation of these tissue-derived matrices in versatile Gel-MA 
hydrogels. The response of embedded cells to these matrices depended on the 
cell type and the matrix components. Chondrocytes performed relatively poor in 
the tissue-derived matrix gels compared with the Gel-MA control group. The 
chondrogenic differentiation capacity of MSCs was comparable across all 
hydrogels.  
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Discussion and future work 
The development of hydrogels and other biomaterials for cartilage tissue 
engineering is an active field of research, with universities and companies 
around the world striving to find the optimal materials for replacing or 
regenerating cartilage. This Chapter summarises some of the recent findings 
related to the development of hydrogels for cartilage regeneration.  
8.1  Hydrogel composition 
In cartilage tissue engineering, hydrogels are being widely used as both models 
and as biomaterials for clinical application. The composition and biochemical 
properties of hydrogels vary enormously, and Chapters 3 and 5 show that these 
properties have major consequences for chondrocyte differentiation and matrix 
production. Despite this, there is relatively little evidence and research 
underpinning the materials that are currently used for clinical cartilage repair.  
Aims iii) and iv) of this thesis were to functionalise Gel-MA hydrogels with 
moieties to promote chondrogenesis and matrix production. In order to 
incorporate these moieties stably into Gel-MA, it was necessary for them to be 
covalently crosslinked into the hydrogel network. To achieve this, we used 
methacrylic anhydride to conjugate methacrylate (or methacrylamide) groups to 
each of the target moieties. The importance of covalent attachment, as opposed 
to physical entanglement, was displayed using low and high molecular weight 
polysaccharides, namely heparin (MW ~ 17-19 kDa, Sigma) and HA (MW 950 
kDa, Novozymes). When unmodified heparin was incorporated into Gel-MA 
hydrogels, virtually all of the heparin diffused out of the gels within 24 hours 
(Figure 8.1). Modification of heparin with methacrylate groups (Hep-MA) 
resulted in stable incorporation, with no change in GAG content over 14 days 
(Figure 8.1). In comparison, incorporation of unmodified HA, with a much 
higher molecular weight, resulted in a more gradual and ultimately incomplete 
loss of HA from Gel-MA hydrogels (Figure 8.1). Nevertheless, ~80% of the HA 
initially incorporated diffused out of the gels within 14 days. In contrast, the 
presence of a hydrogel network in gels containing HA-MA following papain or 
proteinase K digestion indicates that the HA-MA is independently covalently 
crosslinked. It was not possible to quantify HA-MA in the gels using the 
DMMB assay, since once crosslinked, HA-MA it not digested by papain or 
proteinase K, and upon mechanical disruption does not re-enter solution. These 
retention studies highlight the importance of covalent bonding for stable 
incorporation, but we cannot be certain of the effect that modification has on the 
interactions with biological systems.  
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Figure 8.1: Retention of heparin and heparin-methacrylate in cell-free Gel-MA 
hydrogels in PBS over 2 weeks. 
This is particularly important since the mechanisms by which HA-MA enhanced 
outcomes in Chapter 5 are not yet understood. Preliminary evidence suggests 
that link protein, which stabilises the binding of aggrecan to HA in cartilage, 
cannot bind to HA-MA (immunostaining results – data not shown). Further, 
other studies have shown that as the degree of functionalisation increases, the 
rate of digestion with hyaluronidase decreases [272]. In a preliminary study 
using PEG-based hydrogels (Qgel, Switzerland), the addition of 3.3 mg/mL HA 
(Novozymes) into the hydrogels had no effect on GAG production or changes in 
construct stiffness during 14 days culture (data not shown). In addition, in 
Chapter 4, we did not observe differences in the cultures with or without HA, 
although this may be a result of an overly high HA concentration, which was 
chosen primarily to facilitate printing.  
8.2  Hydrogel structure and properties 
Hydrogels are inherently ‘soft and watery’ materials, with a generally low 
modulus and fracture energy (Figure 8.2). Mechanical properties are often cited 
as a limitation of hydrogels for cartilage applications, given the loads that this 
tissue must withstand. Like cartilage, damage to Gel-MA hydrogels is not easily 
repaired, so the gel construct must be sufficiently strong to withstand the loads 
within the joint. The stiffness of Gel-MA based hydrogels have been 
investigated in some detail in this thesis, including the changes in stiffness are a 
product of cell-secreted ECM.  
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One of the advantages of synthetic hydrogels over natural hydrogels is the 
ability to tightly control the properties – such as polymer chemistry, molecular 
weight, cross-link density, and degradation mechanisms and kinetics [273]. In 
contrast, with the notable exception of ionic crosslinking, most conventional 
crosslinking mechanisms for natural hydrogels have traditionally been 
incompatible with cells. The most commonly used crosslinking mechanisms for 
natural hydrogels include glutaraldehyde, carbodiimide, low-wavelength UV 
irradiation or heating [273]. While it is undeniable that synthetic hydrogels offer 
a degree of versatility that natural hydrogels cannot, in this thesis we have 
shown that it is possible to tailor both the mechanical properties and 
biochemical composition of Gel-MA hydrogels. In Chapter 4 we show that the 
compressive modulus of Gel-MA hydrogels can be easily manipulated over a 
wide range (5 to 180 kPa), and by increasing the precursor concentration beyond 
20% (w/v), we expect that the stiffness can be further increased. 
Double network hydrogels offer marked improvements in strength compared to 
their single network counterparts. Double network hydrogels consist of two 
interpenetrating, crosslinked polymer networks. Double network hydrogels are 
most commonly fabricated by crosslinking each network sequentially: the first 
polymer is crosslinked to produce a single network hydrogel; it is then swelled 
in a solution of the second polymer, followed by crosslinking of the second 
network. Most double networks are produced from synthetic polymers, and by 
carefully selecting materials with appropriate properties, along with 
concentrations and crosslink densities, hydrogels with failure strengths 
approaching those of rubbers can be produced (Figure 8.2) [83]. Although 
double-network hydrogels were not studied in this thesis, the combination of 
Gel-MA and HA-MA leads naturally to the question of whether they can be 
used to form double network hydrogels. One of the key requirements for 
formation is that the second polymer must be small enough to diffuse into and 
throughout the first network, at a concentration high enough for the second 
network to be formed. The high molecular weight of HA-MA would likely 
necessitate that it is used as the first network, and Gel-MA is used as the second. 
This technique may also offer biological advantages, since encapsulated cells 
would be expected to have more exposure and contact with the first network 
(HA-MA), which may further improve cell differentiation compared to mixtures 
of Gel-MA and HA-MA 
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Figure 8.2: Fracture energy and modulus of common groups of biomaterials, 
displaying the soft and weak properties typical of hydrogels (from [81]).  
A similar approach was recently reported by Shin et al [124], who formed a first 
network from gellan-methacrylate, followed by swelling for 2 days in 5-20% 
Gel-MA, which was crosslinked to form the second network. Single network 
Gel-MA hydrogels formed from 20% Gel-MA had a swollen polymer content of 
approximately 10% and a failure stress of approximately 3 MPa. In contrast, 
double network hydrogels produced using 0.5% gellan-methacrylate and 20% 
Gel-MA had a swollen polymer content of approximately 15%, and the failure 
stress increased to nearly 7 MPa. Interestingly, the failure strains were 
comparable for the single and double network gels, whereas typically failure 
strains are higher in double network hydrogels. This leads to uncertainty over 
whether the double network structure provides any real additional benefit over 
simply mixing the two components in one solution, and performing a single 
crosslinking step, which was not tested in this study [124]. 
When interpreting the results of this thesis, in particular the significant impact 
that a relatively small proportion of HA-MA can have, it is appropriate to ask 
what the structure of the Gel-MA/HA-MA hydrogels is on a micro-scale. There 
is some indirect evidence from experimental observations that suggests there 
may be more to the microstructure than a simple, homogeneously inter-
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crosslinked mixture. Firstly, the two polymers, gelatin and hyaluronic acid, are 
functionalised with slightly different photocrosslinkable groups. Gelatin is 
predominantly functionalised with methacrylamide groups, while hyaluronic 
acid is functionalised with more reactive methacrylate groups. Thus during the 
early stages of photo-crosslinking, methacrylalte groups may react more readily 
than methacrylamide groups. Secondly, the hydrogels mixtures studied here 
were predominantly Gel-MA, with relatively small quantities of HA-MA. For 
example, in Chapter 6, two of the experimental groups were 10% Gel-MA and 
9.75% Gel-MA with 0.25% HA-MA. The hydrogel constructs made from 10% 
Gel-MA are very rapidly and completely digested by proteinase K – they are 
typically solubilised in approximately 1 hour. In the Gel-MA/HA-MA mixture, 
there is an approximately 40-fold mass excess of Gel-MA over HA-MA. If we 
assume that they are crosslinked with no preference or distinction between the 
two polymers, then we would expect that due to this significant excess of Gel-
MA, that relatively few methacyralate groups on HA-MA would be crosslinked 
to other methacrylate groups on HA-MA. As such, when the Gel-MA 
component is removed via proteinase digestion, we would expect the entire 
network to fall apart. Contrary to this expectation, this does not happen; when 
the Gel-MA component of hydrogels formed from 9.75% Gel-MA and 0.25% 
HA-MA is digested away, a much softer, yet stable hydrogel remains. The 
presence of this hydrogel after digestion indicates that perhaps the methacrylate 
groups on hyaluronic acid do preferentially crosslink with other methacrylate 
groups, resulting in a network of crosslinked hyaluronic acid that is in part 
independent from the Gel-MA network. 
If this were the case, then the structure of hydrogels formed from mixtures of 
Gel-MA and HA-MA would show some elements of double network hydrogels, 
with two interpenetrating, partly independently crosslinked networks. This 
would very likely have major implications for cell encapsulation, and potentially 
help interpret an otherwise unexplained finding from Chapter 5: the impact that 
a small amount of HA-MA had on chondrocyte phenotype, and in particular, 
cell morphology. In Chapter 5, chondrocytes had remarkably different 
morphologies when encapsulated in 10% Gel-MA compared to 9.5% Gel-MA 
with 0.5% HA-MA. In the mixture of Gel-MA and HA-MA, why should the 
presence of 0.5% HA-MA prevent the chondrocytes and attaching to Gel-MA, 
as they do in 10% Gel-MA hydrogels, when Gel-MA accounts for 95% of the 
polymer content? Is HA-MA somehow shielding the chondrocytes from Gel-
MA? This question has particular relevance when we consider the hypothesis 
described above on the microstructure of Gel-MA/HA-MA hydrogels. If the 
hypothesis were correct, then, during crosslinking, the more reactive 
 154 
Discussion and future work 
methacrylate groups would crosslink first, forming an initial network of HA-
MA, and thereby encapsulating the chondrocytes in a network of predominantly 
hyaluronic acid. The secondary network of Gel-MA would crosslink next, but 
crosslinking of the Gel-MA network next to chondrocytes would be restricted 
by the exisiting HA-MA network. Thus on a macro scale, the chondrocytes are 
embedded in a hydrogel that contains 95% Gel-MA by mass and only 5% HA-
MA, whereas their pericellular environment, which is critical for cell 
attachment, cell morphology and differention, could actually contain a higher 
proportion of HA-MA. Furthermore, this suggests that the methacrylation of 
hyaluronic acid is critical for its function in the gel, and may help explain why 
we saw no impact on cell differentiation, matrix production or mechanical 
properties when we added unmodified HA to PEG (data not shown) and Gel-
MA hydrogels (Chapter 4).  
Importantly, though the discussion above is not implausible, it is based on 
limited evidence. However given the remarkable impact on cell morphology, 
further studies to characterise the microstructure of the hydrogels are justified. 
8.3  Matrix organisation 
The ECM of cartilage is highly organised over several length scales. At the 
cellular level, the matrix composition and structures depend on the proximity of 
the matrix to cells, ranging from the pericellular matrix to the more distant inter-
territorial matrix. On a larger scale, cartilage tissue is organised into distinct 
zonal structures, with different matrix physicochemical properties and cell 
phenotypes within each zone.  
Spatial organisation  
Controlling the spatial distribution of the ECM produced within a hydrogel is a 
crucial requirement for tissue engineering. In living tissues, the ECM occupies 
the bulk of the space between cells, and in cartilage, the ECM accounts for the 
large majority of the tissue volume. Allowing the cell-secreted matrix to spread 
throughout hydrogel constructs has been a challenge, with matrix typically 
being confined to the pericellular regions. In Chapter 3, Alcian Blue staining 
showed that ECM was well distributed through Gel-MA constructs, concurrent 
with a dramatic increase in stiffness during 3 weeks culture. In Chapter 5, 
however, the stiffness of Gel-MA-only constructs changed much less during 
culture. This difference is most likely caused by differences in the initial 
stiffness of each group of hydrogels, along with differences in the way in which 
they were crosslinked. In Chapter 3, Gel-MA hydrogels were relatively soft on 
day 1 (~1.5 kPa), while in Chapter 5 they were significantly more rigid (~15 
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kPa), in part because the gels in Chapter 3 were exposed to air during 
crosslinking, while those in Chapter 5 were enclosed. This indicates that the 
initial stiffness influences matrix organisation, and probably also 
chondrogenesis. Studies with other hydrogel materials have shown similar 
outcomes using different hydrogels, with better matrix distribution in gels that 
have lower initial crosslinking densities [80, 122]. 
In Chapter 5, the distribution of collagen type II was much better in Gel-MA 
constructs containing HA-MA than in Gel-MA controls. We expect this to be a 
result of the formation of larger pore sizes; a consequence of the lack of mixing 
that Gel-MA and HA-MA display. This represents the most important finding in 
this thesis, and creates the possibility phase for separation to be a design 
specification for biomedical hydrogels. This concept of using phase-separated 
polymer mixtures to enhance ECM distribution, to our knowledge, has not been 
explored elsewhere. 
Zonal organisation and structure 
Recreating the zonal structure of cartilage in engineered cartilage tissue has not 
been displayed thus far, and traditionally it has perhaps been a secondary 
requirement to generating hyaline cartilage as opposed to fibrous tissue. 
Nevertheless, zonal organisation is responsible for a critical part of cartilage 
function, and recreating the zonal organisation is a key goal of next generation 
cartilage therapies. Previous studies have reported that zonal chondrocytes 
respond differently to HA and CS [106], and that these GAGs can guide the 
differentiation of MSCs towards chondrocytes with zonal phenotypes [184]. 
Both superficial and deep zone chondrocytes responded most positively to CS, 
however it was unclear from this report what concentration of CS was used, 
making comparisons difficult to make [106]. Using MSCs, Nguyen et al. 
concluded that 9% PEG hydrogels supplemented with 9% CS and 2% MMP 
degradation sequences were suitable for promoting the superficial zone 
phenotype, while 19% PEG hydrogels with 1% HA were optimal for deep zone 
differentiation [184]. These selections were based on the relative 
expression/production of collagen type II and GAGs, with low GAG content 
and high collagen type II expression being indicative of the superficial 
phenotype, and high GAG content and low collagen type II indicating the deep 
zone phenotype. These metrics are not well established as markers for 
distinguishing between different zones of cartilage, and further evalution is 
required to establish the true zonal phenotype of MSCs in these gels.  
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Based on these reports, in Chapter 5 we isolated and separately encapsulated 
cells from the superficial and middle/deep zones. The inclusion of HA-MA had 
a significant impact on chondrocyte phenotype and matrix production, but the 
responses shown by superficial chondrocytes were closely mirrored by 
middle/deep chondrocytes. This may also be a consequence of the cell source, 
since it remains unclear how much of the true zonal phenotype is retained in 
osteoarthritic cartilage. Hydrogel printing is a promising technology for the 
assembly of zonal structures, but at this stage, the optimal hydrogel 
compositions required to direct zonal differentiation are not yet known. 
8.4  Photocrosslinking mechanisms 
Depending on the chemical moieties used for crosslinking, hydrogels networks 
can either form via step or chain growth. Polymers can be readily functionalised 
with acrylate, methacrylate and methacrylamide functional groups, and as a 
result these functionalities have been commonly used for photocrosslinking in 
the past decade. More recently there has been interest in hydrogels that are 
crosslinked via othorgonal chemical groups, such as thiol-norbonene [274] and 
thiol-(meth)acrylates [222]. These hydrogels are predominantly crosslinked via 
the reaction of thiols to either (meth)acrylate or norbornene, and thus 
polymerisation proceeds via step growth rather than chain growth. Step growth 
hydrogels have emerged as a promising system for the next phase of hydrogel 
research and development, and recent studies suggest that both mechanical 
properties [275] and cell responses, which are particularly relevant for cartilage 
biology [222], may be superior in step polymerised hydrogels.  
To increase crosslinking kinetics, thiol acrylate/norbornene hydrogels are still 
generally crosslinked by UV light in the presence of a photoinitiator, such as 
IC2959, but critically, the role of reactive oxygen species (ROS) is very 
different to (meth)acrylate crosslinking. In aqueous systems containing oxygen, 
the photo-generated radicals react rapidly with oxygen to form ROS. Despite 
being highly reactive, ROS cannot initiate crosslinking of (meth)acrylates, and 
therefore they accumulate and potentially react with cells. This results in a lag 
phase during crosslinking, in which few photo-radicals initiate polymerisation. 
In Chapter 4, this lag phase was found to be approximately 4 minutes in our 
empirical model using Gel-MA hydrogels. The crosslinking mechanism in thiol-
norbornene or thiol-(meth)acrylate systems is somewhat different: 
photogenerated radicals abstract a hydrogel atom from thiol groups, forming 
thiyl radicals, which react with the unsaturated carbon moiety, such as 
(meth)acrylate or norbornene. The key distinction is that ROS can also abstract 
a hydrogen atom from thiol groups, and thus any ROS that are generated are 
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consumed in the crosslinking reaction. This eliminates the oxygen inhibition 
issues for which (meth)acrylate systems are notorious [224], and crucially for 
cell-encapsulation, prevents the accumulation of intracellular ROS.  
Hydrogels that are polymerised via step or chain growth have been compared in 
a number of recent publications [222, 275]. Chain polymerised hydrogels 
contain regions of high and low crosslink densities, and during loading, the 
weak points fracture relatively easily [276]. In contrast, step polymerised 
hydrogels display a higher degree of homogeneity in the network topology, 
leading to more robust mechanical properties [275]. The tensile toughness of 
step polymerised PEG hydrogels were consistently higher than their chain 
polymerised counterparts [275], but it is unclear whether the distinction between 
the network structures formed from step or chain crosslinked PEG hydrogels 
would also apply to Gel-MA. The PEG hydrogels are typically linear polymers 
that are functionalised at each end. In comparison, Gel-MA contains a number 
of crosslinkable domains along each chain, and it is perceivable that the network 
structure resulting from chain polymerised Gel-MA may be significantly 
different to that resulting from chain crosslinked PEG diacrylate. More 
specifically, crosslinked Gel-MA networks may be inherently more 
homogeneous that PEG diacrylate. 
Roberts and Bryant have recently investigated the role of ROS on chondrocytes 
during crosslinking of PEG diacrylate compared to PEG-thiol-norbornene 
(PEG-TNB) [222]. When present in high concentrations, ROS can be involved 
with cell signalling and regulatory pathways, and can have deleterious effects on 
cell structures. In both hydrogels, photocrosslining was achieved by 10 minutes 
exposure to 352 nm light at an intensity of 6 mW/cm2, in the presence 0.05% 
IC2959 [222]. As expected from the differences in crosslinking mechanisms, 
ROS accumulation was greater in the PEG diacylrate hydrogels. More striking, 
though, was the difference in the composition of the matrix secreted by bovine 
chondrocytes in each of the hydrogels over 14 days (Figure 8.3). In both 
degradable and non-degradable gels, the matrix produced in the chain-
polymerised hydrogels stained strongly for collagen type X, a marker of 
hypertrophic differentiation. No collagen type X was detected in the step 
polymerised PEG hydrogels, indicating that crosslinking chemistry had 
remarkable impact on biological outcomes Figure 8.3. The authors suggest that 
the intracellular ROS produced during crosslinking was likely to be responsible 
for the differences, but further studies are required to confirm this hypothesis.  
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Figure 8.3: The role of crosslinking mechanism and reactive oxygen species in 
ECM production by chondrocytes. Immunofluorescence staining of extracellular 
matrix proteins secreted by bovine chondrocytes encapsulated in either chain or step 
crosslinked PEG-based hydrogels. Upper panels: chain crosslinked PEG-DA, or step 
crosslinked PEG-TNB + PEG-SH; lower panels: degradable, chain crosslinked PEG-
LA-DA or degradable, step crosslinked PEG-TNB + PEG-SH. Scalebars represent 
50 µm. Figure from [222]. 
These studies have several implications for the research presented within this 
thesis. Firstly, these studies evaluated hydrogels formed from relatively small 
PEG chains (in the order of 3 – 10 kDa), whereas the hydrogels we have used 
are formed from much larger macromers, some with considerably higher 
viscosity than PEG solutions. In addition, it is difficult to directly compare the 
rate of ROS generation in our hydrogels during crosslinking. We used the same 
concentration of photoinitiator, but since we used a lower intensity (~2.7 
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mW/cm2) and longer wavelength light, we would expect that the rate of radical 
formation would be significantly lower in our system, potentially resulting in 
lower peak ROS concentrations. Finally, the role of ROS in the signalling 
pathways of primary bovine chondrocytes may be substantially different to the 
expanded human chondrocytes evaluated here.  
In light of the accumulation of ROS during IC2959-initiated crosslinking of 
PEG diacrylate hydrogels, along with the extensive deposition of collagen type 
X, perhaps the low crosslinking efficiencies that we have (unintentionally) used 
are beneficial for cell encapsulation. ROS are present in all tissues at some level, 
and are a routine by-product of oxygen metabolism. At low levels they are an 
important element of cell signalling pathways, but at high concentrations can 
cause cell damage, direct ell fate, or even initiate apoptosis. In cartilage, high 
levels of ROS have been shown to disrupt cell signalling, cause inflammation 
and tissue degradation [277] and importantly, can induce hypertrophy [221]. 
Cells possess mechanisms to eliminate ROS, and thus the accumulation is a 
balance between the rate of generation and rate of elimination. Avoiding cell 
damage and apoptosis during cell encapsulation is critical, and thus lower rates 
of radical formation may limit the maximum ROS concentration by allowing 
temporal elimination by cells.  
Recent studies on chain and step polymerised hydrogels highlight possible 
avenues of future research for the hydrogels biomaterials described in this 
thesis. The mechanical properties of Gel-MA/HA-MA hydrogels require more 
comprehensive characterisation, including evaluation of failure strength and 
strain. The potential for step polymerised Gel-MA and HA-MA hydrogels could 
be investigated using thiolated HA, or thiolated crosslinkers, such as 
pentaerythritol tetrakis(3-mercaptopropionate) (available from Simga Alrich). 
Thiolated HA can be purchased (for example Glyosil® from Glycosan), or for 
consistency, prepared by the addition of cysteine to HA using EDAC/NHS 
crosslinking (1-ethyl-3-(3-dimethlaminoproply) carbodiimide (EDAC), and N-
hydroxysuccinimide (NHS)). [223]. Using thiolated HA may result in a 
combination of crosslinking mechanisms, since based on the ratio of Gel-MA to 
HA used in this thesis, we would expect a higher number of methacrylamide 
groups than thiol groups. Following complete conversion of thiols by reaction 
with methacrylamide, crosslinking would proceed solely via methacrylamide 
groups. The addition of a thiolated crosslinker could be used to further promote 
thiol-to-methacrylamide crosslinking.  
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Methacrylamide modified gelatin is the major component of the materials 
investigated in this thesis. Gelatin can alternatively be functionalised with 
methacrylate or acrylamide groups, with differences in the reactivity of the 
resulting polymers [110, 278]. Methacrylate modification has been achieved via 
the conversion of carboxyl groups using a linker molecule, such as 
ethanolamine, followed by conversion of hydroxyls on the linker to 
methacrylate [110]. No advantages of this indirect modification have been 
shown, and it has the distinct disadvantage of being more difficult to produce. A 
detailed comparison of Gel-MA and gelatin-acrylamide has recently been 
published [278]. As one would expect, gelatin-acrylamide derivates are more 
reactive than Gel-MA, thus requiring shorter UV crosslinking times or lower 
concentrations to achieve gels with similar mechanical properties, but with some 
compromise of cell viability. For high degrees of functionalisation, both the 
molecular weight and polydispersity of gelatin-acrylamide increased during 
functionalisation, suggesting some spontaneous crosslinking. Overall, the slight 
increase in reactivity of gelatin-acrylamide does not appear to convey 
substantial benefits compared with Gel-MA.  
8.5   Clinical status and regulatory pressures 
Clinically, cartilage tissue engineering therapies represent a diverse range of 
treatment strategies, rationales and outcomes. For the past two decades, cartilage 
therapies have been at the forefront of translational tissue engineering – albeit 
with mixed success. To avoid the complexity of OA, most therapies target 
patients with a single, symptomatic lesion of the femoral condyle or trochlea, 
with minimal co-morbidities. It is a changing landscape, and competition to gain 
regulatory approval and bring products to market is fierce. Modern cartilage 
tissue regeneration therapies are classified as single or two stage therapies, 
depending on the number of surgeries required. Tables 8.1 and 8.2 summarise 
the current status of single and two stage cartilage tissue therapies.  
Tissue engineering has an indisputable potential to change the healthcare 
industry, but is far from exempt from market and regulatory forces. The rapid 
development in the field in the last decade has, to some degree, outpaced the 
regulatory processes that serve to administer it, and the costs and challenges of 
gaining regulatory approval and widespread uptake have been the downfall of 
many ventures [279]. In this challenging and highly fluid field, the companies 
driving these products are frequently subject to mergers and acquisitions, while 
others, without prior warning, may cease to exist.  
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The regulatory framework in place in Europe has made it the first-choice 
jurisdiction for commercialisation of many regenerative medicine therapies. In 
2007, the EU introduced a category called Advanced Therapy Medicinal 
Products (ATMP) which is the approval required for complex tissue engineered 
products that include cultured cells or tissues. In comparison, products classed 
as medical devices are required to obtain a CE mark, which is a far easier 
approval process. Current cartilage therapies may be classed as an ATMP or 
medical device, depending on whether cells or tissues are used, and the extent to 
which they are manipulated or cultured outside of the body. Expansion of cells 
in vitro, as is common in ACI-based therapies, classes these therapies as 
ATMPs in the EU. The approval process for ATMPs requires rigorous 
evaluation, including clinical trials, and typically takes many years. 
Any therapies with approval prior to the introduction of ATMPs in 2007 were 
required to undergo re-assessment, and in 2009, after extensive testing, the cell-
based cartilage therapy ChondroCelect became the very first ATMP to gain 
approval. In June 2013, Matrix Applied Characterised Autologous Cultured 
Chondrocytes (MACI, Genzyme Europe B.V.) became the second ATMP 
approved for cartilage repair, and also the first combined tissue-engineered 
medicine approved in the European Union. While some therapies, such as 
ChondroCelect and MACI, have been able to meet the stringent requirements, 
others that entered clinical trials, such as Hyalograft C and Cartipatch have been 
withdrawn from the market (summarised in Table 8.1 and Table 8.2).  
In contrast to ATMPs, cell-free therapies are classified as medical devices, and 
as such only require a CE mark for approval. This is a far simpler, cheaper and 
faster regulatory approval process, and is a major advantage for cell-free 
therapies. Chondux and GelrinC use photocrosslinkable hydrogels for cartilage 
repair, but instead of including cells in the therapy, they are intended to be used 
in conjunction with microfracture (Table 8.2).  
8.6  Single vs. two-stage therapies 
Microfracture is the benchmark treatment for isolated cartilage lesions, and 
benefits from being a relatively simple, quick and low cost procedure. In 
contrast, tissue engineering approaches were first envisioned as two-stage 
therapies, in which tissue was harvested during the first surgery, cells were 
isolated and expanded ex vivo, and implanted some weeks later during the 
second surgery [50].  
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Two-stage procedures are expensive and inefficient, and for the most part, have 
failed to conclusively establish that they offer substantial improvements over 
microfracture. A significant portion of the cost of two-stage cartilage treatment 
therapies arises from the need for two surgeries, and the cost of expanding cells 
ex vivo. In Europe, the cost of the leading cell-based cartilage repair therapy, 
ChondroCelect (Tigenix, Belgium), is approximately €30,000. The reduced cost 
and increased efficiency of single-stage therapies have increased the interest and 
research efforts in this area [280]. Clearly, the common element among single 
stage therapies is that the use of expanded autologous chondrocytes has been 
removed. Several strategies to negate this requirement are:  
- Delivering cell-free biomaterials to fill the defect. These can be 
delivered in combination with microfracture, thus providing an artificial 
ECM to allow cell invasion and guide remodelling. 
- Using alternative cell sources, such as allogeneic cells, or autologous 
stem/stromal cells that can be isolated from other tissues, such as bone 
marrow aspirates or adipose tissue. 
- Using techniques to ‘particulate’ cartilage, which can then be 
seeded/incorporated into a biomaterial to fill the lesion. Both autograft 
cartilage (for example CAIS) and allogeneic donor cartilage are being 
investigated (for example DeNovo NT). 
- Rapid digestion protocols for isolating chondrocytes or chondrons from 
autologous cartilage intra-operatively. 
- Combinations of the above strategies, such as rapid digestion of 
chondrocytes, combined with allogeneic stromal cells (for example the 
IMPACT trial [51] – Instant MSC Product accompanying Autologous 
Chondron Transplantation).  
With the exception of microfracture, single-stage cartilage therapies are in the 
early stages of development and testing, so it is too early to tell what clinical 
significance they may have. Another relevant consideration is the relative 
importance of cost versus repair tissue quality. These therapies are substantially 
cheaper than their two-stage counterparts, but if clinical outcomes from single-
stage therapies are inferior to two-stage treatments, what weightings should be 
applied to determine the ‘best’ treatment?  
 
 
 
 163 
Chapter 8 
Table 8.1: Current status of two-stage clinical treatments for cartilage repair.  
Product  Brief description and regulatory status References 
Carticel® a 
Original commercial product for autologous 
chondrocyte implantation. In 1997 it became the first 
ever cell therapy to receive FDA approval.  
[281] 
Chondro- 
Celect® b 
Expanded, autologous chondrocytes, which are 
characterised using proprietry technology and 
inserted into the lesion. The area is sealed with a 
collagen membrane. In October 2009 it became the 
first advanced therapy medicinal product (ATMP) to 
receive EU approval.  
[282, 283] 
MACI c 
Expanded autologous chondrocytes are seeded 
onto a bilayered collagen I/III scaffold (porcine) 
(ACI-Maix, Matricel, Germany). The scaffold is 
trimmed to shape, implanted cell-side down, and 
fixed in the defect using fibrin glue. Approved in the 
EU (June 2013).  
[282] 
Hyalograft® C d 
Expanded autologous chondrocytes seeded onto a 
Hyaff 11 scaffold (esterified hyaluronic acid) and 
pressed into the defect. Withdrawn from European 
market in January 2013, with focus shifting to single 
stage therapy.  
[216] 
NeoCart® e 
Expanded autologous chondrocytes seeded onto a 
bovine collagen type I scaffold, cultured in a high-
pressure bioreactor with perfusion and controlled 
oxygen tension. Multicentre, phase III clinical trial 
(US).  
[284, 285] 
BioCartTM II e 
Autologous chondrocytes expanded with autologous 
serum and FGF2. Cells are seeded onto a 
fibrin/hyaluronic acid matrix. Multicentre, phase II 
clinical trial underway (US and Israel); commercially 
available in Israel. 
[286, 287] 
Cartipatch® f 
Expanded autologous chondrocytes suspended 
within an alginate-agarose hydrogel and implanted. 
Phase III trials (EU) commenced, but development 
of this product has ceased. 
[288, 289] 
CaReS g 
Primary autologous chondrocytes seeded onto a 
collagen type I membrane (rat tail), cultured using 
autologous serum for up to 2 weeks in vitro and 
implanted with fibrin glue. 
[290] 
Novocart® 3D h 
Expanded autologous chondrocytes seeded onto a 
collagen type I-chondroitin sulfate sponge. Phase III 
trial (EU). 
[291, 292] 
aGenzyme Biosurgery, U.S.; bTiGenix, Belgium; cGenzyme Europe B.V.; dAnika 
Therapeutics, US.; eHistogenics, Waltham, MA, USA; fTBF Genie Tissulaire, 
France; gArthro Kinetics, Germany; B Braun-Tetec, Germany.  
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Table 8.2: Current status of single-stage clinical treatments for cartilage repair. 
Product Brief description and regulatory satus References 
Cartilage 
autograft 
implantation 
system (CAIS) a 
Particulated autologous cartilage that is distributed 
onto a PGA-PCL foam (65% PGA, 35% PCL). 
Particulated cartilage is glued with fibrin, and the 
implant is immobilised in the defect with staples. 
Phase III clinical trial (Singapore) vs microfracture. 
[293, 294] 
DeNovo NT b 
Particulated cartilage from a juvenile, allogeneic 
donor, sealed within fibrin glue. Large, multicentre, 
phase IV clinical trial underway (US).  
[227, 295, 
296] 
RevaFlexTM c 
Originally called Neocartilage implant; until recently 
was called DeNovo ET. Allogeneic chondrocytes 
isolated from juvenile donors, seeded at 0.5-1 × 106 
cells/cm2 and cultured for ~50 days in defined 
medium. Neotissue is implanted using fibrin glue. 
Phase III clinical trial (US). 
[225, 297, 
298] 
GelrinC d 
Adjunct to microfracture. Cell-free 
photocrosslinkable hydrogel composed of denatured 
fibrinogen conjugated to polyethylene glycol. Phase 
I/II clinical trial underway (EU and Israel). 
[299, 300] 
Autologous 
Matrix Induced 
Chondrogenesis 
(AMIC®) e 
Adjunct to microfracture. A collagen I/III, cell-free 
matrix (ChondroGide®, Geistlich) stabilised with 
stitches and fibrin glue. Phase II/III clinical trial 
underway (EU). 
[301, 302] 
BST-CarGel f 
Adjunct to microfracture. A thermosensitive 
chitosan-glycerophosphate hydrogel is mixed with 
whole blood (1:3 ratio) and crosslinked in situ. 
Phase III clinical trial (Canada, EU). 
[303, 304] 
ChonduxTM g 
Adjunct to microfracture. A chondroitin sulfate 
adhesive is applied to the microfractured defect, 
which is then filled with a cell-free, 
photocrosslinkable PEG-DA hydrogel containing 
0.5% HA. Clinical trials in EU have been 
prematurely terminated. 
[73, 305] 
RepliCartTM h 
Injection of allogeneic MSCs after reconstruction of 
the anterior cruciate ligament following keen injury. 
Strictly aims to prevent degeneration and onset of 
OA in this at risk group, rather than regenerate 
damaged cartilage. Phase II clinical trials. 
[306, 307] 
VeriCart i 
Double-structured collagen scaffold that can be 
combined with microfracture or seeded with bone 
marrow derived cells. Application underway for CE 
mark in Europe.  
[308, 309] 
CaReS-1S j One-step procedure with the collagen type I matrix used in CaReS. CE mark awarded in EU. [290, 310] 
aDepuy Mitek, MA, USA; bZimmer Orthobiologics, Inc, IN, USA; cISTO 
Technologies, MO, USA; dRegentis Biomaterials, Haifa, Israel; eGeistlich Pharma 
AG, Wolhusen, Switzerland; fPiramal Healthcare; gBiomet Inc, IN, USA; 
hMesoblast; iHistogenics; jArtho Kinetics, Germany. 
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Many clinical trials have shown that symptomatic lesions can be regenerated 
with excellent, hyaline cartilage. However, these outcomes are not consistently 
achieved, and in a large proportion of patients, the outcomes are not dissimilar 
to microfracture. The challenge is to identify and exploit mechanisms that can 
be used to increase the proportion of patients with excellent repair tissue. This 
may be through selecting a subpopulation of patients or indications that are most 
suited for a certain therapy, or through different rehabilitation programs. To this 
end, studies are underway to identify molecular markers and patient 
characteristics that can be used to predict the chance of success prior to surgery 
[311]. Similarly, characterised chondrocyte implantation was shown to be 
superior to microfracture for patients treated within 3 years of injury, while 
outcomes were similar with either treatment for those with delayed treatment (> 
3 years) [312]. These studies aim to identify subpopulations that are particularly 
likely to benefit from the additional expense, risk and time associated with 
cartilage tissue engineering therapies.  
Much remains to be done for cartilage tissue engineering to be adopted as a 
widespread and mainstream therapy. In a recent review of the clinical status of 
cartilage repair, Mollon and co-authors state that “The notion that ACI-like 
procedures produce hyaline-like cartilage in humans remains unsupported by 
high quality clinical research” [313]. This is not through lack of effort – 
cartilage tissue engineering has been the subject of intense basic and 
translational research for two decades – but rather a reflection of the substantial 
challenges facing cartilage repair. Many of these are unique to cartilage, and the 
title of another recent review gives a succinct picture of the progress in 
engineering cartilage compared to bone: “Unlike bone, cartilage regeneration 
remains elusive” [46]. Nevertheless, efforts to regenerate cartilage are steadily 
increasing [314], and it is hoped that increased understanding of biological 
processes and scaffold requirements will deliver meaningful advances in 
cartilage tissue engineering.  
8.7  Clinical application of photocrosslinkable hydrogels  
Recently, two photocrosslinkable hydrogel systems (GelrinC and ChonDuxTM) 
have been applied in clinical cartilage repair. The surgical procedure used is an 
evolution of conventional microfracture; following debridement and perforation 
of the subchondral bone, the void volume is filled with a cell-free hydrogel 
precursor and crosslinked with UV light.  
The research group led by Professor Jennifer Elisseeff has been at the forefront 
of research in photocrosslinkable hydrogels for the past decade, and among 
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other interests, has a strong reputation for cartilage research. Her group’s work 
in this area has focused largely on PEGDA-based hydrogels, in which 
chondrocytes or MSCs are encapsulated. In 2013, Sharma et al., from the 
Elisseeff group, published a study in which PEGDA hydrogels were used 
clinically in combination with microfracture (ChonduxTM) [73]. The PEGDA 
hydrogel was mixed with 5 mg/mL of unmodified 1.2 MDa HA to increase 
viscosity, and thus ease of handling of the precursor solution. Notably, this is 
the same concentration of HA that was used in Chapter 5 (0.5% w/v), but no 
mention is made of the potential biological function of the HA [73], whereas in 
Chapter 5, the addition of methacrylated HA was shown to have a substantial 
impact on chondrocyte phenotype and matrix synthesis and properties. The 
hydrogel was applied in combination with an adhesive based on chondroitin 
sulfate to enhance attachment with the surrounding tissues [315]. Repair was 
evaluated in vitro, in a goat model, and subsequently in 15 human patients. A 
larger clinical trial of ChonDux commenced in Europe, but for unknown reasons 
has been prematurely terminated [305].  
GelrinC is a hydrogel composed of PEGDA that has been covalently bound to 
denatured fibrinogen (‘PEGylated’ fibrinogen) [316]. The material was 
developed primarily by Professor Dror Seliktar, and is being commercialised by 
Regentis Biomaterials. Similarly to ChonduxTM, is crosslinked in situ using UV 
light following conventional microfracture [300]. The gel degrades over 6 – 12 
months, and is replaced with repair tissue. The results 24 months after operation 
were reported at the International Cartilage Repair Society in September 2013, 
and appear promising, with significant improvement in patient-reported metrics 
after 24 months, and continued improvement between 18 and 24 months [317]. 
It is a versatile hydrogel platform, and the degradation kinetics can be tailored 
by altering the amount of fibrinogen. The repair of several tissues, including 
bone, nerve, cartilage and cardiac tissue has been investigated using this 
material, but cartilage repair is the current focus for Regentis Biomaterials.  
It is promising to see photocrosslinked hydrogels being used for clinical 
cartilage repair, since these materials offer meaningful improvements over those 
that are currently commonly used. UV light has been used to crosslink the 
hydrogels in situ, which allows the hydrogel to mold precisely to the shape and 
size of the defect, assuring complete fill and enhancing attachment. However 
this exposes the patients’ tissue to some level of UV radiation, with associated 
safety implications. By using a cell-free hydrogel, the possibility for UV-
induced cell damaged is reduced, and the road to clinical translation is 
significantly simplified. Photocrosslinked hydrogels are estabilishing a presence 
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in clinical cartilage repair in the form of cell-free, hydrogel seals for 
microfracture, but cell-encapsulated hydrogels are still in preclinical 
development, and are subject to considerable additional challenges. 
8.8   Bioprinting 
In Chapter 4 we investigated the potential to print Gel-MA based hydrogel 
structures. Because Gel-MA solutions have a relatively low viscosity, we 
printed Gel-MA in combination with HA to increase viscosity, with and without 
PCL as a support structure. Using these methods, it was possible to print 
constructs with transverse porosity using 20% Gel-MA with HA. Layered 
constructs without porosity could be printed using 10% Gel-MA with HA and a 
PCL support. Recently, the printability of Gel-MA without viscosity enhancers 
or support structures has been demonstrated, using a system that allows a high 
degree of control over printing parameters, such as pressure, temperature, and 
stage speed [112]. The main advantage that this system has over the 
BioScaffolder used in Chapter 4 is that the temperature is controlled right up 
until the point that the gel is dispensed from the needle, giving a much greater 
level of temperature control. In the BioScaffolder, the temperature of the bio-ink 
reservoir in the syringe is maintained by liquid heating/cooling, but the needle is 
exposed to ambient conditions, and the water temperature of the water bath 
fluctuates to a degree and cannot be quickly changed. As the solution flows 
through the needle it cools, and has a tendency to gel and block the needle, 
causing uneven flow rates. To prevent blockages, the temperature of the 
reservoir is increased to compensate for cooling in the needle, thus precise 
control of the temperature at the needle exit point is difficult to achieve. The 
study by Billiet et al. [112] demonstrates the importance of precise control over 
multiple parameters for high resolution hydrogel printing.  
Hydrogels have a number of properties that make them particularly suited for 
the fabrication of bioprinted cartilage constructs. They allow cells to be 
encapsulated in a native three-dimensional state, are highly cell compatible, and 
generally the surfaces have a very low friction coefficient. However, as 
previously discussed, the mechanical properties are a limitation. Bioprinting 
offers possibilities to utilise the low friction and cell-compatible properties of 
hydrogels, while using stronger and stiffer materials such as PCL to provide 
mechanical reinforcement [213]. In Chapter 4, we have printed hybrid structures 
composed of an outer shell of rigid PCL, filled with two layers of hydrogel. In 
this way, the cells can be maintained in a highly hydrated and diffusive 
environment, while the mechanical strength is provided by the PCL shell. Clear 
limitations are that the high friction of the PCL would likely cause unacceptable 
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wear if congruent with opposing cartilage surfaces, and stable integration with 
surrounding tissues may be more challenging with PCL than hydrogels. Ideally 
the PCL support structures would be wholly encompassed by the hydrogel, and 
current research efforts are directed towards developing such materials [318].  
Printed Gel-MA constructs can be crosslinked by UV light and IC2959. As 
previously discussed, this mechanism is subject to oxygen inhibition, and this is 
particularly relevant for printed structures, which have a significantly larger 
surface area to volume ratio. This allows increased diffusion of oxygen into the 
construct, with additional crosslinking inhibition, and potentially 
inhomogeneous crosslinking. The use of thiol-containing crosslinkers may offer 
additional advantages overcoming oxygen inhibition in the crosslinking of 
printed structures.  
8.9  Limitations 
The primary goal of this thesis is to make a contribution to the field of cartilage 
tissue engineering research. In carrying out the studies described within, we 
have also gained some insight into hydrogel properties, chondrocyte biology, 
and cell-material interactions, as assessed using in vitro culture models. In vitro 
studies allow materials to be compared in controlled and consistent conditions, 
and enable more detailed evaluations than are possible in vivo. They are a 
valuable, if not essential step in the development of tissue engineered therapies, 
and by increasing the level of evidence used to select materials for in vivo 
studies and clinical therapies, in vitro models should contribute to improved 
clinical outcomes in the future. On the down side, the full complexity and 
challenges of cartilage tissue engineering cannot be entirely recreated in an in 
vitro environment. In particular, the in vitro models used here completely 
remove the immune response of the patient, which is a critical factor for success 
of tissue engineering therapies. Thus, although it was outside of the scope of this 
project, the in vitro studies described within must be complemented with 
subsequent in vivo repair studies before conclusions can be drawn on the 
suitability of these materials for cartilage tissue engineering. In vivo studies of 
Gel-MA/HA-MA hydrogels for cartilage tissue engineering have begun at 
Utrecht University, and future work using in vivo models will show the true 
potential of the materials discussed in this thesis. 
Biological variation – that is the inherent variability between individuals – is a 
significant limitation of the work described in this thesis. Human chondrocytes 
were sourced from OA patients receiving knee replacements, so the potential for 
donor variation is further increased by taking cells from patients with different 
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stages of OA and potentially different co-morbidities. In Chapters 3 and 5, we 
used a single, different biological donor, and measured the difference in the 
performance of this donor using different hydrogels. This decision was made to 
allow a larger number of hydrogel groups to be included, and the hydrogel 
groups that were identified as the most promising were subsequently 
investigated using a greater number of donors. Pleasingly, good consistency was 
observed between the four donors used in Chapter 6. 
IC2959 is the most widely used photoinitiator for cell encapsulation, and was 
used in all studies in this thesis. Ultimately, it is likely that despite its extensive 
use, IC2959 is not an ideal photoinitiator for cell-encapsulation. Developing and 
evaluating water-soluble photoinitiators for biomedical use is an active research 
area in its own right. In 1991, a lithium acylphosphinate salt (LAP) was shown 
to act as a water soluble, visible light photoinitiator, but no mention was initially 
made of its potential application for cell-encapsulation [319]. More recently, 
there has been renewed interest in this photoinitiator from tissue engineering 
research groups, who have demonstrated cell encapsulation using visible light, 
with good cytocompatibility [220]. VA-086 has also shown advantages to 
IC2959 for crosslinking alginate methacrylate, and is another photoinitiator that 
is of increasing interest in this field. Fortunately, we expect that as improved 
photoinitiators become increasingly available, they should be compatible with 
Gel-MA based hydrogels.  
According to the manufacturer, the output from the UVP longwave crosslinker 
is centred about 365 nm, which lies right at the edge absorption region of 
IC2959 (Figure 8.4). We therefore expect the crosslinking efficiency at this 
wavelength to be very low, and the UV exposure required to attain a given 
degree of crosslinking is likely to be much higher than the exposure required at 
lower wavelengths. While this may have been beneficial in some aspects, such 
as lower rates of ROS formation, ultimately minimising UV exposure is going 
to be highly advantageous. 
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Figure 8.4: Absorption spectrum of Irgacure 2959 at 0.1 mg/mL (A), and 
absorption between 340 - 390 nm for concentrations of 0.1 – 5 mg/mL (B).  
The production of GAGs is a hallmark of chondrocytes, and for over two 
decades, staining and quantifying GAG production has been a fundamental tool 
for cartilage regeneration and tissue engineering research. Significantly, in this 
thesis GAG production did not correlate well with chondrogenesis in several 
instances. We believe that this is an important limitation of ‘total GAG’ 
measurements, which may be especially relevant when using chondrocytes. 
Several ratios have been suggested as being indicative of the differentiation state 
of chondrocytes, namely the ratio of collagen type II to type I expression [116], 
and the ratio of aggrecan to versican expression [320]. In the latter, aggrecan is 
expressed in differentiated chondrocytes, while versican is expressed in 
dedifferentiated chondrocytes. Notably, however, these are both GAG-rich 
proteoglycans. Therefore quantifying the total amount of GAGs produced in 
constructs does not necessarily provide any insight into the differentiation state 
of the chondrocytes, in the same way that quantifying total collagen content 
cannot. Interestingly, total collagen content assays have fallen out of use with 
many cartilage research groups, but GAG measurements are still common. The 
difference may lie in an easily overlooked detail: quantitative GAG assays using 
DMMB are simple, fast, sensitive and cheap, but total collagen (hydroxyproline) 
assays are very time consuming and labour intensive. 
In this thesis we have primarily used hydrogels based on gelatin, thus the 
hydroxyproline assay is not a feasible method for quantifying total collagen 
content. Nevertheless, collagen quantification is important for cartilage tissue 
engineering, since whereas GAG content of tissue-engineered cartilage often 
approaches the level in native cartilage, the collagen content is often 
substantially lower [47]. In particular, since it is far more valuable to know 
collagen type II content rather than total collagen, future studies should aim to 
quantify collagen type II in the constructs, for example using enzyme linked 
immunosorbent assays (ELISA).  
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In Chapter 3 it was evident that dedifferentiated chondrocytes produce 
substantial amounts of GAGs in Gel-MA. From these results, we concluded that 
the GAG assay and Alcian Blue were acceptable for measuring how much 
matrix was produced, which is important, but does not reflect the matrix quality. 
This trend was recently observed in a study comparing two different PEG 
hydrogels. The hydrogel group with the higher GAG content showed 
significantly less staining for aggrecan, and the overall tissue quality appeared 
lower in this group [222]. These results demonstrate the clear limitation of GAG 
measurements, and highlight the importance of combining these measurements 
with more reliable indicators of differentiation state – such as 
immunohistochemistry or gene expression.  
From a practical perspective, experience is important with Gel-MA hydrogels. 
Gel-MA is sensitive to temperature, light, and enzymatic degradation, and thus 
handling can influence gel properties. For cell culture, it is important to make 
every effort to standardise procedures and handling. This is further complicated 
by the addition of other components, such as HA-MA, which appear to alter the 
kinetics and nature of the temperature sensitivity – mixtures of Gel-MA and 
HA-MA, for example, form thermal gels more rapidly than Gel-MA solutions 
alone. Furthermore, stability and sterility are practical challenges for using 
polymers in cell culture. HA-MA has limited stability, even when dried and 
stored at low temperatures, and so should be used as soon as practicable after 
functionalisation. Maintaining the sterility of HA-MA is also a practical 
challenge when used on a small, laboratory scale. Conventional approaches for 
sterilising cell culture materials, such as autoclaving, short wave UV exposure 
and gamma irradiation are not compatible with HA-MA solutions. For low 
concentrations (<~1%), filter sterilisation is possible, however for higher 
concentrations, the high visosity makes filtration difficult.  
Finally, it is worth re-iterating the two cell subpopulations that emerge on Gel-
MA based constructs. Cells at the surface of the hydrogel readily attached and 
spread, as they do on two dimentional surfaces and adopt a dedifferentiated 
phenotype. This is not ideal for cartilage tissue engineering, and complicates the 
interpretation of some results, such as gene expression, in which these two 
subpopulations are pooled. It remains to be seen whether this is phenomenon 
would be observed for a hydrogel crosslinked within a cartilage defect, in which 
case only the articulating surface would not be adjacent to other structures. 
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8.10 Future directions  
Further research is required to advance our understanding of the hydrogels used 
in this thesis, and progress their application towards cartilage repair.  
In vitro studies should assess the impact that UV exposure and 
photocrosslinking has on encapsulated cells, particularly in light of the recent 
comparison of photocrosslinked PEG hydrogels [222]. Following this finding, 
possibilities to enhance chondrogenic outcomes should be studied, including the 
use of thiolated HA or thiol crosslinkers, and/or other methods to reduce ROS 
during crosslinking, such as mixing endogenous superoxide dismutase into the 
hydrogel precursor solution.  
The optimum conditions for photocrosslinking Gel-MA based hydrogels should 
be investigated in detail. For example, it remains to be shown whether it is 
preferable to use a shorter period exposure to 350 nm light, or a longer period of 
exposure to 360 nm light. Such studies should use the exposure period required 
to produce gels with similar stiffness, which would be indicative of similar 
degrees of crosslinking.  
The prolonged delivery of growth factors is a common feature of in vitro 
studies, especially in cartilage, and of course is not possible in clinical 
situations. Ideally, the growth factor would be immobilised within the defect, 
and continue guiding regeneration over the weeks following implantation. As a 
consequence of its negative charge, heparin displays a high affinity for many 
growth factors, and has been incorporated into various hydrogels for the 
retention and gradual release of growth factors, including FGF-2, VEGF, TGF-
β1 and BMP-2, among others [321]. In preliminary studies, we have 
functionalised Gel-MA hydrogels with photocrosslinkable heparin, and shown 
that the heparin remains stably bound in the gel. Using this platform, co-
encapsulation of cells with growth factors should be investigated to determine 
whether the need for continual growth factor delivery can be reduced.  
MSCs are a potential cell source for cartilage regeneration, and can be used in 
combination with or instead of chondrocytes. Directing the differentiation of 
MSCs towards a chondrogenic lineage is a prerequisite for their use, and is 
commonly achieved using growth factors. It would be interesting to evaluate the 
differentiation of MSCs encapsulated in Gel-MA – HA-MA hydrogels. Previous 
work has shown that when MSCs are encapsulated in Gel-MA and implanted 
subcutaneously in mice, they attach, spread and undergo osteogenic 
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differentiation [322], so the potential for HA-MA to promote chondrogenic 
rather than osteogenic differentiation would be an interesting line of research.  
Thorough in vivo studies with these hydrogels will be essential for assessing the 
true potential of these materials to be used in cartilage regeneration. Early 
studies should focus on cell viability, the production of ECM, and critically, 
methods to secure the hydrogels within the defect. Following these pilot studies, 
comparisons with other treatments, such as microfracture, should be 
investigated.  
8.11 Conclusion 
Gel-MA based hydrogels have been identified as potential materials for 
cartilage tissue engineering applications. When used alone, Gel-MA hydrogels 
support significantly more matrix production that other commonly used 
hydrogel systems. Controlling the physical and swelling properties of Gel-MA 
can be achieved through two simple means: adjusting the concentration of the 
precursor solution, or the length of UV exposure. Further, Gel-MA retains its 
temperature sensitivity, allowing printed structures to be formed. The 
incorporation of small quantities of HA-MA and to a much lesser extent, CS-
MA, markedly improves chondrogenesis, matrix production and developed 
mechanical properties. Finally, tissue from cartilage, tendon and meniscus can 
be solubilised, functionalised and incorporated into Gel-MA hydrogels, 
although outcomes for chondrogenesis do not appear to be promising.  
Cartilage tissue engineering is an exciting and dynamic field. Over the past 
decade, it has been at the forefront of clinical tissue engineering and 
regenerative medicine. There is an increasing level of activity across the entire 
field, from molecular studies of cell signalling and differentiation pathways, 
right through to clinical trials and commercial products for cartilage repair. 
Much of the progress in biomaterials for cartilage regeneration has yet to be 
realised in clinical practice, and we expect this to continue to fuel new products 
and techniques in cartilage repair in the coming years. 
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 Summary 
The materials used throughout this thesis are photocrosslinkable hydrogels that 
are based predominantly on photocrosslinkable gelatin, or Gel-MA. In Chapter 
3, Gel-MA hydrogels stood out as the material in which chondrocytes produced 
the most ECM and had the greatest increase in compressive stiffness. These are 
key metrics used to assess tissue-engineered cartilage, and as a consequence, 
Gel-MA became the core component of the hydrogels investigated in this thesis. 
The limited extent of chondrogenic redifferentiation in Gel-MA was a key 
limitation, with chondrocytes appearing to redifferentiate best when 
encapsulated in HA-MA.  
Exploring the properties and versatility of Gel-MA hydrogels was the subject of 
Chapter 4. In this study we showed that the physical properties of Gel-MA 
hydrogels could be varied over a wide range by making simple adjustments to 
the polymer concentration and UV crosslinking time. In addition, physical 
properties were dependent on the temperature at which the UV crosslinking took 
place. This allows the thermosensitivity of gelatin to be used as a means to 
increase the stiffness of covalently crosslinked hydrogels. The potential for Gel-
MA hydrogels to be used as a bioink for printing defined constructs was also 
tested, using a commercially available printing device (BioScaffolder). 
Controlling the temperature is critical for achieving the appropriate rheological 
properties for printing, and this was very challenging with this device. To 
overcome this, the viscosity of the Gel-MA solution was dramatically increased 
by adding HA. This reduced the rate at which Gel-MA flows under gravity, 
allowing more time for the Gel-MA to cool and thereby preserve the geometry 
and architecture of the structure. When Gel-MA/HA mixtures were printed into 
PCL support structures, layered constructs could be printed with a reasonable 
degree of separation between the layers. Finally, the effect of adding 2.4% HA 
on matrix production and viability was investigated using equine chondrocytes, 
although no clear differences were observed with or without HA. 
In Chapter 5 we investigated the impact of functionalising Gel-MA hydrogels 
with two of the most abundant and important GAGs in cartilage, HA and CS. In 
order to achieve stable and lasting incorporation of these GAGs, particularly the 
much smaller CS, they were first modified with methacrylate groups, to produce 
HA-MA and CS-MA. The differences in the impact of HA-MA vs. CS-MA 
could not have been more apparent. HA-MA had a strongly positive influence 
on the production of ECM, the cell morphology and chondrogenic 
differentiation. Most strikingly, HA-MA resulted in substantially improved 
mechanical properties, which was supported by an increased distribution of 
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collagen type II and aggrecan. In comparison, CS-MA had only very minor 
impacts on cell phenotype and matrix production, although much higher 
concentrations of CS-MA could potentially be used with this polymer. 
Chondrocytes from the superficial and mixed middle/deep zones were treated 
separately in this study, but no notable differences were observed between these 
cell subpopulations.  
The development of mechanically strong and functional constructs is of critical 
importance when trying to regenerate a load-bearing tissue, and the findings 
from Chapter 5, in which HA-MA substantially improved the developed 
mechanical properties throughout culture, was the focus of a more detailed 
investigation in Chapter 6. Specifically, we sought to investigate in further detail 
the impact that HA-MA has on the developed mechanical properties, including 
failure strength, compressive modulus, dynamic modulus and equilibrium 
modulus. In addition, we used 0, 0.25, 0.5, 1 or 2% (w/v) HA-MA, and used 
chondrocytes from four different donors to compare donor-to-donor variability. 
Changes in compressive, dynamic and equilibrium modulus all tended to 
increase with culture time and HA-MA concentration. Across all four patients, 
HA-MA resulted in substantial improvements to mechanical properties. For 
example the compressive modulus of constructs with 0% HA-MA increased by 
an average of 37 kPa over 8 weeks culture, while those with 2% HA-MA 
increased by an average of 129 kPa. The failure strength was approximately 
two-fold higher in all groups with HA-MA, but was not dependent on HA-MA 
concentration. Collectively, these results confimed that the addition of HA-MA 
to Gel-MA constructs is a useful way to improve the mechanical functionality of 
the cell-synthesised ECM. 
Producing biomaterials and scaffolds from decellularised tissues is potentially 
an ideal way to recreate a specific cell niche. This has not been investigated 
widely for cartilage applications, and in Chapter 7 we functionalised Gel-MA 
hydrogels with tissue derivatives from three equine tissues: cartilage, meniscus 
and tendon. The tissues were enzymatically digested and decellularised, then 
functionalised to include photocrosslinkable methacrylate and/or 
methacrylamide groups. Functionalising tissue-extracts to allow them to be 
directly covalently crosslinked is a novel approach, and to our knowledge has 
not been demonstrated before. Equine chondrocytes and MSCs were 
encapsulated in hydrogels composed of 8% Gel-MA blended with 2% of either 
of the functionalised cartilage, meniscus or tendon tissue. Although substantial 
improvements in cell responses were not observed, the focus of this study was 
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developing the process for producing the functionalised tissues, and stably 
incorporating these tissue derivatives into hydrogels.  
In summary, this thesis has identified hydrogel materials that are promising for 
cartilage tissue engineering. In particular, blends of photocrosslinkable gelatin 
and hyaluronic acid performed well in in vitro models, with significant 
formation of new ECM and substantial improvements in the developed 
mechanical properties. When either material was used alone, both had 
significant limitations, but together the materials appear very promising.  
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De foto-polymeriseerbare hydrogelen die in dit proefschrift zijn beschreven 
bestaan voornamelijk uit foto-crosslinkbare gelatine, genaamd Gel-MA. In 
Hoofdstuk 3 viel Gel-MA hydrogel op als het materiaal waarin chondrocyten 
een hoge extracellulaire matrix productie toonden die gepaard ging met een 
toename in stijfheid. Dit zijn belangrijke parameters die gebruikt worden om 
gekweekt kraakbeenweefsel te evalueren, met als gevolg dat Gel-MA verder 
onderzocht is als dragermateriaal in dit proefschrift. Echter, de beperkte mate 
van chondrogene redifferentiatie in Gel-MA bleek een belangrijke limitatie, en 
chondrocyten leken beter te redifferentiëren wanneer zij ingekapseld zijn in 
foto-polymeriseerbaar hyaluronzuur (HA-MA). 
Het onderzoeken van de eigenschappen en de veelzijdigheid van Gel-MA 
hydrogelen werd het onderwerp van Hoofdstuk 4. In deze studie hebben we 
aangetoond dat de fysische eigenschappen van Gel-MA hydrogelen sterk 
gevarieerd kunnen worden door simpele aanpassingen aan de 
polymeerconcentratie en UV polymerisatietijd. Bovendien waren de fysische 
eigenschappen afhankelijk van de temperatuur waarop UV crosslinking plaats 
vond. Hierdoor kan de thermosensitiviteit van Gel-MA gebruikt worden als een 
middel om de stijfheid van covalent gecrosslinkte netwerken te verhogen. De 
potentie van Gel-MA hydrogelen om gebruikt te worden als bioinkt voor 
geprinte driedimensionale constructen werd getest met behulp van een 
commercieel verkrijgbare bioprinter (BioScaffolder). Een nauwkeurige controle 
over de printtemperatuur bleek cruciaal om de juiste reologische eigenschappen 
voor printen te verkrijgen, wat erg uitdagend bleek. Door de viscositeit van de 
Gel-MA oplossing sterk te verhogen door de toevoeging van hyaluronzuur (HA) 
kon de printbaarheid sterk worden verbeterd. Deze toevoeging vermindert de 
snelheid waarmee Gel-MA stroomt onder zwaartekracht, waardoor de gel meer 
tijd had om af te koelen, en de geometrie en ordening van de structuur behouden 
konden worden. Door Gel-MA/HA mengsels te printen samen met 
verstevigende PCL netwerken konden gelaagde constructen geprint worden met 
een redelijke mate van scheiding tussen de lagen. Er werden geen duidelijke 
verschillen waargenomen van het toevoegen van 2,4% HA op matrix productie 
en levensvatbaarheid van equine chondrocyten.  
In Hoofdstuk 5 onderzochten we het effect van het toevoegen van twee van de 
meest voorkomende en belangrijke glycosaminoglycanen (GAG’s) in 
kraakbeen, HA en chondroïtinesulfaat (CS), aan Gel-MA hydrogelen. Om 
stabiele en duurzame opname van deze GAG’s in de hydrogel te verkrijgen, 
werden zij eerst gemodificeerd met methacrylaatgroepen (MA), waardoor HA-
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MA en CS-MA ontstonden. HA-MA had een sterk positieve invloed op 
extracellulaire matrix productie, celmorfologie en chondrogene differentiatie. 
Daarnaast resulteerde de toevoeging van HA-MA in aanzienlijk verbeterde 
mechanische eigenschappen van de hydrogel-constructen. Daarentegen had CS-
MA slechts geringe invloed op het fenotype van de cel en op matrix productie. 
Dit werd afzonderlijk onderzocht met chondrocyten uit de oppervlakkige en 
middel/diepe kraakbeenzones, maar er werden desondanks geen 
noemenswaardige verschillen waargenomen in de respons van deze cel 
subpopulaties.  
De ontwikkeling van mechanisch sterke en functionele constructen is van 
cruciaal belang voor de regeneratie van dragende weefsels. De resultaten van 
Hoofdstuk 5, waarin HA-MA de ontwikkelde mechanische eigenschappen sterk 
verbeterde, leidden tot een meer gedetailleerd onderzoek in Hoofdstuk 6. In het 
bijzonder wilden we de impact die HA-MA heeft op de ontwikkelde 
mechanische eigenschappen nader onderzoeken, waaronder de materiaalsterkte, 
compressiemodulus, dynamische modulus en evenwichtsmodulus. Daarnaast 
gebruikten we 0, 0.25, 0.5, 1 of 2% (w/v) HA-MA en chondrocyten van vier 
verschillende donoren om donor-tot-donor variabiliteit te vergelijken. 
Aanpassingen in compressie-, dynamische en evenwichtsmodulus hadden allen 
de neiging om te stijgen met kweektijd en HA-MA concentratie. In de 
experimenten met cellen van alle vier patiënten leidde HA-MA tot een 
aanzienlijke verbetering van de mechanische eigenschappen. De 
compressiemodulus van constructen met 0% HA-MA steeg bijvoorbeeld met 
gemiddeld 37 kPa gedurende 8 weken in kweek, terwijl die met 2% HA-MA 
een stijging lieten zien van gemiddeld 129 kPa. De materiaalsterkte was 
ongeveer twee keer zo hoog van alle groepen met HA-MA, maar was niet 
afhankelijk van de HA-MA concentratie. 
Het produceren van scaffolds gebaseerd op gedecellulariseerd weefsel is 
potentieel een ideale manier om een specifieke celomgeving te creëren. Dit is 
echter slechts in beperkte mate onderzocht voor kraakbeentoepassingen, en in 
Hoofdstuk 7 hebben we daarom Gel-MA gefunctionaliseerd met 
weefselderivaten van drie equine weefsels: kraakbeen, meniscus en pees. De 
weefsels werden enzymatisch gedegradeerd en gedecellulariseerd, en vervolgens 
gefunctionaliseerd met fotocrosslinkbaar methacrylaat- en/of 
methacrylamidegroepen. Het functionaliseren van weefselderivaten om hen in 
staat te stellen covalent te crosslinken is een nieuwe aanpak. Equine 
chondrocyten en mesenchymale stamcellen (MSCs) werden ingebed in 
hydrogelen die bestonden uit 8% Gel-MA gemengd met 2% van het 
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gefunctionaliseerde (en gedecellulariseerde) kraakbeen-, meniscus- of 
peesweefsel. Hoewel aanzienlijke verbeteringen in celreacties niet werden 
waargenomen, was de focus van deze studie om het proces van productie van 
gefunctionaliseerde weefsels en stabiele opname van deze weefselderivaten in 
hydrogelen te ontwikkelen.  
Samenvattend heeft dit proefschrift hydrogel materialen geïdentificeerd die 
veelbelovend zijn voor tissue engineering van kraakbeen. Mengsels van foto-
crosslinkbare gelatine en hyaluronzuur presteerden goed in in vitro modellen, 
met aanzienlijke extracellulaire matrix vorming en forse verbeteringen van de 
mechanische eigenschappen. Beide materialen hadden belangrijke beperkingen 
wanneer ze niet in combinatie gebruikt werden. Echter, samengevoegd lijken de 
materialen veelbelovend. 
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Figure S3.1: Viability of chondrocytes after 4 weeks culture in gel-MA (A), PEG-
MA (B), HA-MA (C) or AL-MA (D) hydrogel constructs. Live cells appear green, 
and dead cells appear red. Scale bars represent 100 μm. 
 
Figure S3.2: Photographs of cell-laden hydrogel constructs on day 1 and day 
21. Intervals represent 1 mm. 
 
Figure S5.1: Morphologies of chondrocytes that were encapsulated (A) or at 
the surface (B) of a G-HA construct, and collagen type I immunofluorescence 
showing strong staining at the edge of a G-HA-CS construct (C). Constructs 
were cultured for 8 weeks, and in A and B, cell membranes were stained using cell 
mask (green) and nuclei were counterstained with DAPI (blue). Scale bars in A and B 
are 50 μm, and C is100 μm.  
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Figure S5.2. Total GAG content at 8 weeks in cell-free hydrogels (A) and 
hydrogel constructs with middle/deep chondrocytes (B). Bars and error bars 
show the means and standard deviations of 4 samples.  
 
Figure S5.3. Cumulative GAG release into culture media from cell-free gels (A), 
and corrected cumulative GAG release from chondrocyte laden constructs (B). 
Corrected values were calculated as the difference between the amount of GAGs 
secreted from cell-laden constructs and cell-free gels. Each data point represents the 
mean of 4 samples.  
 
Figure S5.4. Change in swelling ratios of cell-laden hydrogel constructs during 
8 weeks culture. Groups without a like Roman numeral are statistically different (p < 
0.05).  
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Figure S5.5. EPIC-μCT scans of hydrogel constructs cultured for 2 weeks. The 
scale bar represents 2 mm, and the same scale applies to all panels. The attenuation 
range is 10,000 – 22,000 for all panels. 
 
Figure S5.6. EPIC-μCT scans of hydrogel constructs cultured for 5 weeks. The 
scale bar represents 2 mm, and the same scale applies to all panels. The attenuation 
range is 10,000 – 22,000 in all panels. 
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Figure S5.7. EPIC-μCT scans of hydrogel constructs cultured for 8 weeks. The 
scale bar represents 2 mm, and the same scale applies to all panels. The attenuation 
range is 10,000 – 22,000 in all panels. 
 
Figure S6.1: Photographs of gel precursor solutions at 37 °C and 4 °C. Mixing of 
Gel-MA and HA-MA is temperature dependent, with HA-MA causing much greater 
opacity when the mixtures are cool. 
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Figure S6.2: Proton nuclear magnetic resonance spectra of gelatin and 
hyaluronic acid and their photocrosslinkable derivatives. The appearance of two 
peaks in the region 5.5-6.5 ppm show the addition of unsaturated, photocrosslinkable 
groups. 
  
Figure S6.3: High magnification confocal micrographs of actin structures from 
a 0% HA-MA construct cultured for 28 days. Images were taken from the surface 
of the gel (A and C) or the centre (B). Scalebars represent 100 µm (A), 50 µm (B) or 
10 µm (C). 
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Table S7.1: Names, symbols and primer sequences of selected genes 
for qRT-PCR analysis. For each primer pair, the top sequence denotes 
the forward primer and the bottom sequence the reverse. 
Gene name Symbol Primer sequence 
Collagen type I A1 COL1A1 5’-AGCCAGCAAGATCGAGAACAT-3’ 5’-CGTCTCCATGTTGCAGAAGA-3’ 
Collagen type II A1 COL2A1 5’-GGCAATAGCAGGTTCACGTACA-3’ 5’-CGATAACAGTCTTGCCCCACTT-3’ 
Aggrecan ACAN 5’-AAGACAGGGTCTCGCTGCCCAA-3’ 5-ATGCCGTGCATCACCTCGCA-3’ 
Matrix metalloproteinase-3 MMP-3 5’-TTTTGGCCATCTCTTCCTTCA-3’ 5’-TGTGGATGCCTCTTGGGTATC-3’ 
Matrix Metalloproteinase-13 MMP-13 5’-CAAGGGATCCAGTCTCTCTATGGT-3’ 5’-GGATAAGGAAGGGTCACATTTGTC-3’ 
Matrix Metalloproteinase-14 MMP-14 5’-GGACTGTCCGGAATGAGGATCT-3’ 5’-TTGGAATGCTCAAGGCCCA-3’ 
Hypoxanthine-guanine-
phosphoribosyltransferase 1  
HPRT-1 5’-TGGACAGGACTGAACGGCTTGC-3’ 5’-GCAGGTCAGCAAAGAATTTATAGCCCC-3’ 
Signal recognition particle 14 
kDa SRP-14 
5’-TGCTGGAGAGCGAGCAGTTCCT-3’ 
5’-AGCCCTCCACGGAACCTTTCCT-3’ 
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